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Abstract 
 
Recently a new inhibitor of apoptosis, Golgi anti-apoptotic protein (GAAP), 
was discovered in camelpox virus and in some vaccinia virus (VACV) strains. GAAP 
is non-essential for VACV replication but affects virus virulence, is located in the 
Golgi, inhibits apoptosis and modulates Ca2+ fluxes. The VACV GAAP (vGAAP) 
shows high sequence identity with a previously uncharacterized human protein, 
named human GAAP (hGAAP). GAAPs belong to the Bax inhibitor-1 family and are 
highly conserved among eukaryotes, sharing a similar sequence, length and 
hydrophobicity profile. 
 A yeast system was used to express and purify vGAAP and Arabidopsis 
thaliana GAAP3 (AtGAAP3). Data from patch clamp experiments using reconstituted 
purified protein in artificial lipid bilayers showed that vGAAP and AtGAAP3 allow the 
passage of ions, suggesting that GAAPs might form ion channels or ion exchangers. 
Amino acid sequence alignments of GAAP with other known ion channels or ion 
exchangers allowed the identification of amino acid residues in GAAP that might be 
involved in channel gating or ion selection. These residues were mutated in vGAAP 
and the mutants screened for anti-apoptotic and Ca2+ modulation activity, and 
purified to confirm and further characterize GAAP’s ion channel-like activity. Using 
chemical crosslinking, FRET and cysteine mutagenesis it was shown that GAAPs are 
able to form oligomers in a cysteine-dependent (vGAAP) or cysteine-independent 
(hGAAP) manner.  
Using detachment and attachment assays it was shown that hGAAP 
overexpression is able to increase cell adhesion and, conversely hGAAP knock down 
caused decreased adhesion and an elongated cell phenotype. Using a focal 
adhesion (FA) marker it was observed that the FA turnover after GAAP knockdown is 
reduced.  
Taken together, these results suggest that GAAP modulation of apoptosis 
and cell adhesion may be via its ion channel activity and subsequent modulation of 
Ca2+ fluxes. 
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1.1 Vaccinia virus (VACV) and the poxvirus family 
 The most well known member of the Poxviridae family is the causative agent 
of smallpox, variola virus (VARV). The term smallpox was initially used in the 15th 
century to differentiate it from the so-called “great pox” or syphilis. Smallpox, the 
disease caused by VARV, led to an estimated 300-500 million deaths in the 20th 
century (Fenner, 1993; Mack, 1972). 
 Edward Jenner discovered in 1796 that inoculation with material from a 
cowpox lesion led to immunity against smallpox in humans. The immunization 
process consisted of the inoculation of material from a cowpox virus (CPXV) lesion 
into humans by scarification. Jenner created the term vaccine from the Latin word for 
cow (Vacca) from which the material used for immunizing the patients was extracted. 
In the 20th century it was recognized that the vaccine used to immunize against 
VARV was a different virus and this was called vaccinia virus. The origin of this virus 
remains unknown (Baxby, 1981). VACV is best known as the agent used for 
smallpox vaccination and eradication (Fenner F, 1988). The World Health 
Organization certified the eradication of the disease in 1979. This was possible due 
to the absence of an animal reservoir for VARV, the high level of antigenic similarity 
between VACV and VARV (Macdonald and Downie, 1950), the fact that VARV does 
not establish latent or persistent infections, and because the vaccine was cheap, 
abundant and easy to administrate.  
 Beyond its importance as a smallpox live vaccine, VACV has been used as a 
vaccine vector mainly due to its high immunogenicity, ability to infect a broad range 
of cells and to achieve high expression levels of recombinant antigens in the infected 
cells (Moss et al., 1983; Smith et al., 1983). Successive passages in chicken embryo 
fibroblasts of the chorioallantois virus Ankara strain of VACV led to the creation of a 
highly attenuated VACV strain known as modified vaccinia virus Ankara (MVA). The 
use of this virus as a vaccine vector is currently being tested for diseases such as 
acquired immune deficiency syndrome (AIDS), malaria and tuberculosis (Gomez et 
al., 2008). The fact that MVA replication in most mammalian cells is defective makes 
this a very safe vaccine.  
 The study of the mechanisms used by VACV to replicate and shut down the 
host responses to infection has allowed important discoveries in basic cell biology 
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and immunology. An example of how the study of VACV contributed to our 
understanding of not only virus pathogenesis but also basic physiological processes 
came from the study of the VACV soluble interleukin-1 β (IL-1β) receptors, that can 
block the activity of IL-1β by binding and sequestering this cytokine. VACV prevents 
the febrile response in infected mice, whereas strains that lack the receptor induce 
fever (Alcami and Smith, 1996). This was the first example where the suppression of 
fever by a virus and the molecular mechanism leading to it was described. Another 
more recent example is the finding and study of the human Golgi anti-apoptotic 
protein (hGAAP) due to the discovery of a similar gene in camelpox virus (CMLV) 
(Gubser et al., 2007). 
 
1.1.1 Poxvirus classification 
 VACV is the prototypic member of the Poxviridae, and is the most intensely 
studied virus of this family. Poxviruses are notable for their exclusive cytoplasmic 
replication, large ovoid virion size and large linear double-stranded (ds) 
deoxyribonucleic acid (DNA) genomes (130-360 kilobase pairs), with termini that 
form covalently closed hairpin loops. The Poxviridae is divided into two sub-families 
based on their host range: Entomopoxvirinae, infecting insects, and 
Chordopoxvirinae, infecting vertebrates. The sub-family Chordopoxvirinae includes 
eight genera; Orthopoxvirus, to which VACV belongs, Parapoxvirus, Avipoxvirus, 
Capripoxvirus, Leporipoxvirus, Suipoxvirus, Molluscipoxvirus and Yatapoxvirus. The 
Entomopoxvirinae sub-family consists of 3 genera termed A, B and C.   
 The genome organization, gene content and DNA and protein sequences 
were used to study the phylogenetic relationships of poxviruses (Gubser et al., 
2004). Using these parameters it was shown that the central region of the genome of 
the Chordopoxvirinae has a conserved gene content and arrangement. VACV is 
closely related to CPXV. Also VARV and CMLV clustered together forming a 
subgroup. Horizontal gene acquisition from host cells is likely to be a very common 
event within the poxvirus family because many of the viral genes encode proteins 
with a considerable amino acid similarity and therefore have a similar evolutionary 
origin to those found in their eukaryotic hosts. This process is enabled by the large 
  
             25 
  
capacity of the virion structure to accommodate variable amounts of DNA (Smith and 
Moss, 1983). 
 
1.1.2 Poxvirus and human diseases  
 Other than VARV, the causing agent of smallpox, there are several other 
poxviruses that can infect and cause symptoms in humans. Moluscum contagiosum 
virus is a human-specific pathogen that spreads through direct contact and can 
cause benign flesh-coloured, dome-shaped lesions (Hanson and Diven, 2003). 
Zoonotic transmission of virus such as monkeypox virus and CPXV, which natural 
host is rodents, despite the names of the virus, to humans can cause much more 
severe symptoms, especially in immune-compromised individuals (Czerny et al., 
1991).  
 
1.1.3 VACV life cycle  
 VAVC replication leads to the formation of two different infectious particles, 
the intracellular mature virus (IMV) and the extracellular enveloped virus (EEV), 
(reviewed in Roberts and Smith, 2008). The IMV particle is surrounded by a single 
membrane and does not get released from the cell until lysis, whereas the EEV 
possesses two membranes and is transported and released from the cell prior to cell 
death. EEV particles localised to the cell surface are called cell-associated 
enveloped virus (CEV). 
 The IMV and CEV/EEV forms have different numbers of membranes and they 
present different viral proteins on their surface, this makes these virion forms 
structurally, antigenically and functionally different (Boulter and Appleyard, 1973). 
Both particles play a particular role in VACV dissemination. The CEV and the EEV 
are important for virus spread within a host. CEV can induce the formation of actin 
tails from the cell surface that allows the infection of neighbouring cells and EEV, 
although representing only a small portion of the infectious progeny, are very 
important in virus long-range dissemination (Payne and Kristensson, 1985; Smith et 
al., 2002). 
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1.1.3.1 Entry 
 The existence of two structurally different types of VACV virus particles (EEV 
and IMV) makes virus entry complex. The cell receptor for both VACV EEV and IMV 
particles remains unknown. It is believed that VACV IMV particles fuse their 
membrane with the host cell plasma membrane in a pH-independent manner (Carter 
et al., 2005) or with endocytic vesicles after endocytosis that is enhanced by low pH 
(Townsley and Moss, 2007). One of the mechanisms by which EEV particles get 
access to the cytosol relies on the EEV outer membrane disruption upon contact with 
the cell surface. This reveals an IMV particle that can now enter through membrane 
fusion or endocytosis (Law et al., 2006). It was also shown recently that EEV 
particles can enter the cell through micropinocitosis followed by an exposure to low 
pH in endocytic vacuoles that is necessary to disrupt the outer membrane. This 
results in exposure of the inner membrane that can then fuse with the vacuolar 
membrane and release the virus core into the cytosol (Schmidt et al., 2011). 
 
1.1.3.2 Morphogenesis 
 After the initial removal of the IMV or EEV membranes, the virus core, which 
contains viral structural proteins, viral genome and viral transcription enzymes, is 
released into the cytosol. This structure is then transported on microtubules close to 
the perinuclear region in a process that depends on core surface proteins (Carter et 
al., 2003). Partial uncoating of the genomic DNA allows transcription or early 
messenger ribonucleic acids (mRNAs) by the virus-associated DNA-dependent RNA 
polymerase. Viral factories form in the cytosol, where the viral genome is replicated 
and new virions are assembled.  
 The VACV genome encodes approximately 200 genes, these are transcribed 
by the virus-encoded RNA polymerase. Around half of these genes are expressed 
early during infection and are involved in processes such as viral DNA replication, 
deviating the cellular machinery to the virus advantage and in escaping the host cell 
immune response to infection. Some intermediate genes encode regulatory proteins 
(transcription factors) that trigger late gene transcription. Late genes encode most of 
the structural virion proteins and enzymes that must be packed in the virion to allow 
initiation of transcription in the next infected cell (reviewed in Broyles (2003)). 
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 A crescent-shaped lipid structure wraps the new virion cores forming 
immature virions. After proteolytic cleavage of core proteins the characteristic brick-
shaped IMV is formed (Moss and Rosenblum, 1973). A small portion of IMV particles 
are transported in microtubules away from viral factories (EEV) and wrapped in a 
double membrane, derived from either endosomal (Tooze et al., 1993) or tran-Golgi 
cisterna (Hiller and Weber, 1985), forming an intracellular enveloped virus (IEV). 
Virions are transported to the cell surface in an A36 dependent mechanism (Ward 
and Moss, 2001). After fusion with the cell membrane a CEV particle is exposed at 
the cell surface. A36 then triggers actin polymerization (Frischknecht et al., 1999) 
leading to the formation of an actin tail that pushes the viral particle away from the 
infected cell. This mechanism relies on A36-mediated recruitment of the non-catalytic 
region of tyrosine kinase adaptor proteins (NCK) and growth factor receptor-bound 
protein 2 (GRB2) (Scaplehorn et al., 2002) which in turn can recruit neuronal 
Wiskott–Aldrich Syndrome protein (N-WASP) and WASP- interacting protein 
(Moreau et al., 2000) to stimulate actin-related proteins (ARP) 2 and 3-mediated 
actin polymerization. Recently a novel VACV super-infection inhibition mechanism 
linked to actin tail formation was described. It was found that the early viral proteins 
A36 and A33 are expressed early on the surface of infected cells and can repel some 
incoming EEV virions by triggering the formation of new actin tails (Doceul et al., 
2010). Using this strategy the virus is able to “bounce” on the surface of infected cells 
until it finds a non-infected cell where no actin tail formation will be induced allowing 
the virus to enter the cell.  
 
1.1.4 Genome structure 
 Poxviruses have dsDNA genomes that contain tightly packed genes with no 
introns and little non-coding DNA. The two ends of the genome contain inverted 
terminal repeats and the two strands of DNA are covalently linked to produce hairpin 
termini (Baroudy et al., 1982). Genes tend to be organized in blocks that are 
transcribed in the same direction, possibly to facilitate mRNA synthesis or to prevent 
formation of double stranded RNA. The overall genome structure of the 
Chordopoxviridae subfamily members can be divided in two regions, (i) a central 
portion, where a core of around 90 essential genes involved in replication, 
transcription and morphogenesis are found and (ii) the end portions of the genome, 
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where nonessential genes are located, these are involved in controlling the host’s 
responses to infection (Gubser and Smith, 2002). Although most of the genes 
located at the terminal regions are classified as nonessential for replication in cell 
culture, most of them play an important role in host range and/or virulence. 
 
1.1.5 Genome replication 
 One of the unique features of all poxviruses is the ability to replicate the DNA 
genome in the host cell cytosol. The first infectious viral particles are produced 
around 8 h post-infection (Salzman, 1960). In order to do this all poxviruses encode 
their own DNA polymerase and a series of other enzymes directly or indirectly 
involved in DNA replication such as thymidine kinase, thymidylate kinase, 
ribonucleotide redutase, DNA ligase and a DNA topoisomerase (Moss, 2007).  
 The most generally accepted model for poxvirus DNA replication is the rolling 
hairpin strand displacement mechanism (Tattersall and Ward, 1976). According to 
this model, a nick is introduced within the terminal 200 base pairs (bp) of the genome 
providing the 3’ end to prime the replication complex. The newly synthesised DNA 
strand folds back on itself allowing the rest of the genome to be replicated.  
 
 
1.2 Apoptosis 
 Programmed cell death, also known as apoptosis, is a conserved process 
used by all multicellular organisms to dispose of unnecessary, old or potentially 
dangerous cells. It is essential for the maintenance of tissue homeostasis, the 
shaping of the immune repertoire, termination of immune responses, embryo 
development and as an innate defence against infections and cancer (reviewed in 
Hengartner (2000)). To achieve this, mammalian cells use a highly regulated and 
conserved process that can be triggered by several different mechanisms (Figure 
1.1) such as: (i) the intrinsic pathway, also known as the mitochondrial pathway 
(Cory and Adams, 2002), (ii) the extrinsic pathway, better known as the death 
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receptor pathway (Boldin et al., 1996; Muzio et al., 1996), (iii) the caspase-2-
dependent pathway (Lassus et al., 2002) or (iv) the caspase independent, 
perforin/Granzymea (GrA) mediated pathway (Beresford et al., 2001).  
 The death receptor pathway is triggered by death receptors at the cell 
surface, such as Fas and tumour necrosis factor receptor 1 (TNFR1) binding their 
ligands TNF and Fas ligand, and initiating a signalling pathway that eventually leads 
to caspase 8 activation (Boldin et al., 1996; Muzio et al., 1996). The intrinsic pathway 
is activated in response to internal insults such as DNA damage, endoplasmic 
reticulum (ER) stress or virus infection. Type one cells can activate pro-caspase 3 
directly in a mitochondrion-independent manner. In type two cells, both pathways 
converge at the mitochondrion often through the activation of a pro-apoptotic 
member of the B cell lymphoma 2 protein (Bcl-2) family (Cory and Adams, 2002). 
This leads to recruitment of pro and anti-apoptotic proteins to the mitochondrion 
outer membrane where they compete to regulate and activate catabolic hydrolases 
(mainly caspases and nucleases) (Schmidt et al., 2011). If the cell commits to 
undergo apoptosis, mitochondrial membrane permeabilization (MMP) will occur and 
cytochrome c (cyt c), second activator of caspases (Smac), pro-caspases and 
apoptosis inducing-factor (AIF) (Susin et al., 1996) are released from the 
mitochondria into the cytosol. Cyt c released from the mitochondrion associates with 
the apoptotic protease-activating factor 1 (Apaf 1) and with caspase 9 to form the 
apoptosome (Li et al., 1997). Pro-caspases and Smac (Du et al., 2000) will activate 
effector caspases and AIF will activate a DNase located in the nucleus. This process 
is also regulated by inhibitors of caspases that are themselves negatively regulated 
by Smac and Omi (Hegde et al., 2002). The caspase-2-dependent pathway is 
triggered by DNA damage and leads to cyt c release and apoptosome formation, 
although the mechanism by which this happens is not fully understood (Lassus et al., 
2002; Robertson et al., 2002).  
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Figure 1.1 - Apoptosis pathways in mammalian cells. The diagram represents the main four different signalling pathways that can lead 
to apoptosis execution in mammalian cells. GAAP anti-apoptotic activity prevents apoptosis at the level of or upstream of pro-caspase 8 
activation, protecting from both intrinsic and extrinsic induced apoptosis. Adapted from Orrenius et al. (2003). 
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 All these process lead to effector pro-caspase 3 activation that, together with 
caspases 6 and 7 are responsible for most of the death substrate cleavage. These 
include essential cell components such as cytoskeletal proteins, or act indirectly by 
activating other enzymes such as nucleases. This leads to the characteristically 
morphological changes that occur during apoptosis such as cell shrinking and blebbing.  
 The serine protease GrA, mediates a pathway that can trigger apoptosis in a 
caspase-independent manner (Beresford et al., 2001; Fan et al., 2003). Perforin-
mediated pores allow GrA to enter the cell and to induce the cleavage of some 
elements of the ER SET complex such as SET (a Granzyme A-Activated 
Deoxyribonuclease (GAAD) inhibitor), HM62 and Ape1. Upon cleavage of these 
elements GAAD is released, activated and translocated to the nucleus where it can 
generate single stranded DNA (ssDNA) nicks that are known to lead to an apoptotic 
cell morphology (Fan et al., 2003). 
 A good understanding of the molecular mechanisms that regulate apoptosis is 
essential because it is known to be a central factor in prominent diseases such as 
cancer, where cell resistant to apoptosis is increased (Hanahan and Weinberg, 2000), 
and neurodegenerative disorders (Fadeel et al., 1999; Orrenius et al., 2003), in which 
neurons undergo unwanted apoptosis (Mattson, 2000).  
 During most viral infections, control of host cell death by the virus is essential to 
allow the completion of the virus life cycle (Tschopp et al., 1998). In many cases 
apoptosis is a major host anti-viral response because it is one of the first defence 
mechanisms used to eliminate infected cells in multicellular organisms (Hengartner, 
2000). Infected apoptotic cells display an array of characteristic features that target 
them for removal by specialised immune effector cells such as local nonprofessional 
phagocytes or specialized phagocytes such as macrophages (Savill et al., 2002), 
helping to control infection.  
 
1.2.1 The Golgi and ER in apoptosis  
 Several organelles are able to sense stressful or pathogenic alterations and to 
either adapt to such alterations or initiate pro-apoptotic signals that may lead to cell 
death. Although stress sensors have not been found for all organelles it is likely that 
most will be equipped with such sensing elements that can detect stresses related to 
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each organelle function and structure (Hicks and Machamer, 2005). The ER is a major 
site for folding and modification of transmembrane and secreted protein. Accumulation 
of unfolded or misfolded proteins and depletion of ER lumenal Ca2+ can trigger specific 
stress responses such as the unfolded protein response (UPR) (described in detail in 
1.4.4.1) (Ron and Walter, 2007) that lead to either increased ER folding capacity or, if 
the stress persists for a long period, to cell death by apoptosis.  
 The Golgi apparatus was discovered over 100 years ago and is a very dynamic 
structure involved in the sorting, processing (glycosylation, sulphation and 
phosphorylation) and transport of both transmembrane and secreted proteins and of 
lipids from the ER to the plasma membrane and other destinations (reviewed in Glick 
and Nakano (2009)). Although the textbook structure of the Golgi apparatus consists of 
several polarized (cis and trans sides) stacked flattened cisternae membranes, the 
Golgi manifests a variety of morphologies in different cell types. The existence of Golgi 
stress sensors has not been proven but some evidences point to the importance of this 
organelle in apoptosis. The inhibition of Golgi to ER traffic is known to cause the Golgi 
to collapse back into the ER and (Dinter and Berger, 1998) in fact the maintenance of 
the Golgi apparatus structure appears to be dependent on the correct balance between 
inward and outward membrane traffic (Hicks and Machamer, 2005). Together with the 
fact that inhibition of protein glycosylation, caused by swainsonine (Goss et al., 1995), 
is able to trigger cell death, these observations support the hypothesis that the Golgi is 
a stress sensor. There are several local damage responses from the Golgi that can 
lead to apoptosis: focal initiator caspase-2 activation can lead to caspase cascade 
activation (Mancini et al., 2000), the release of Fas receptor from the Golgi membrane 
to the plasma membrane in response to p53 activation (Bennett et al., 1998) and 
activation of Ganglioside (GD3) synthase that converts ceramide in GD3, which goes 
into the mitochondrion and can induce MMP (Rippo et al., 2000).  
 
1.2.2 Poxvirus inhibition of apoptosis 
 Induction of apoptosis by immune effector cells is one of the most effective 
mechanisms by which the host controls and clears virus-infected cells (Russell and 
Ley, 2002). Most viruses have evolved strategies to control the host innate and 
adaptive immune responses and programmed cell death to insure an efficient viral 
replication (Benedict et al., 2002; Hay and Kannourakis, 2002).  
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 In response to the selective pressure initiated by the host immune system, 
many viruses, including poxviruses, developed a large array of strategies to avoid the 
host anti-viral responses including inhibition of apoptosis (Taylor and Barry, 2006). The 
repertoire of poxvirus strategies to inhibit apoptosis can be divided into two categories: 
neutralization of extracellular signals or manipulation of the cell death pathways within 
the cell.  
 Examples of strategies used by poxviruses to neutralize extracellular death 
signals include major histocompatibility complex I (MHC I) downregulation and death 
receptors decoys. A mechanism used by the host to identify infected cells involves the 
display of viral antigens associated with the MHC I on the cell surface that are detected 
by CD8+ cytotoxic T lymphocytes. These can then target the infected cell for apoptosis 
by the activation of death receptors or by delivery of pro-apoptotic proteases (Edwards 
et al., 1999). The myxomavirus ER resident leukemia-associated protein is able to 
downregulate the levels of MHC I at the cell surface of myxoma virus infected tissues 
(Guerin et al., 2002). Viral production of secreted cytokine receptors or binding proteins 
is a very recurrent anti-apoptotic strategy in the poxvirus family. The first poxvirus TNF 
decoy, M-T2, was discovered in myxoma virus (Smith et al., 1990). This protein acts by 
binding TNF thereby inhibiting its binding to the cellular TNFR, preventing activation of 
the downstream signalling cascade. VACV protein cytokine response modifier E 
(CrmE) is also a membrane bound TNFR homolog that can sequester TNF and has 
been shown to contribute to virus virulence in a murine model (Reading et al., 2002). 
CPV encodes three TNFRs (CrmB, CrmC and CrmD), the equivalent genes to CrmB 
and CrmC in VACV (Alcami et al., 1999). 
 Proteins such as cytokine response modifier A (CrmA), or the VACV equivalent 
B13, and N1 or F1 act within the cell and are able to inhibit crucial steps in the 
apoptotic cascade, hence blocking downstream signals that could otherwise lead the 
cell commitment to apoptosis. CrmA is a serine protease inhibitor (serpin) that is 
produced early in a CPXV infected cell and has a potent caspase 1 and caspase 8 
inhibitory activity. CrmA works by acting as a pseudo substrate for active caspases, 
leading to the formation of a stable inhibitory complex (Tewari et al., 1995). VACV 
encodes a family of proteins that adopt a Bcl-2-like fold despite sharing no significant 
sequence similarity with cellular Bcl-2 family proteins. Some of these family members 
are able to prevent apoptosis, F1 and N1 are good examples of such proteins. N1 can 
prevent apoptosis by binding Bcl-2 homology 3 (BH3) motif peptides of pro-apoptotic 
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Bcl-2 family members (Cooray et al., 2007) and F1 localizes to the mitochondrion and 
inhibits loss of MMP and cyt c release induced by a large number of stimuli (Stewart et 
al., 2005). 
 The high number of proteins coded by poxviruses to prevent apoptosis attests 
to the importance of viral inhibition of infection-induced apoptosis in the poxviruses life 
cycle.   
 
 
1.3 Golgi anti-apoptotic proteins (GAAPs) 
1.3.1 Viral GAAP discovery 
 The analysis of the CMLV genome sequence revealed that this virus was the 
closest known relative of VARV and encoded several novel proteins with possible 
immunomodulatory activity at the genome terminal regions (Gubser and Smith, 2002), 
one of which was initially referred to as protein 6L encoded by gene 6L. 
 The CMLV 6L gene was shown to encode an early protein of 237-amino acid 
that migrates at 23 kiloDaltons (kDa) in sodium dodecyl sulphate – polyacrylamide gel 
electrophoresis (SDS-PAGE) although it has a predicted size of 26.5 kDa. Using an 
antibody (Ab) raised to the N-terminus and a haemaglutinin (HA)-tagged version of 6L, 
the protein was shown to be localized in the Golgi during infection and had a broad 
spectrum of anti-apoptotic activity (Gubser et al., 2007). In view of these properties the 
protein was called viral Golgi anti-apoptotic protein (vGAAP). The gene was found to 
be absent in most orthopoxviruses but present in three VACV strains, Lister, USSR and 
Evans. These VACV GAAPs were very similar (94-95% identity) to CMLV 6L (Gubser 
et al., 2007). 
 To determine the importance of vGAAP for virulence the gene was deleted from 
VACV strain Evans (ΔvGAAP) and re-inserted with or without a C-terminal HA tag 
(vGAAP revertant or vGAAP-HA revertant). Experiments done with these viruses 
showed that the protein was mainly localized to the Golgi complex during infection, was 
expressed early during viral life cycle and was not essential for virus replication but 
influenced virus virulence in vivo (Gubser et al., 2007).  
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 Furthermore, stable cell lines overexpressing VACV strain Evans and CMLV 
vGAAP displayed significant resistance to apoptosis triggered by a wide range of 
intrinsic and extrinsic signals used (Gubser et al., 2007). The same results were 
obtained in apoptosis assays where transient overexpression of GAAPs was used.  
 
1.3.2 GAAP subfamily (TMBIM4) 
 Viral GAAP is very closely related (73 % aa identity) to a human protein (called 
z-protein, CG1-119 and S1R in different databases) identified from the human genome-
sequencing project and expressed in all human tissues tested (Gubser et al., 2007). 
This protein was named human GAAP (hGAAP) because it localized to the Golgi 
apparatus and also exhibited anti-apoptotic properties, protecting the cells from intrinsic 
and extrinsic apoptotic signals at a similar level as vGAAP, either at the level of or 
upstream of pro-caspase 8 activation. hGAAP is essential for cell survival because 
siRNA-mediated knockdown of hGAAP led to cell death by apoptosis (Gubser et al., 
2007). It was also identified as a possible housekeeping gene using statistical analysis 
of microarrays (Lee et al., 2007). hGAAP messenger RNA (mRNA) levels were found 
to be upregulated in some breast tumours in humans making it a putative oncogene 
(van 't Veer et al., 2002). In an attempt to investigate this possible link with 
tumorigenesis, a member of our laboratory has demonstrated that hGAAP over-
expression contributed to transformation of primary rat embryo fibroblasts in co-
operation with a constitutively active Harvey ras (Hras) (Benjamin Johnson, 
unpublished data). It was found that co-expression of Hras and hGAAP increased the 
number of transformed cells by three fold when compared to Hras transfection alone. 
 GAAPs are highly conserved among eukaryotes and closely related proteins 
are predicted from the genome sequences of most eukaryotes including fungi, plants, 
where four different putative GAAPs have been identified, insects, fish, amphibians and 
mammals. All these GAAPs, from evolutionary diverse sources, share a similar 
sequence length and hydrophobicity profile that points to an important and 
evolutionarily conserved function. In fact, human and viral GAAP are so similar in terms 
of function that cells in which hGAAP was knocked down using siRNA can be rescued 
from cell death by the expression of vGAAP (Gubser et al., 2007).  
 Different bioinformatic prediction programs used to determine GAAP topology 
gave either six or seven transmembrane domains (TMD), with the seventh TMD being 
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the inconsistent TMD (Carrara et al, submitted). Using digitonin to selectively 
permeabilize the plasma membrane before performing IF with an Ab specific for tags 
strategically located at either the ends of GAAP or the inter TMD loops, it was shown 
that vGAAP, hGAAP and Bax inhibitor one (BI-1) have only six TMDs and that both the 
N terminus and the C terminus of these proteins are located in the cytosol (Figure 1.2).  
 hGAAP and its counterparts from other species are included in the 
transmembrane Bcl-2-associated X protein (Bax) inhibitor containing motif (TMBIM) 
family and represent number four (TMBIM4) of this family.  
 
1.3.3 The Bax inhibitor-1 family (TMBIM)  
 Bioinformatic analysis assigned vGAAP and hGAAP to the protein family 
UPF0005, also known as TMBIM. These proteins are characterized by having a similar 
secondary protein structure of multiple (6 or 7) transmembrane spanning segments 
with short interconnecting loops, a charged C terminus (Reimers et al., 2008) and a 
conserved motif in the beginning of the third to the middle of the fourth predicted 
transmembrane domain. GAAP (TMBIM4) is one of the seven members described so 
far for this family. The TMBIM family includes other anti-apoptotic proteins like Bax 
inhibitor 1 (described in more detail in 1.3.3.1), lifeguard protein (LFG), and 
mitochondrial morphology and cristae structure 1 (MICS1).  
 LFG, also known as TMBIM2, is a plasma membrane associated protein that is 
abundant in neurons, although there are contradictory data about its expression in 
other tissues. It can protect cells from Fas, but not from TNFα, -induced apoptosis and 
binds to the Fas receptor (Somia et al., 1999). 
 MICS1, also known as TMBIM5 localizes to the mitochondrial inner membrane 
and is required for mitochondrial cristae organization. MICS1 knockdown by siRNA 
stimulates the release of cyt c from the mitochondrion whereas its overexpression 
partially inhibits cyt c release (Oka et al., 2008). 
 More recently it was proposed that GAAPs are very widely distributed and very 
ancient within eukaryotes. Phylogenetic analysis supports the expansion of some of the 
members of the BI-1 family from a GAAP ancestor about 2,000 milion years ago (Hu et 
al., 2009). This and the fact that a set of conserved sequence motifs was found for a 
subset of the members of the BI-1 and N-methyl D-aspartate-associated protein 1 
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(NMDARA1) families led to the proposed creation of a new gene family, the LFG family 
(Hu et al., 2009).   
 
 
 
 
Figure 1.2 - GAAP (TMBIM4) protein topology. GAAPs topology as described by 
Carrara et al, (submitted). The N- and C-terminal regions of both vGAAP and hGAAP 
were shown to be located at the cytosolic side of the Golgi membrane. There is still 
some uncertainty about the C-terminal region organization as there are still two 
possible situations, (i) the C-terminal region is free in the cytosol or (ii) it is a re-entry 
loop that partially enters the membrane without crossing it. 
 
 
1.3.3.1 Bax inhibitor-1 
 The most studied member of the TMBIM family, BI-1, was identified in a 
screening of mammalian proteins that rescued yeast from Bax-induced apoptosis. Like 
GAAP, BI-1 is a widely expressed and evolutionarily conserved integral membrane 
protein that protects cells against many different intrinsic and extrinsic death stimuli (Xu 
and Reed, 1998). Cells from BI-1 knockout mice display an increased hypersensitivity 
to apoptosis induced by ER stress agents (Chae et al., 2004). This phenotype was later 
shown to be related to the ability of BI-1 to bind the ER stress sensor Ser/Thr protein 
kinase and endoribonuclease IRE1α and reduce its endoribonuclease activity, leading 
to a reduction in levels of X-box-binding protein-1 and hence downregulating the UPR 
target gene expression (Lisbona et al., 2009). Bax inhibitor-1 primarily localizes to the 
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ER membrane where it increases Ca2+ leakage in a pH-dependent manner, reducing 
the ER Ca2+ concentration and consequently the amounts of Ca2+ that can be released 
upon stimulation (Xu et al., 2008). Deletion of the charged C terminus of the protein 
abrogated its ability to modulate ER Ca2+ content. Acidic conditions induced both BI-1 
oligomerization and Ca2+ leakage from the ER (Kim et al., 2008). Work done with pure 
BI-1 protein reconstituted in liposomes suggests that BI-1 has a Ca2+/H+ anti-porter-like 
activity because it allowed Ca2+ entrapped in liposomes to be released (Ahn et al., 
2009). The anti-porter activity is regulated by the lipid composition of the membrane 
that BI-1 is reconstituted in (Ahn et al., 2010). Moreover, recent data from Bultynck et 
al. (2011) showed that a peptide containing 20 amino acid residues from BI-1 C 
terminus was sufficient to create a pore that can cause the release of Ca2+ from the 
ER. Two aspartic acid (D) residues (D209 and D213) proved to be essential for Ca2+ 
flux. This could explain the mechanism by which BI-1 regulates the ER Ca2+ filling 
state, presenting a possible mechanism for its anti-apoptotic function. The physiological 
relevance of BI-1 ability to prevent cell death is highlighted by the fact that its activity is 
manipulated by the enteropathogenic Escherichia coli in order to prevent apoptosis in 
infected cells by expressing the NheH protein that binds to BI-1 and modulates its Ca2+ 
release activity (Hemrajani et al., 2010). 
 Increased actin polymerization is observed when BI-1 is overexpressed, and 
this is dependent on the Ca2+ release activity of BI-1 and leads to increased cell 
adhesion (Lee et al., 2010a). Expression levels of BI-1 are upregulated in some human 
breast cancer cells (Igney and Krammer, 2002) and prostate cancer (Grzmil et al., 
2006) and indeed BI-1 can contribute to cancer development and drug resistance 
(Grzmil et al., 2006; Igney and Krammer, 2002). Moreover BI-1 was shown to increase 
metastasis by increasing cell motility and invasiveness and by altering glucose 
metabolism (Lee et al., 2010b). Recently, BI-1 has been identified as a good putative 
target for anti-cancer therapy (Yun et al., 2011). 
 
1.3.4 hGAAP and Ca2+ modulation 
 The only insight into the possible molecular mechanism by which GAAPs 
modulate apoptosis came from de Mattia et al. (2009). Using both hGAAP 
overexpression and knockdown it was shown that hGAAP is capable of reducing the 
cytosolic and mitochondrial Ca2+ raises observed upon stimulation with an apoptotic 
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stimuli (staurosporine (STS)). The same result was observed for histamine-induced 
rises in cytosolic and mitochondrial Ca2+. This is very important because it is known 
that changes in Ca2+ homeostasis play a central role in determining cell susceptibility to 
an apoptotic stimuli and hence to apoptosis (detailed in section 1.4). Moreover, this 
mechanism pointed to hGAAPs ability to reduce the Ca2+ filling state of the intracellular 
Ca2+ stores, the Golgi and the ER. The findings that hGAAP could co-
immunoprecipitate with type 3 IP3R and was able to alter the IP3-induced Ca2+ release 
from intracellular stores were consistent with the hypothesis that hGAAP Ca2+ 
modulation was occurring via interaction and modulation of IP3R activity instead of by 
acting as an ion channel itself (de Mattia et al., 2009).  
 
 
1.4 Ca2+ homeostasis  
 Ca2+ signalling is involved in controlling many different cellular functions such as 
migration, contraction, gene transcription and cell proliferation (Carafoli et al., 2001). 
Variations in duration, localization, frequency and amplitude of Ca2+ transient rises 
makes Ca2+ one of the most versatile cellular signal elements (Berridge et al., 2000). 
Cytosolic Ca2+ levels are tightly regulated and are the result of the balance between a 
number of reactions that introduce Ca2+ in the cytosol (“on” reactions) and reactions 
that remove Ca2+ from the cytosol (“off” reactions) (Figure 1.3) (Berridge et al., 2003) 
and it is this tight control that allows the large variety of Ca2+ signals. Ca2+ is released 
into the cytosol from either the extracellular medium or from intracellular Ca2+ stores 
such as the ER or the Golgi. The result is a transient increase in cytosolic Ca2+ 
concentration and because most of this Ca2+ is quickly chelated by buffers or pumped 
out of the cytosol into the ER, the mitochondrion, the Golgi and the extracellular 
medium (Berridge et al., 2003), only a very small portion will be available to bind 
effectors and lead to the stimulation of Ca2+-dependent processes. 
 To control and manipulate Ca2+ signalling, different cells express different 
repertoires of Ca2+-modulating molecules such as Ca2+ receptors, transducers, 
channels, buffers, effectors, pumps and exchangers. Using this large tool kit, cells can 
generate a huge variety of Ca2+ pulses by manipulating the “on” and the “off” reactions 
(Berridge et al., 2003). 
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Figure 1.3 - Ca2+ signalling and homeostasis. The group of reactions that remove 
free Ca2+ from the cytosol are generically called “off” reactions while the series of 
reactions that introduce Ca2+, from either the intracellular Ca2+ stores or from the 
extracellular medium, are known as “on” reactions. The balance between the “on” and 
the “off” reactions determines the levels of active Ca2+ (free to bind effectors) in the 
cytosol at any given time. This activated Ca2+ can trigger very different cellular 
processes depending on the intracellular localization, intensity and duration of the Ca2+ 
release. Adapted from Berridge et al. (2003). 
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1.4.1 Ca2+ flow across the plasma membrane   
 Ca2+ flow into the cytosol coming from the extracellular medium can be 
triggered by a variety of stimuli such as membrane depolarization, stretch, extracellular 
agonists, intracellular messengers or by depletion of intracellular stores. These stimuli 
can also lead to the formation of second messengers that can trigger the release of 
Ca2+ from intracellular stores (reviewed in Bootman et al. (2002)). This release is 
mostly controlled by Ca2+ itself and by messengers such as inositol-1,4,5-triphosphate 
(IP3) or cyclic ADP ribose and nicotinic acid adenine dinucleotide phosphate (Lee, 
1997). Many stimuli work by phospholipase C (PLC) to generate IP3. Different PLC 
isoforms are activated by different stimuli and this leads to the generation of different 
IP3 production levels and for different periods (Kelley et al., 2001; van der Wal et al., 
2001). Entry of Ca2+ from outside is mostly driven by the electrostatic gradient that 
exists through the plasma membrane (Berridge et al., 2003). Different channels in the 
plasma membrane open in response to different stimuli allowing the generation of 
different Ca2+ signals that will lead to different outcomes. These channels at the plasma 
membrane can respond to voltage (voltage-operated channels - VOCs) (Dolphin, 
2006), to the binding of a ligand (receptor-operated channels - ROCs), to second 
messengers (second-messenger-operated channels - SMOCs) such as the 
arachidonic-acid-sensitive channel (Mignen and Shuttleworth, 2000), to intracellular 
store Ca2+ content (store-operated channels - SOCs) (Parekh and Putney, 2005) and to 
many other stimuli such as temperature or stretch. VOCs are usually found in excitable 
cells and are able to generate fast Ca2+ fluxes to control fast cellular processes such as 
muscle contraction. A good example of a ROC is the N-methyl-D-aspartate receptors 
NMDAR that allow a Ca2+ flow in response to glutamate (Masu et al., 1993). SOCs 
respond mainly to ER lumen Ca2+ depletion. This response allows the entry of external 
Ca2+ that can mediate longer cytosolic Ca2+ signals and also contribute to the 
replenishment of intracellular Ca2+ stores. 
 After an increase in cytosolic Ca2+ levels a number of pumps located at either 
the plasma membrane or at cellular organelles will actively remove Ca2+ from the 
cytosol to re-establish its normal resting Ca2+ concentration of approximately 100 nM 
(Carafoli, 1987). The plasma-membrane Ca2+-ATPase (PMCA) (Carafoli, 1994) and the 
Na+/Ca2+ exchanger (NCX) (Blaustein and Lederer, 1999) are the main pumps that 
actively remove Ca2+ from the cytosol into the extracellular medium. Different pumps 
present different transport rates and affinities to Ca2+ and different pumps will respond 
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to different Ca2+ concentrations allowing the cell to control cytosolic Ca2+ levels quickly, 
precisely and efficiently after a Ca2+ rise. PMCA and the sarco(endo)plasmic reticulum 
Ca2+ ATPase (SERCA) (Vangheluwe et al., 2005) respond to small Ca2+ elevations but 
with a low transport rate. These pumps are essential in setting the basal cytosolic Ca2+ 
levels. In contrast, NCX and the mitochondrial uniporter have a much higher transport 
rate allowing them to limit Ca2+ rises within a bigger range (Collins et al., 2001). 
 
1.4.2 Ca2+ intracellular stores    
 The ER has a central role as the main cellular Ca2+ store although other 
organelles such as the Golgi or lysosomes are also able to store Ca2+ and release it in 
response to stimuli. High Ca2+ levels in the ER lumen (100-500 µM) are maintained by 
the action of the SERCA pump that actively transports Ca2+ from the cytosol into the 
ER lumen (Vangheluwe et al., 2005). Release of Ca2+ from the ER is mainly regulated 
by the activity of the IP3 receptor (IP3R) (Thrower et al., 2001) and the ryanodine 
receptor (RYR) (Bezprozvanny et al., 1991). Both these channels are sensitive to Ca2+ 
and can lead to Ca2+-induced Ca2+ release (CICR), a process involved in generating 
rapid Ca2+ rises (Endo, 2009). There are three isotopes of the IP3R and they can form 
homo or hetero-tetramers. IP3R is also regulated by, among others factors, IP3 which 
induces a conformational change in the channel (Thrower et al., 2001) that can 
increase the channel sensitivity to Ca2+ at low Ca2+ concentrations but has an inhibitory 
effect at high Ca2+ concentrations.  
 The Golgi apparatus is involved in processing and sorting membrane bound 
and secreted proteins and occupies a perinuclear position in most cell types. Some of 
its functions are regulated by Ca2+ concentration changes within the Golgi lumen or in 
the adjacent cytosol. The Golgi’s ability to accumulate Ca2+ relies on the activity of the 
two main Ca2+ transport pumps located on the Golgi membrane, the secretory pathway 
Ca2+ ATPase (SPCA) (Wuytack et al., 2003) and the SERCA pump. While these two 
pumps are responsible for Ca2+ uptake that lead to an accumulation of Ca2+ in the Golgi 
lumen, IP3R localized in the Golgi membrane is able to release Ca2+ in to the cytosol. 
Most IP3Rs are expressed in the ER membrane but it has been reported that IP3 is able 
to stimulate Ca2+ release from the nuclear envelope or the Golgi (Pinton et al., 1998).  
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1.4.3 Ca2+ spatial and temporal organization 
 Temporal and spatial control of Ca2+ signals contributes to the high versatility of 
Ca2+ signals. Spatial control of Ca2+ release is relevant for rapid cellular processes, 
such as contraction, but appears to be less important in slower processes, such as cell 
proliferation (Lipskaia and Lompre, 2004), where Ca2+ signals are usually present as 
repetitive Ca2+ waves. Ca2+ binding proteins or buffers, such as D-28, calretinin, or 
parvalbumin are important for both the establishment of spatial and temporal regulated 
Ca2+ signals because Ca2+ binding and releasing dynamics of these molecules are able 
to fine-tune Ca2+ concentrations (John et al., 2001). A temporal control of Ca2+ signals 
is essential because different length Ca2+ signals will trigger different cellular responses 
(Figure 1.3). The longer a Ca2+ rise lasts for the more likely it is that it will spread as a 
wave that spreads through the cell or locally. When subjected to a prolonged 
stimulation these Ca2+ signals can form regular Ca2+ oscillations caused by several 
rounds of Ca2+ release and diffusion from IP3R or RYP clusters (Niggli, 1999). The Ca2+ 
oscillation frequency is crucial to determine what cellular process is activated and Ca2+ 
oscillations are known to regulate processes such as cell growth, migration (Gomez et 
al., 1995) or disassembly of focal adhesions during cell migration (Giannone et al., 
2002, Taufiq Ur et al., 2009).  
 
1.4.4 Ca2+ role in apoptosis 
 The role of Ca2+ in apoptosis has been compared to the “conductor of an 
orchestra” (Orrenius et al., 2003) regulating different portions of the cell death program. 
Ca2+ overload is known since the late 1960s to be highly toxic and to cause activation 
of proteases and phospholipases. Although this effect has been associated with 
necrosis, more recent data point to an important role in other types of cell death such 
as apoptosis. Indeed different studies detected an increase in Ca2+ cytosolic 
concentration in early and late stages of apoptosis (Lynch et al., 2000). It is now a 
common view that an increase in cytosolic Ca2+ concentration can occur when the cell 
is subjected to insults, promoting apoptosis.  
 There are two main mechanisms by which Ca2+ can contribute to the induction 
of cell death; (i) by increasing mitochondrial matrix Ca2+ concentration leading to cyt c 
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release or (ii) by activating effectors such as calcineurin or calpain2 that can lead to a 
downstream activation of an apoptotic pathway.  
 (i) Mitochondrial matrix Ca2+ plays a central role in regulating ATP production by 
activating the citric acid enzymes (Rizzuto et al., 2004) but a Ca2+ overload results in a 
mitochondrial depolarization that leads to the release of mitochondrial matrix proteins, 
such as cyt c. This activates apoptotic pathways leading to activation of caspases and 
nucleases that finalize the apoptotic process (Orrenius et al., 2003). The mitochondrial 
matrix Ca2+ levels can rise in response to a generalized increase in cytosolic Ca2+ 
levels, originated for instance by PMCA cleavage by caspases, preventing it from 
pumping Ca2+ out of the cytosol (Schwab et al., 2002), or, as a result of Ca2+ influx, 
through the plasma membrane. IP3R is involved in apoptosis because cells lacking or 
knocked down for some types of IP3R show an increased resistance to apoptotic stimuli 
(Jayaraman and Marks, 1997; Khan et al., 1996). IP3R itself is a caspase-3 substrate 
and its cleavage creates a leaky IP3R channel that can allow Ca2+ to flow out of the ER 
and possibly the Golgi (Nakayama et al., 2004). More recently a series of molecules 
involved in apoptosis such as cyt c, Bcl-2 and B-cell lymphoma-extra large (Bcl-xl) 
were also found to be able to control IP3R activity. Cyt c release from mitochondria 
adjacent to the ER was found to bind ER IP3Rs, increasing Ca2+ release from the ER 
and resulting in a positive feedback loop of cyt c release from the mitochondrion 
(Boehning et al., 2003). This was proposed as the mechanism by which a cell can 
synchronize cyt c release from all mitochondria. Bcl-2 is also able to bind IP3R 
preventing Ca2+ release (Rong et al., 2008). Bcl-xl binding to IP3R increases its 
sensitivity to Ca2+ and IP3 reducing the Ca2+ filling state of the ER and by doing so, 
reducing the amount of Ca2+ release upon an apoptotic stimuli (White et al., 2005). 
 (ii) IP3R Ca2+ release can lead to calcineurin activation and this enzyme will 
dephosphorylate Bad leading to its translocation from the cytosol to the mitochondrion 
and induction of cyt c release (Jayaraman and Marks, 1997). The Ca2+-activated 
cysteine proteases calpain family includes several tissue-specific isoforms and two 
ubiquitous izozymes calpain1 (also known as µ-calpain) and calpain2 (also known as 
m-calpain). Many of these proteins are responsible for cleaving several cellular proteins 
during apoptosis (Vanags et al., 1996). Calpain is able to cleave pro-caspase-12 
thereby activating it and leading to pro-caspase 3 and 7 activation (Nakagawa et al., 
2000). Calpain activity is controlled, among other factors, by its inhibitor calpastatin. 
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This protein can be cleaved by caspase-3 during apoptosis, thus activating calpain 
activity (Porn-Ares et al., 1998).  
 
1.4.4.1 ER stress responses 
 The ER is responsible for folding, modifying and sorting of newly formed 
transmembrane and secreted proteins and to store Ca2+. The disruption of any of these 
functions can lead to ER stress. The ER can respond to the accumulation of unfolded 
proteins by activating two responses that can increase the folding capacity of the ER 
and remove incorrectly folded proteins, the UPR (reviewed in Ron and Walter (2007)) 
or the ER overload response (EOR). The three main ER stress transducers are the 
inositol-requiring protein-1 (IRE1), the activating transcription factor-6 and the protein 
kinase RNA-like ER kinase. In all three cases an integral membrane protein senses the 
protein-folding status of the ER lumen and transmits that information to the cytosol 
(Schroder and Kaufman, 2005). The UPR leads to the activation of expression of ER 
chaperons (Kozutsumi et al., 1988) and to the inhibition of translation. Prolonged ER 
stress can also lead to apoptosis by activation of calpain that cleaves pro-caspase 12 
in the ER membrane and activates effector caspases (Nakagawa et al., 2000). The 
EOR leads to the production of cytokines and interferons through activation of the 
nuclear factor κB (NF-κB). Changes in ER Ca2+ concentration can lead to both reactive 
oxygen species production and calpain2 activation.  
  
1.4.5 Viral manipulation of Ca2+ homeostasis  
 Viruses are known for their abilities to subvert the cellular machinery to their 
advantage allowing them to generate the conditions needed to complete their life cycle. 
As the most common and versatile cellular messenger it is to be expected that viruses 
have developed strategies to modulate cellular Ca2+ signals to their benefit (Zhou et al., 
2009). 
 Most viral infections tend to increase the host-cell cytosolic Ca2+ levels in an 
attempt to facilitate the virus life cycle. Increases in cytosolic Ca2+ concentration can 
activate and accelerate several enzymatic processes and can activate several 
transcription factors. These include nuclear factor of activated T-cells (NFAT), which 
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can be important for promoting viral replication or to establish a persistent infection 
(Ding et al., 2002; Kinoshita et al., 1997; Lee et al., 2005). Ca2+ released from the ER 
can be taken up by mitochondria, and in some circumstances this can activate 
adenosine triphosphate (ATP) production that is essential to meet the high levels of 
energy required for virus replication (Li et al., 2007). Some viruses can reduce the ER 
and Golgi Ca2+ levels and inhibit protein traffic to the plasma membrane, thus 
preventing some of the host-cell anti-viral responses to be initiated (Doedens and 
Kirkegaard, 1995). The accumulation of ER and Golgi-derived vesicles might also be 
important for some viruses that require the microenvironment created by these vesicles 
to replicate their RNA (van Kuppeveld et al., 2005). By promoting or preventing Ca2+ 
trafficking from the ER to the mitochondrion viruses can also either prevent or induce 
apoptosis.  
 To achieve all these effects viruses can encode proteins that directly or 
indirectly manipulate the host-cell Ca2+ homeostasis by either altering membrane 
permeability or by subverting Ca2+ signalling pathways. Some of those viral proteins 
can form pores and alter membrane permeability by allowing the flow of ions, and 
these proteins are generically called viroporins. Examples of these proteins that are 
partially or totally selective for Ca2+ include the ER located proteins 2B from 
coxsakievirus (Nieva et al., 2003), p7 protein from hepatitis C virus (HCV) (Griffin et al., 
2003), and protein p13” from the human T-lymphotropic virus-1 (HTLV-1) located at the 
mitochondrial inner membrane (D'Agostino et al., 2005). 
 
 
1.5 Ion channels 
 An ion channel is typically defined as a protein that can form a pore in a lipid 
bilayer, allowing the passive flow of ions, such as Na+, K+. Ca2+, Mg2+, Cl- and H+, along 
electrochemical gradients across the membrane, which is otherwise impermeable to 
ions (Darnell et al., 1990). Ion channels can create changes in membrane potential or 
alter ion concentrations in the cell. By doing this ion channels are essential for electrical 
excitability, maintenance of membrane potential, hormone/neurotransmitters release, 
regulation of cell volume, apoptosis, activation of secondary messengers and signalling 
cascades, among others.  
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 Because ion channels are involved in controlling so many cellular events and 
functions, it is not surprising that ion channel malfunctions are responsible for many 
human pathologies such as cystic fibrosis (Boucher, 2002). Due to this fact they have 
revealed to be important targets for drug development and so far there are 
approximately 180 drugs approved by the food and drug administration (FDA) that 
exert their effect through ion channels, and these include peptides, toxins and small 
organic molecules. These drugs act by either blocking (Catterall, 2000; Voets et al., 
2002) or by modifying the gating properties of ion channels (Swartz and MacKinnon, 
1995). 
 The development of the “patch-clamp” technique that enabled the recording of 
electrical activity in small areas of the membrane was essential for ion channel 
characterization and understanding. The use of this technique allowed Neher and 
Sakmann (1976) to resolve single channel events and formally demonstrate the 
presence of ion channels. This technique remains the gold standard approach to ion 
channel functional analysis. Another technique that has proven essential in revealing 
the mechanisms behind ion channel properties is protein structure determination by X-
ray crystallography. In 1998 the structure of the first ion channel, K+ bacterial channel 
KcsA, was published, (Doyle et al., 1998) and in 2005 the first mammalian ion channel 
structure was solved (Long et al., 2005). These findings helped answer many questions 
regarding channel assembly, permeability and gating.  
 Most known ion channels are composed of a single repeat-structure protein or 
by multiple “subunits” arranged to form a water-filled pore across the lipid bilayer. 
Hydrophobic segments of these units span the membrane as coiled “α-helices” 
typically 20-27 amino acids long or as β-barrel sheets with 9-13 amino acids and are 
both referred to as transmembrane domains (TMD) (Kew and Davies, 2010). These 
TMDs form the core region of the channel and include the pore-forming region. 
 In most cells the cytosolic side of the plasma membrane is negatively charged 
due to the accumulation of negatively charged organic acids and proteins. This 
gradient is maintained by the action of pumps that actively force ions across the 
membrane against electrochemical gradients (Darnell et al., 1990). One of the most 
important pumps that maintains electrochemical gradients in the membrane is the 
Na2+/K+ ATPase, and similar ion transporters exist for Cl- and Ca2+. The accumulation 
of negative charges on the inside attracts positive charges to the outside face of the 
membrane creating a potential difference across the membrane, better known as 
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cellular membrane potential. The movement of ions across the membrane, down 
concentration gradients, into or out of cells, is offset by this electrical gradient (Hille, 
1992).  
  
1.5.1 Ion channels versus ion pumps 
 Pumps can also allow passage of ions across the lipid bilayer but at a rate more 
than 1000 times slower that ion channels. The main difference between ion channels 
and ion pumps is that the first can only allow ions to flow if a favourable 
electrochemical gradient exists, in contrast, the second can use energy to actively push 
ions across the membrane against a gradient at a much slower rate than observed for 
ion channels (reviewed in Gadsby (2009)). Ion channel activity will allow the generation 
of electrical currents while ion pumps can create and/or maintain ion gradients. Pumps 
can use two main sources of energy: primary pumps use energy from ATP hydrolysis; 
while secondary pumps use energy stored in electrochemical gradients by coupling 
thermodynamically downhill movements of ions to drive uphill transport of another 
substrate. These are also called co-transporters or exchangers (Jardetzky, 1966). The 
main structural difference between pumps and channels relates to the number of gates 
required for function. A gate is the part of the protein that prevents ions from moving 
across the channel in its closed conformation but allows its passage in the open 
conformation. While ion channels only need one gate that will open and allow ions to 
flow, an ion pump needs to have two gates that are never open at the same time 
(Gadsby, 2004). Pump gates work by opening alternately, creating a space in which 
the ion is kept before being release to the other side of the membrane against a 
gradient. But although ion channels only need one gate, many actually have two gates 
(Hille, 1992) and if both gates of an ion pump get open at the same time it will behave 
as an ion channel. These observations highlight the fact that ion channels and ion 
transporters are actually not that different in practice although they have conceptually 
two very distinct functions. 
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1.5.2 Ion channel permeability and ion selectivity 
 Different ion channels have different single channel conductance values 
(expressed in Siemens (S)) and these values can range between fS up to several 
hundreds pS. Conductance represents the rate at which a given ion channel allows 
ions to flow and in a constant voltage situation (“clamped”) is directly related to current 
and can be calculated as the slope of a linear regression between the voltage applied 
to the membrane and the current of ions obtained in “patch-clamp” experiments (Kew 
and Davies, 2010). Some channels can exhibit what is known as rectifications, where 
the current-voltage relationship is not linear (Matsuda et al., 1987). 
 Several aspects contribute to the fact that different ions flow more or less 
readily through different ion channels. The relative permeability of a given ion channel 
is defined by a series of factors such as the hydrated state, the shape and charge of 
the ion in question, and also by the pore structure that includes the selectivity filter. 
This filter, that works as a sieve, is usually made up by a series of charged amino acid 
residues and is usually 3-7 angstroms in diameter (Kew and Davies, 2010). The ion 
selectivity will depend on the balance between the energy required to remove water 
molecules from the ion and the energy of allowing the partially dehydrated ion to 
interact with the charged amino acid residues in the filter (Hille, 1992). 
 Some channels show mixed selectivity, usually for either cations or anions. 
Other factors such as ion relative abundance and concentration, can also influence the 
ions that eventually flow through the channel. For example in the ER where Ca2+ is 
very abundant, some Ca2+ ion channels that allow Ca2+ out of the ER lumen, such as 
the IP3R, don’t need to have a very strong or specific ion selectivity filter because Ca2+ 
is the major cation with an appreciable electrochemical gradient across the ER 
membrane (Foskett et al., 2007; Williams et al., 2001).  
 
1.5.3 Ion channel gating 
 Most channels have different conformational states, each with a different 
conductance, and gating describes the process by which a channel changes between 
these different states. The transition between the closed state, at which the channel is 
impermeable to ions, and the open state, that allows ions to flow through the pore, is 
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called activation (Ulbricht, 2005). Classically, ion channels are classified accordingly to 
their gating mechanism and they can be included in two main classes: voltage-gated or 
ligand-gated. Ligand-gated ion channels are activated by ligands such as Ca2+, 
nucleotides or neurotransmitters, while voltage-gated channels are activated by 
changes in membrane potential (Kew and Davies, 2010). Although useful this is 
certainly a very simplistic classification because each class is sub divided into many 
subclasses. Some ion channels can be included in both classes because they are 
regulated by both voltage and ligands or they can be activated by other stimuli such as 
light or mechanical stress (Kew and Davies, 2010). The overall activity and selectivity 
of an ion channel is controlled not only by its gating mechanism but also by factors 
such as phosphorylation, oligomerization (homo or hetero), association with regulatory 
proteins, subcellular localization and tissue specificity. 
 
1.5.3.1 Ligand versus voltage-gated channels: focus on Ca2+ channels  
 Ion channels that allow the flow of Ca2+ selectively can be included in the two 
classes of ion channels, the ligand-gated and the voltage-gated ion channels. The first 
class includes the IP3R, RYR and store-operated Ca2+ channels among others; some 
of these were already referred in section 1.4. This group of ion channels is typically 
constituted by three domains: in the case of a plasma membrane channel these are 
the: extracellular domain involved in binding the ligand, transmembrane cylinder that 
constitutes the pore, and the intracellular region that might be involved in subcellular 
localization and regulation by cytosolic secondary messengers (Striggow and Ehrlich, 
1996).  
 The voltage-gated channels class includes channels that require depolarization 
of the membrane to be activated. They can be divided into subclasses according to the 
levels of membrane depolarization that they require for activation (Ertel et al., 2000). L, 
P and N-type channels are examples of Ca2+ channels that require large membrane 
depolarization for activation. L-type channels are found in cardiac muscle and are 
essential for muscle contraction, P and N-type are mainly found in the brain and are 
involved in neurotransmitter release. T-type channels respond to relatively small levels 
of plasma membrane depolarization but show a very rapid voltage-dependent 
activation. These channels can be found in cells with “pacemaker” activity and are 
involved in sinus rhythm regulation. 
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 The selectivity filter domain for voltage-gated Na+ channels (Nav) usually 
contains the signature amino acid sequence DEKA (Heinemann et al., 1992) while 
TVGYG is frequently found in voltage-gated K+ channels (Kv) (Jiang et al., 2002). For 
voltage-gated Ca2+ channels (Cav) EEEE is found commonly (Sather and McCleskey, 
2003), although both aspartic acid (D) and glutamic acid (E) can contribute to the four 
COO- groups usually present in Ca2+ channels selectivity filters. Ca2+ ion channel 
selectivity filters are highly negatively charged so they can attract cations, balancing 
the charges and minimizing free energy. This will force cations such as Na+ and Ca2+ to 
compete for the space in the filter. The charge/space mechanism competition model 
implies that Ca2+ can more efficiently balance the charges of the filter because it 
provides twice as much charge per ion than Na+ while occupying a similar space. This 
model implies that the main determinant of Ca2+ versus Na+ selectivity is the filter 
volume (Malasics et al., 2009).  
 
1.5.4 Ion channel basic structure 
 The basic structure of the K+ voltage gated ion channels (Kv) consists of a 
tetramer of 6 TMDs (named S1-S6) with a short re-entrant P-loop between S5 and S6 
(Figure 1.4). Na+ and Ca2+ voltage gated channels, Nav and Cav, respectively, have a 
similar structure to the Kv but whereas the Kv is composed of four subunits with 6 
TMDs each called homologous repeat domains, Nav and Cav are usually composed of 
a single protein that contains all 24 TMDs (Kew and Davies, 2010). S4 typically 
contains the voltage sensor while S5, the P-loop and S6 contain the selectivity filter 
(Noda et al., 1984).  
 The non-voltage-gated inward rectifying K+ channels constitute the most basic 
structure of an ion channel. These are tetramers of subunits that contain two TMDs 
(M1 and M2), which are analogous in function and structure to the S5 and S6 TMDs of 
Kv channels (Figure 1.4). This implies that a minimum of eight TMDs is required to 
form an ion channel, although it is possible to form membrane pores with much smaller 
peptides (Choe, 2002). 
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Figure 1.4 - Examples of ion channel topologies. (A) 6TM/P channels, which are the 
predominant class among ligand-gated and voltage-gated K+ channels (B) 2TM/P 
channels (which consist of two transmembrane (TM) helices, M1 and M2, with a P loop 
between them), exemplified by inwardly rectifying K+ channels and by bacterial K+ 
channels such as KcsA. Adapted from Choe, 2002.  
 
 
1.5.5 Viral ion channels 
 Some viruses encode ion channels and these are generically called viroporins. 
Viral ion channels are usually smaller that cellular ion channels and they seem to 
represent a miniaturized and simplified channel system. The first viral ion channel was 
found in influenza virus and is called M2. This is a small protein composed of 97 amino 
acid residues that can form tetramers (Sugrue and Hay, 1991) to create a pore 
permeable to H+ (Schroeder et al., 1994). This protein is important during virus entry 
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because it promotes virus uncoating within the endosomes by lowering the pH of the 
virion interior (Mould et al., 2000). M2 can also affect glycoprotein processing and 
trafficking (Henkel and Weisz, 1998).  
 Another example of a viroporin is the human immunodeficiency virus-1 (HIV-1) 
viral protein u (Vpu). This protein plays a role in CD4 degradation (Schubert et al., 
1994) and is important for viral particle release (Klimkait et al., 1990). The N-terminal 
region of Vpu was found to have ion channel activity and to interact with TWIK-related 
acid-sensitive K+ 1 (TASK-1), a mammalian ion channel, forming a dysfunctional 
heteromultimer that may reduce TASK-1 activity (Hsu et al., 2004). The ion channel 
activity of Vpu has not yet been connected to its role in viral particle release.  
 Some other examples of viral Ca2+ channels were already referred in section 
1.4.5. 
  The study of these proteins may prove relevant for the development of new 
antiviral drugs that can modulate viroporins activity. Examples of drugs that target viral 
ion channels include the influenza A M2 protein inhibitor amantadine that is clinically 
used (Oxford and Galbraith, 1980). 
 
 
1.6 Cell adhesion and migration 
 A major role of Ca2+ is in cell migration. Cell migration involves a series of 
sequential events starting with protrusion of the cell membrane followed by formation of 
new adhesions at the cell front, that establish the physical connection between the 
substratum and the actin cytoskeleton, leading to the generation of traction forces that 
ultimately make the cell move forward. Movement requires the disassembly of 
adhesions at the rear of the migrating cell.  
 Cell migration can be triggered by several stimuli such as the presence of 
growth factor or chemokine gradients, extracellular matrix (ECM) proteins, mechanical 
forces or electrochemical gradients (Petrie et al., 2009). The polarization and extension 
of protrusions of the cell membrane towards the stimuli initiate the migration process. 
Protrusions are driven by the polymerization of actin filaments and comprise large 
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broad lamellipodia and spike-like lamellipodia (Pollard and Borisy, 2003). These 
structures are stabilized by adhesions that link the intracellular actin cytoskeleton to the 
ECM proteins and allow, together with actomyosin contractions and the generation of 
the traction force. Contractibility will also allow the cell to move forward by allowing the 
disassembly of adhesions at the rear of the cell (Ridley et al., 2003). Signals generated 
by both newly formed and more stable adhesions, cytoskeleton reorganization and 
actin polymerization can influence each other and ultimately coordinate the directional 
cell movement.  
 Several cell adhesion receptors such as integrins, syndecans and cadherins   
have been identified. Integrins were first discovered about 25 years ago (Tamkun et al., 
1986). Members of this large family of heterodimeric (subunit α and subunit β) 
glycoproteins (Ruoslahti and Pierschbacher, 1987) are expressed in most cells and are 
directly involved in cell migration due to their direct involvement in cell-substrate 
adhesion. Integrins work as receptors, their extracellular domain can bind ECM 
proteins such as fibronectin (Tamkun et al., 1986), vitronectin (Pytela et al., 1985) or 
collagen (White et al., 2004) and generate intracellular signals (Hynes, 2002). These 
receptors are important targets for drug development as their deregulation or 
malfunction is associated with many disorders such as cancer, thrombosis and 
autoimmune disease (Cox et al., 2010). 
 
1.6.1 Cell adhesions 
 Integrins can directly link the actin cytoskeleton with the extracellular 
substratum by suffering a conformational change upon binding to ECM proteins that 
allows them to interact with intracellular proteins such as talin (Campbell and Ginsberg, 
2004), vinculin (Ziegler et al., 2006), or the actin cross-linking protein α- actinin (Otey 
and Carpen, 2004). These can all bind filamentous-actin (F-actin) and, by doing so, 
establishing a link with the actin cytoskeleton (Figure 1.5). Integrin activation also 
induces the recruitment of scaffolding and signalling proteins such as paxillin (Brown 
and Turner, 2004) and focal adhesion kinase (FAK) (Mitra et al., 2005). These 
scaffolding proteins are rich in phospho tyrosines (Choi et al., 2008) which indicate that 
these are active signalling complexes. These proteins will in turn associate with 
molecules that are involved in regulating the activity of the Rho-family of guanosine 
triphosphate (GTP) hydrolases (GTPases) (which includes Rac, Rho and CDC42) by 
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recruiting guanine nucleotide exchange factors (GEFs) and GTPase activating proteins 
(GAPs) to the adhesion complexes (Cote and Vuori, 2007; Premont et al., 2004; Tomar 
et al., 2009). Rho GTPases act as a central node that regulates adhesion assembly 
and disassembly by promoting contraction and actin polymerization.  
 Podosomes and invadipodia are other types of cell adhesions, both work as 
sites for localized protease release that leads to ECM proteins degradation (Albiges-
Rizo et al., 2009) and contributes to cell invasiveness (Linder, 2007). Podosomes are 
small, circular, highly dynamic adhesions that contain a central actin core with integrins 
and other adhesion-associated proteins arranged in a ring-like shape (Linder, 2007). 
These structures are mostly found in leukocytes of the monocytic lineage, endothelial 
and smooth muscle cells. Invadipodia are only found in tumour cells and are 
structurally similar to podosomes but are much more stable structures (Linder, 2009). 
 Actin polymerization in the lammellipodium and in the lamellum drives the 
formation of protrusions at the leading edge of the migrating cell. In the lamellipodium 
actin polymerizes into a branched structure, and this is driven by the ARP 2 and 3 
complex (Nicholson-Dykstra et al., 2005) that is itself regulated by Rac and CDC42. 
Branched actin is reorganized in bundles, also called stress fibres, in the region where 
the lamellipidium and the lamellum meet (Shemesh et al., 2009). The contraction of the 
actin fibres is controlled my myosin-II (Parsons et al., 2010). This protein binds actin 
stress fibres and can move the actin fibres in an anti-parallel way. Myosin-II can also 
bind together several actin filaments in bundles (Vicente-Manzanares et al., 2008; 
Vicente-Manzanares et al., 2009). This movement is responsible for providing the force 
necessary to rearrange the actin cytoskeleton.  
 Adhesions act mainly as traction points. They provide the necessary resistance 
to the forces generated by the rearward flow of actin filaments and transfer this force 
into the substrate allowing the formation of protrusions (Petrie et al., 2009). 
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Figure 1.5 - Molecular organization of a typical focal adhesion. The link between 
the extracellular and intracellular components of this structure is provided by integrins 
that bind both the ECM proteins and some of the intracellular components of the focal 
adhesion. Several proteins, namely talin, FAK, vinculin and paxillin, serve as 
scaffolding and signalling molecules to establish the stable linkage of the adhesion to 
the actin cytoskeleton by inducing the connection with actin stress fibres. It is important 
to point out that this is a highly dynamic structure and what is represented here is a 
snapshot of a focal adhesion that tries to include the typical elements that regulate and 
compose this complex molecular structure. Adapted from Mitra et al. (2005). 
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1.6.2 Adhesion dynamics 
 The assembly or nucleation, maturation and disassembly of adhesions 
represent a continuous dynamic process that is modulated by actin polymerization and 
actomyosin contraction. At any given time in a typical migrating cell several different 
adhesion structures can be present. These represent different stages of a continuous 
process rather than different classes of adhesions. Just behind the cell leading edge, in 
the lamellipodium, we can find small and short-lived nascent adhesions that can either 
disassemble or mature into bigger and more stable structures called focal complexes 
that localize to the transition zone between the lamellipodium and the lamellum 
(Parsons et al., 2010). These structures can finish the maturation process leading to 
the formation of focal adhesions that are typically located at the ends of large actin 
stress fibres (Zimerman et al., 2004). 
 There are currently two not mutually exclusive models that try to explain the 
mechanisms by which adhesion sites assemble. The first model assumes that it is the 
binding of integrins to ECM proteins that triggers the clustering of all adhesion 
intracellular components and that these will assemble on the cytosolic domains of 
integrin clusters (Miyamoto et al., 1995). The second model considers that assembly of 
adhesion proteins is triggered by actin polymerization, using branched actin as the 
template for adhesion complexes to nucleate (Choi et al., 2008).  
 The tension generated by myosin activity is the main determinant in the balance 
between adhesion disassembly and maturation. Inhibition of myosin-II with blebbistatin 
prevents adhesion maturation and increases the number of nascent adhesions (Puklin-
Faucher and Sheetz, 2009). Myosin has two main functions that contribute to stabilize 
adhesions it can generate the tension necessary to induce conformational changes in 
the adhesion complex proteins that will trigger maturation (del Rio et al., 2009) and it 
can also cross-link actin filaments creating actin bundles. 
 There is adhesion disassembly at both the front and at the rear of the cell 
(Broussard et al., 2008). At the front of the cell this process happens mostly at the 
lamellipodium-lamellum interface and its major driving force comes from actin 
depolymerisation and reorganization. At the rear of the migrating cell where retraction 
happens, the adhesions appear to slide, in a Rho GTPase and myosin-II dependent 
process (Ballestrem et al., 2001; Digman et al., 2008), just before the complete 
adhesion structure disassembles. The fact that integrins are often found in the 
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substratum behind a migrating cell indicates an abrupt cut with the intracellular 
components of the adhesion complex (Palecek et al., 1998). Calpains are Ca2+-
activated proteases that play an important role in adhesion complexes disassembly in 
retracting areas, because they are responsible for the proteolytic cleavage of several 
adhesion molecules such as FAK, talin and paxillin, among others (Franco et al., 
2004a) (introduced in more detail in section 1.6.3). 
 It is ultimately the balance between actin-mediated protrusion formation and 
myosin-II mediated contraction that regulates adhesion dynamics. The family of Rho 
GTPases, including Rac, Rho and CD42, control cell adhesion dynamics by directly 
controlling actin-mediated protrusion formation and myosin-II mediated contraction 
(Nobes and Hall, 1995). Rac and CDC42 are preferentially active at the front of the cell 
and they have partially overlapping functions in promoting actin-rich protrusions 
formation at the leading edge (Kurokawa et al., 2005). Rho is active in both the front 
and the rear of the cell. At the rear edge Rho activates myosin-II by activating the Rho-
associated protein kinase, which can inactivate the myosin phosphatase, allowing the 
sustainable phosphorylation of myosin-II by regulatory light chains (Machacek et al., 
2009). At the front edge it can complex with the formin mDia1 (Goulimari et al., 2005) 
which binds the fast polymerizing ends of actin filaments promoting actin 
polymerization (Chesarone et al., 2010).  
 Adhesion dynamics are regulated by complex feedback loops involving the Rho 
GTPases. The activation of these proteins is mediated by both GEFs and GAPs (Cote 
and Vuori, 2007; Lim et al., 2008; Premont et al., 2004; Sanz-Moreno et al., 2008). The 
scaffolding protein Tyr kinases such as Src and FAK can phosphorylate adhesion 
proteins such as paxillin which will then regulate the activation of Rho GTPases by 
modulating GEFs and GAPs localization and activation states (Mitra and Schlaepfer, 
2006; Parsons, 2003; Tomar and Schlaepfer, 2009). Because the phosphorylation of 
Tyr residues in FAK and paxillin leads to the recruitment of regulators of Rho GTPases 
and of other signalling proteins, FAK and paxillin work as ‘switchable’ scaffolds 
(Parsons and Parsons, 2004). 
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1.6.3 Ca2+ in cell adhesion and migration 
 Cell adhesion to the substratum and migration are complex cellular processes 
in which Ca2+ plays an important regulatory role at several levels. Many different steps 
in these processes have been shown to be directly or indirectly regulated by Ca2+ 
because many signalling and structural molecules involved in these processes are 
themselves regulated by Ca2+. The findings that Ca2+ is differentially distributed in the 
cytosol of migration cells, being present at higher concentrations at the cell rear, 
suggest a role in cell detachment (Brundage et al., 1991; Marks and Maxfield, 1990). 
This differential distribution has been suggested to be partially due to Ca2+ influx 
through stretch-activated Ca2+ channels (SACC) at the cell rear and to be essential for 
rear detachment and retraction (Lee et al., 1999). At the leading edge transient 
microdomains of elevated Ca2+ concentration (flickers) can also be detected and these 
were at least partially linked to the activity of the F-actin and myosin II binding transient 
receptor potential M7 (TRPM7) SACC (Clark et al., 2006; Wei et al., 2009). The 
involvement in cell adhesion of store operated Ca2+ channels has also been more 
recently suggested by the fact that the flickering caused by TRPM7 can be amplified by 
IP3R Ca2+ release from cellular stores (Wei et al., 2009). Moreover Ca2+ influx through 
TRPM7 was shown to promote Ca2+-induced Ca2+ release through RYR during cell 
migration (Chen et al., 2010). STIM1 was identified as the sensor for ER Ca2+ content 
and was shown to activate Orai at the plasma membrane upon ER Ca2+ depletion and 
to allow the entry of extracellular Ca2+ to fill the cellular stores (Varnai et al., 2009). The 
important role of Orai and STIM1 in both store-operate Ca2+ entry and cell migration 
highlights the importance of store-operate Ca2+ entry in adhesion and migration 
regulation (Varnai et al., 2009; Yang et al., 2009). 
 
1.6.3.1 Calpain in cell adhesion and migration 
 The fact that localized Ca2+ oscillations can trigger focal adhesion disassembly 
points to an important role of Ca2+ in focal adhesion turnover (Giannone et al., 2004; 
Giannone et al., 2002). The link between Ca2+ and adhesion disassembly was later 
shown to be at least partially due to the activity of some members of the intracellular 
Ca2+-activated cysteine protease family, known as calpain (reviewed in Franco and 
Huttenlocher (2005)). The two most studied members of this family are the two 
ubiquitously expressed proteins calpain1 and calpain2, also known as µ-calpain and m-
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calpain, respectively because they are activated by µM or mM concentrations of Ca2+ 
(Molinari and Carafoli, 1997; Sorimachi et al., 1994). Besides Ca2+, the proteolytic 
activity of these proteases is also regulated by its intracellular inhibitor calpastatin and 
by phosphorylation by the mitogen-activated protein kinase, among others (Croall and 
DeMartino, 1991). The first hint that suggested a connection between calpain activity 
and adhesion came from the findings that pharmacological inhibition of calpain led to 
an inhibition of cell migration; the same inhibitors were also found to reduce cell 
retraction at the cell rear during migration (Huttenlocher et al., 1997). The influence of 
calpain2 on cell adhesions was shown later to be due to its ability to cleave several 
components of the focal adhesion molecular complex, such as FAK (Chan et al., 2010), 
talin (Franco et al., 2004b) or paxillin, among others, and to trigger its disassembly 
mainly at the cell rear (Franco et al., 2004a). Calpain may also play a role in adhesion 
assembly because calpain-mediated proteolytic cleavage of talin was also found to 
promote integrin activation as the talin head domain can bind integrin β-tail 
(Calderwood, 2004). Calpain inhibition can inhibit cell spread in several different cell 
types (Parnaud et al., 2005; Rock et al., 2000). 
 
1.6.3.2 Ca2+ regulation of small GTPases – relevance for cell adhesion 
and migration  
 In addition to the examples referred to above, there are many more situations 
where a link between Ca2+ and cell adhesion/ migration is suggested. One of these is 
the Ca2+ regulation of the Rho GTPases that play a central regulatory role in cell 
adhesion/ migration as well as cell cycle and proliferation. The Ras-like GTPases are a 
protein superfamily that includes the Ras, Rab, ARF, Rac, Rho and Rad/Gem/Kir 
subfamilies (Ehrhardt et al., 2002). These proteins become active when bound to GTP 
and can hydrolyse GTP to GDP causing a conformational change that can now trigger 
the activation/inactivation of target proteins (Shields et al., 2000). The GTP hydrolysis 
rate of these molecules is very low and this activity can be either increased or 
decreased by GEFs or GAPs respectively, as previously referred in 1.6.2 (Ehrhardt et 
al., 2002). These two groups of proteins are the two main signalling determinants for 
GTPases activity, but spatial and temporal distribution of both GTPases and their 
regulators also plays an important role in regulating GTPases activity. The fact that 
many GTPase regulatory proteins contain Ca2+ binding motifs, such as EF domains, 
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C1, C2 and IQ motifs points to a possible role of Ca2+ in regulating GEFs and GAPs 
activity. GEFs and GAPs can themselves regulate GTPases which are involved in 
many crucial steps during the adhesion and migration processes (Cullen and Lockyer, 
2002; Ying et al., 2009). 
 Recently a new link between extracellular Ca2+ and cell adhesion and migration 
was suggested by studies made with the nutrient sensor Ca2+-sensing receptor 
(CaSR). This receptor was found to promote cell migration and adhesion by being 
present in signalling complexes with integrins, in thyroid carcinoma cells, that can 
activate phospholipase C and the release of intracellular Ca2+ (Tharmalingam et al., 
2011). The importance of these findings is highlighted by the important role that CaSR 
plays in both cell migration in the development of the nervous system and its recent 
implication in cancer metastasis (Saidak et al., 2009; Vizard et al., 2008). 
 
1.6.4 Modulation of adhesion and migration by poxviruses 
 Poxviruses can promote host cell motility by inducing cell migration and the 
development of projections in the infected cells (Sanderson et al., 1998). During this 
motile phase the virus also induces Ca2+-independent (not sensitive to EGTA) adhesion 
of the cell to the ECM proteins (Sanderson and Smith, 1998). Increased actin-
dependent cell migration found in VACV-infected cells 8-10 h post infection coincides 
approximately with the period in the virus life cycle when the highest number of virus 
particles is released (Salzman, 1960; Sanderson et al., 1998). This process depends 
on the viral F11 protein that can inhibit RhoA signalling by interacting with its 
downstream effectors Rho-associated kinase and mDia (Valderrama et al., 2006). The 
development of cellular projections is a late event and is dependent on the expression 
of late genes because it is inhibited by AraC (Sanderson et al., 1998). The deletion of 
the C2L gene from VACV genome was found to affect the development of cellular 
projections and Ca2+-independent adhesion of the infected cell to the ECM proteins 
during late infection (Pires de Miranda et al., 2003).  
 The induction of motility in poxvirus-infected cells could be an attempt by the 
virus to induce virus particle dissemination, as CEV particles found on the cell surface 
would in theory stand a much better chance of infecting a non-infected cell if the initially 
infected cell could move in to an area of non-infected cells. Alternatively the induction 
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of cell motility by the virus could be a consequence of virus-induced alterations in the 
cellular processes to create the appropriate conditions to allow the completion of the 
viral life cycle and the production of infectious particles (reviewed in Sanderson and 
Smith, (1999)). The first hypothesis seems less likely because MVA expressing F11 
can induce cell motility, while MVA lacking F11 cannot, but does not show an increase 
in plaque size (Zwilling et al., 2010). Although the role that these processes might play 
in an in vivo situation is still not fully understood, as most of the data described above 
were mostly obtained in the context of a cell monolayer infection.  
 
 
1.7 Project aims 
 GAAP is a novel membrane protein from the TMBIM family that possesses both 
anti-apoptotic and Ca2+ modulation properties. The discovery of hGAAP and vGAAP in 
our lab was followed by an initial analysis of their function (de Mattia et al., 2009; 
Gubser et al., 2007). This work seeks to further our understanding of GAAP and other 
members of the TMBIM family, including BI-1. The study of the TMBIM4 protein 
subfamily will allow us to improve our understanding of Ca2+ involvement in cellular 
processes such as apoptosis, response to viral infection and cell adhesion. Research 
on apoptosis, Ca2+ and cell adhesion is important to understand normal cellular 
processes as well as diseases such as cancer. The high degree of conservation 
between hGAAP and other members of the family found in other mammals, 
invertebrates and even plants, suggests that GAAP has a fundamental role in cells, 
making these proteins strong candidates for further investigation. 
 
 The aims of this project are: 
• Purify TMBIM family proteins for functional and structural analysis 
• Determine the molecular mechanism behind GAAPs ability to modulate Ca2+ 
• Characterize GAAP oligomerization mechanism 
• Investigate hGAAP involvement in cell adhesion   
  63 
 
 
 
 
 
 
 
 Chapter II 
 Material and Methods 
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2.1 Molecular Biology 
2.1.1 Polymerase chain reaction (PCR)  
 To create C-terminally tagged GAAP mammalian expressing vectors, 
oligonucleotide primers were designed so that they would include the desired 
restriction enzyme cleavage sites to allow the cloning of the PCR product in the 
selected mammalian expression vector. A sequence encoding a flexible linker (amino 
acid sequence: KRGGSGGSGGSG) was also included between the end of GAAP and 
the tag. 
 All PCRs were carried out in a 50 µl volume containing 1x high fidelity PCR 
buffer (Invitrogen), 2 mM MgSO4, 0.2 mM dNTP mix (Invitrogen), 0.2 µM of each primer 
(Table 2.1) and 1U Platinum HiFi Taq DNA polymerase (Invitrogen). Ten ng of plasmid 
DNA was used as a template.  
 
Table 2.1 - Oligonucleotides used to amplify DNA fragments of interest by PCR. F 
and R refer to the forward and reverse primers, respectively. 
 
Oligonucleotide Sequence 5'-3' Allele
hGAAP-GFP/Tom F ctagctagctagatggctgaccccgacccccg
hGAAP-GFP/Tom R
cgaccggtgcgctgccgccgctgccgccgctgccgccccg
cttctttttattaactgcttcca
vGAAP-GFP/Tom F ctagctagctagatggccatgccgagcctctc
vGAAP-GFP/Tom R
cgaccggtgcgctgccgccgctgccgccgctgccgccccg
ctttttcttattagatacttcca
hGAAP TMD1-4.HA F cgcggatccgcgatggctgaccccgacccccg
hGAAP TMD1-4.HA R
ccggaattccggttaagcgtaatcaggcacgtcgtaaggg
tacttcttagattgtagag
hGAAP TMD5-7-HA F cgcggatccgcgatgGgatttcagcaaatttggag
hGAAP TMD5-7-HA R
ccggaattccggttaagcgtaatcaggcacgtcgtaaggg
tactttttattaactgcttcc
vGAAP TMD1-4-HA F cgcggatccgcgatggccatgccgagcctctccg
vGAAP TMD1-4-HA R
ccggaattccggttaagcgtaatcaggcacgtcgtaaggg
tatctctttgattgtagag
vGAAP TMD5-7-HA F cgcggatccgccgatggatttcagtaaacttggag
vGAAP TMD5-7-HA R
ccggaattccggttaagcgtaatcaggcacgtcgtaaggg
tatttcttattagatacttcc
hGAAP TMD5-7
hGAAP
vGAAP
hGAAP TMD1-4
vGAAP TMD1-4
hGAAP TMD5-7
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 PCR were performed in a thermocycler using an initial denaturing temperature 
of 94 °C for 5 minutes (min) followed by 30 cycles of 94 °C for 30 s, annealing at 55 °C 
for 1 min and extension at 68 °C for 1 min. Finally the temperature was kept at 68 °C 
for 5 min for the final extension. The annealing temperature of the primers was 
calculated by the formula:      Tm = [n(C/G) × 4 °C + n(A/T) × 2°C] - 5 °C 
Where G, C, A and T correspond to the 4 different nucleotides in each primer that 
hybridize with the template DNA. 
 PCR products were resolved by agarose gel electrophoresis to confirm the 
fragment sizes. 
 
2.1.2 PCR-based site-directed mutagenesis 
 Single amino acid mutations were generated using PCR-based site-directed 
mutagenesis. A forward primer (Table 2.2) was designed containing the desired 
nucleotide change, and a PCR as well as subsequent transformation was carried out 
using the QuikChange multi site-directed mutagenesis kit (Stratagene) following the 
manufacturer’s instructions. The selection of the correct clones was made by 
automated DNA sequence of plasmid DNA extracted from different clones. 
 
2.1.3 Agarose gel electrophoresis 
 DNA samples were mixed with 1/5 volume of 6x loading buffer [0.25 % 
bromophenol blue, 0.25 % xylene cyanol, 30 % (v/v) glycerol, 50 mM EDTA pH 8] and 
loaded on a 1-2 % agarose gel. Agarose gels were prepared in tris-acetate ethylene 
diamine tetraacetic acid (EDTA) buffer (TAE) (40 mM Tris base, 40 mM sodium 
acetate, 1 M EDTA pH 8.0) and containing approximately 5 µl SYBR® Safe (Invitrogen) 
per 100 ml of gel. The electrophoresis was carried out in TAE at 60-100 V for the time 
necessary to achieve a good fragment resolution (depending on DNA fragment size). 
The resolved DNA was visualized using the Chemi Doc gel documentation systems 
(Bio-Rad) with Quantity One software (Bio-Rad). 
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Table 2.2 - Oligonucleotides used for site directed mutagenesis PCR. All gene 
mutagenesis was done in pcDNA3.1. 
 
 
2.1.4 Isolation of DNA from agarose gels 
 DNA resolved in an agarose gel was visualized under a long wave ultraviolet 
(UV) transillumination and the band of interest excised with a clean scalpel. The 
QIAquick gel extraction kit (Qiagen) was used according to the manufacturer’s protocol 
to extract the DNA from the agarose. 
 
2.1.5 Restriction enzyme digest 
 DNA endonuclease restriction enzyme digestions were carried out in a volume 
of 20-50 µl and according to the manufacturer’s instructions. Briefly, a mix containing 1-
2 U of enzyme per µg of DNA and the appropriate buffer (Roche or NEB) was left to 
incubate at 37 °C for 1-3 h. Digested DNA was purified from agarose gels using the gel 
extraction kit (Qiagen) after electrophoresis. 
 
Sequence 5'-3' Allele
tgtttgctcttttgtggatattgagcctgtcaggattct hGAAP C164S-HA
gcaggagcccttcttttcagtggattcatcatctatg hGAAP C191S-HA
gagcctctccgcgagctcctccatcg vGAAP C9S-HA
ctaagaaaagtctacggtatccttagtctacaatttcttttaacaacg vGAAP C42S-HA
tgcagtatttttatactttgacagcatgcggacatttatacaagg vGAAP C60S-HA
cctgaatctgtacctgcttagtggatttacactgtcg vGAAP C101S-HA
cttttggggcccttgtattcagtggattcattatctatgac vGAAP C190S-HA
gtggatttacactgtcgcagtctctaacgctggcctc vGAAP E107Q-HA
catatactctacaatcaaagagaaatttcagtaaacttggagcagga vGAAP D147N-HA
gagatttcagtaaacttgcagcaggattgtttgctgc vGAAP G152N-HA
gcaaaatgagacagtgcagctggtcctgtctgc vGAAP E178Q-HA
ctggtcctgtctgcttttgcggcccttgtattc vGAAP G185A-HA
cccttgtattctgtggattcattatctataacacgcactcactaa vGAAP D196N-HA
tcactaatacataagctctcgcctcagcagtatgtgttagcctctatc vGAAP EE207-208QQ-HA
gcctctatcaatctctacttgaatatcatcaatctgttcttgc vGAAP D219N-HA
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2.1.6 Quantification of DNA 
 A NanoDrop ND1000 spectrophotometer (Labtech International) was used to 
determine the concentration of DNA solutions using the OD260 reading. DNA purity was 
assessed using the OD260/OD280 ratio, with a ratio between 1.8 and 2.0 being ideal. 
 
2.1.7 DNA ligation 
 DNA fragments and linearised vector, both with sticky ends, in a molar ratio of 
3:1 were ligated in a reaction volume of 20 µl in the presence of 1 U of T4 DNA ligase 
(Roche) in 1x T4 DNA ligase buffer (Roche). The ligation reaction was incubated 
overnight at 16 °C.  
 
2.1.8 Transformation of competent bacteria with plasmid DNA 
 Chemically competent XL-10 cells (30 µl) were thawed on ice and 3 µl from a 
DNA ligation reaction was added to the competent cells. The mix was incubated on ice 
for 30 min and then heat shocked for 90 seconds (s) at 42 °C. After 5 min incubation on 
ice, 200 µl of Super optimal catabolite medium was added and the mix was placed in a 
shaking incubator at 37 °C for 1 h. The cells were spread on agar plates containing the 
appropriate antibiotic and left to incubate overnight at 37 °C. 
  
2.1.9 Small and large scale preparation of plasmid DNA 
 Plasmid DNA was purified by the QIAGEN miniprep or maxiprep method 
according to the manufacturer’s instructions. Minipreps were prepared from 5 ml 
Escherichia coli cultures and were used for screening plasmids. Maxipreps were 
prepared from 250 ml cultures and were used in assays described in the results 
chapters. 
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2.1.10 Automated sequencing of DNA 
 Each sequencing reaction was prepared with 150 - 300 ng DNA per 3 kb of 
plasmid DNA and 0.2 µM of sequencing primer (Table 2.3), made up to 10 µl with 
water. Sequencing was carried out by the Advanced Biotechnology Centre (part of 
Imperial College London, Hammersmith Campus). 
 
Table 2.3 - Oligonucleotides used in sequencing reactions. Universal primers used 
to sequence genes cloned in Invitrogen pcDNA3.1 and Clontech fluorescent protein 
vectors (pEGFP-C1 and pTom-C1). 
 
 
2.1.11 Preparation of glycerol stocks 
 A small-scale culture containing the appropriated antibiotic was inoculated with 
a single colony from an agar plate and left to grow at 37 °C overnight. The next day 
equal volumes of the culture and 30 % (v/v) glycerol were combined and stored at -80 
°C. 
 
2.1.12 Plasmids 
 All plasmids used in this work are listed below in Tables 2.4 and 2.5. All the 
PCR generated fragments used to construct the listed plasmids were sequenced by 
automated DNA sequencing and were shown to be correct. 
 
 
Plasmid Oligonucleotide Sequence 5'-3'
pcDNA3.1 CMV FWD taatacgactcactataggg
BGH REV ctagaaggcacagtcgaggc
pEGFP-C1 EGFP-N gcagcggcaggtcgagctggtc
EGFP-C catggtcctgctggagttcgtg
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Table 2.4 - Mammalian expression plasmids used in this study.  
 
Plasmid Name Description Source/Reference
pcDNA3.1 hGAAP-HA C terminal HA tagged hGAAP Gubser et al., 2007
pcDNA3.1 hGAAP TMD1-4-HA hGAAP aa 1-146 N. Saraiva
pcDNA3.1 hGAAP TMD5-7-HA hGAAP aa 147-238 N. Saraiva
pcDNA3.1 hGAAP C164S-HA hGAAP cysteine 164 mutated to serine N. Saraiva
pcDNA3.1 hGAAP C191S-HA hGAAP cysteine 91 mutated to serine N. Saraiva
pcDNA3.1 hGAAP CXS-HA hGAAP with all cysteines mutated to serines N. Saraiva
pcDNA3.1 vGAA-HA C terminal HA tagged vGAAP Gubser et al., 2007
pcDNA3.1 vGAAP TMD1-4-HA vGAAP aa 1-145 N. Saraiva
pcDNA3.1 vGAAP TMD5-7-HA hGAAP aa 146-237 N. Saraiva
pcDNA3.1 vGAAP C9S-HA vGAAP cysteine 9 mutated to serine N. Saraiva
pcDNA3.1 vGAAP C42S-HA vGAAP cysteine 42 mutated to serine N. Saraiva
pcDNA3.1 vGAAP C60S-HA vGAAP cysteine 60 mutated to serine N. Saraiva
pcDNA3.1 vGAAP C101S-HA vGAAP cysteine 101 mutated to serine N. Saraiva
pcDNA3.1 vGAAP C190S-HA vGAAP cysteine 190 mutated to serine N. Saraiva
pcDNA3.1 vGAAP C9 + 60S-HA vGAAP cysteines 9 and 60 mutated to serines N. Saraiva
pcDNA3.1 vGAAP C"all"S-HA vGAAP with all cysteines mutated to serines N. Saraiva
pcDNA3.1 vGAAP E107Q-HA N. Saraiva
pcDNA3.1 vGAAP D147N-HA N. Saraiva
pcDNA3.1 vGAAP G152N-HA N. Saraiva
pcDNA3.1 vGAAP E178Q-HA N. Saraiva
pcDNA3.1 vGAAP G185A-HA N. Saraiva
pcDNA3.1 vGAAP D196N-HA N. Saraiva
pcDNA3.1 vGAAP EE207-208QQ-HA N. Saraiva
pcDNA3.1 vGAAP E207Q-HA N. Saraiva
pcDNA3.1 vGAAP E208Q-HA N. Saraiva
pcDNA3.1 vGAAP D219N-HA N. Saraiva
pC1 hGAAP-EGFP C terminal GFP tagged hGAAP N. Saraiva
pC1 vGAAP-EGFP C terminal GFP tagged vGAAP N. Saraiva
pC1 vGAAP-EGFP C9S vGAAP-EGFP cysteine 9 mutated to serine N. Saraiva
pC1 vGAAP-EGFP C60S vGAAP-EGFP cysteine 60 mutated to serine N. Saraiva
pC1 vGAAP-EGFP C9+60S
vGAAP-EGFP cysteines 9 and 60 mutated to 
serines N. Saraiva
pC1 hGAAP-tdTomato C terminal tdTomato tagged hGAAP N. Saraiva
pC1 vGAAP-tdTomato C terminal tdTomato tagged vGAAP N. Saraiva
pC1 vGAAP-tdTomato C9S vGAAP-tdTom cysteine 9 mutated to serine N. Saraiva
pC1 vGAAP-tdTomato C60S vGAAP-tdTom cysteine 60 mutated to serine N. Saraiva
pC1 vGAAP-tdTomato C9+60S
vGAAP-tdTom cysteines 9 and 60 mutated to 
serines N. Saraiva
pcDNA3.1(+) Invitrogen
pEGFP-C1 Clonetech
ptdTomato-C1 Clonetech
pEYFP-C1 Clonetech
ER-YFP Clonetech
Golgi-GFP Clonetech
YFP-LamB1 Clonetech
VSV-G.GFP Clonetech
pcDNA CD20 CD20 mammalian expression plasmid Daniele Bergamaschi 
GFP-Vinculin Susan Craig
GRASAP65-GFP Barr et al. 1998
p IP3R-YFP Parker et al., 2004 
p IP3R-YFP truncations A series of YFP tagged truncated IP3R type 1 Parker et al., 2005
vGAAP "ion channel" mutants
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Table 2.5 - Yeast expression vectors used in this study. TEVp refers to the TEV 
protease cleavage site. 
 
 
2.1.13 RNA extraction 
 RNA was extracted from U2OS and HeLa cells using the QIAgen RNeasy RNA 
extraction kit according to the manufacturer’s instructions.  
 
2.1.14 Reverse transcription-PCR (RT-PCR) 
 cDNA was synthesized by reverse transcription from total cellular mRNA. For 
each reaction 1 µg RNA, 2.5 µM oligo dT, 500 µM dNTP, and water nuclease-free to 
make up to 13 µl were mixed. The reactions were incubated at 65 oC for 5 min and 
transferred in to ice for 1 min. To each reaction 4 µl 5x First-strand buffer (Invitrogen), 5 
mM DTT, 40 U RNase OUT (Invitrogen) was added, 50 U Superscript III reverse 
transcriptase (Invitrogen) and made up to a total of 20 µl with nuclease-free water. The 
reactions were incubated at 50 oC for 1 h, followed by 70 oC for 15 min.  
 The cDNA obtained (2-4 µl) was then used in a standard PCR using primers 
specific for hGAAP or for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
(Table 2.6). A reaction where the reverse transcriptase was not added was used as a 
control for DNA contamination of the RNA samples. 
 
Plasmid Name Description Source/Reference
p426 GAL1 
Yeast expression vector with Galactose inducible 
promoter Mumberg et al., 1995
p426 GAL1 TEVp GFP-8His
p426 GAL1  with a TEVp cleavage site before 
the GFP and 8His tag David Drew  et al., 2006
p426 GAL1  vGAAP CMLV TEVp GFP-8His
p426 TEVp GFP-8His with vGAAP CMLV cloned 
before the TEVp site N. Saraiva
p426 GAL1  hGAAP T88I TEVp GFP-8His
p426 TEVp GFP-8His with hGAAP T88I cloned 
before the TEVp site N. Saraiva
p426 GAL1  AtGAAP3 TEVp GFP-8His 
p426 TEVp GFP-8His with AtGAAP3 cloned 
before the TEVp site N. Saraiva
p426 GAL1  BI-1 TEVp GFP-8His 
p426 TEVp GFP-8His with BI-1 cloned before 
the TEVp site N. Saraiva
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Table 2.6 - Oligonucleotides used to amplify endogenous hGAAP and GAPDH. 
 
 
2.2 Cells and virus 
2.2.1 Tissue culture 
 The mammalian cell lines used in this study were: human cervical carcinoma 
cells (HeLa) (including HeLa puro, HeLa vGAAP-V5 and HeLa hGAAP-V5 generated 
by Benjamin Johnson), human embryonic kidney cells with SV40 T antigen (HEK 
293T), African green monkey kidney fibroblast cells (COS-7), human osteosarcoma 
U2OS cells (including U2OS neo, U2OS hGAAP, U2OS vGAAP and U2OS hGAAP 
Ctmut created by Caroline Gubser), a sarcoma osteogenic cell line (Saos-2), african 
green monkey epithelial cell line of kidney origin (BSC-1) and rabbit kidney cells 
(RK13). The HEK 293T, U2OS, COS-7, Saos-2 and BSC-1 cells were kept in 
Dulbecco’s modified Eagle’s medium (DMEM [Gibco]) with 10 % heat-treated (56 °C for 
1 h) foetal bovine serum (FBS [Gibco]), 50 µg/ml penicillin and 50 µg/ml streptomycin. 
The HeLa cells were grown in minimum essential medium (MEM [Gibco]) with 10 % 
heat-treated FBS, 50 µ/ml penicillin and 50 µg/ml streptomycin and 2 mM L-glutamine. 
RK-13 cells were maintained in MEM supplemented with 10 % (v/v) FBS and 
penicillin/streptomycin (P/S) (50 µg/ml). All cell lines were kept at 37 °C in a humidified 
incubator (Heraeus) with 5 % CO2. All the stable cell lines used in this study are listed 
in table 2.7. 
 
Oligonucleotide Sequence 5'-3' Allele
hGAAP 117F aggacgacttcaactatggc
hGAAP 773R ccagaaaccgtaacaggtgc
GAPDH F cacagtccatgccatcactg
GAPDH R tactccttggaggccatgtg
hGAAP
GAPDH
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Table 2.7 - List of U2OS and HeLa stable cell lines.  
 
 
2.2.2 DNA Transfection 
 For all transfection methods cells were seeded so that they would be 70-90 % 
confluent the next day. The medium was replaced 1 hour (h) before transfection by 
medium containing 1 % FBS with no antibiotics. All methods were used to induce 
transient expression of target genes.  
 Polyethylinimine (PEI) transfection reagent (Sigma-Aldrich). The DNA to 
transfection agent ratio used was 1:2 (2 µg of DNA per 1 µl of PEI). The DNA was 
diluted in Opti-MEM (Gibco), mixed, PEI was added to the mix and left to incubate at 
room temperature (RT) for 15 min. The DNA, PEI and Opti-MEM mix was added to the 
cells drop wise. 
 Lipofectamine 2000 (Invitrogen). The protocol used was as indicated by the 
manufacturer, ratios of transfection agent volume to µg of DNA were generally 1:2 (2 
µg of DNA per 1 µl of lipofectamine 2000). The DNA and the Lipofectamine 2000 were 
mixed with Opti-MEM (Gibco) separately and incubated for 5 min at room temperature. 
The mix containing DNA was added to the mix containing Lipofectamine 2000 and left 
to incubate for 30 min at RT. The final mix was added to the cells drop wise.  
 Fugene 6 (Roche). The protocol used was as indicated by the manufacturer, 
ratios of transfection agent volume to µg of DNA were 1:3 (1 µg of DNA per 3 µl of 
Fugene 6). The DNA and the Fugene 6 were mixed with Opti-MEM separately and 
incubated for 5 min at RT. The mix containing the DNA was added to the mix 
Cell line Description Source/Reference
U2OS neo
clonal U2OS cell line expressing the neomycin resistance 
gene (from empty pcDNA3.1) Gubser et al., 2007
U2OS hGAAP-HA clonal U2OS cell line expressing hGAAP-HA Gubser et al., 2007
U2OS hGAAP-HA Ct mut
clonal U2OS cell line expressing hGAAP-HA Ct mut 
(E233AVNKK>A233AVAAA) C. Gubser, unpublished
U2OS vGAAP-HA clonal U2OS cell line expressing vGAAP-HA Gubser et al., 2007
HeLa puro
polyclonal HeLa cell line expressing the puromycin 
resistance gene from empty pDL vector B. Johnson
HeLa hGAAP-V5 polyclonal HeLa cell line expressing hGAAP-V5 B. Johnson / N. Saraiva
HeLa vGAAP-V5 polyclonal HeLa cell line expressing vGAAP-V5 B. Johnson / N. Saraiva
HeLa A36-V5 polyclonal HeLa cell line expressing A36-V5 V. Doceul
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containing Fugene6 and left to incubate for 30 min at RT. The final mix was added to 
the cells drop wise.  
 
2.2.3 Small interfering RNA (siRNA) transfection 
 HeLa or U2OS cells were seeded so that they would be 20-30 % confluent the 
following day. The siRNA oligonucleotides duplexes (Table 2.8) (Invitrogen) and the 
Oligofectamine (Invitrogen) were diluted in OptiMEM separately and incubated for 8 
min at RT. The content of the siRNA containing tube was added to the tube containing 
oligofectamine and left to incubate for 25 min at RT. The final mix was added to the 
cells drop wise and cells were analysed at 24 h and 36 h after transfection. 
 
Table 2.8 - siRNA molecules used for hGAAP knock down. 
 
 
2.2.4 Amplification of crude virus stocks 
 For preparation of working stock crude virus, five 175 cm2 flasks of RK-13 cells 
per virus were infected at 0.1 plaque forming unit (p.f.u.) per cell for 48 h. The cells 
were collected as described above and resuspended in 5 ml infection medium. 
Recombinant viruses were stored at -80 °C. 
 
2.2.5 Virus titration 
 Viruses were titrated by plaque assay, on monolayers of BSC-1 cells grown in 
six- well plates. The viruses were diluted in 2.5 % FBS MEM (10-5 to 10-9 dilutions, total 
volume 500 µl) and were incubated with the cells for 90 min at 37 °C, rocking the plate 
every 15 min. After this time the virus was removed and 2 ml 50 % 2x MEM 
siRNA Sequence 5'-3' strand Gene KD Reference
hGAAP siRNA 1 cgaucgaggaacgacuucaacu hGAAP Gubser et al 2008
hGAAP siRNA 2 cuguacggacauuuguacaug hGAAP Gubser et al 2008
Control siRNA propriatary sequence form Invitrogen GFP Invitrogen
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(supplemented with 5 % (v/v) FBS and 100 µg/ml P/S): 50 % 3 % (w/v) carboxy methyl 
cellulose was added to each well. The cells were incubated for 48-72 h to allow for 
plaque formation. The MEM/carboxy methyl cellulose mix was removed, cells were 
washed once with phosphate saline buffer (PBS) and stained for 30 min with crystal 
violet (5 % (v/v) crystal violet solution (Sigma), 25 % (v/v) ethanol). Wells were then 
washed with water and the number of plaques was counted to determine the virus titre. 
 
2.2.6 VACV infection of mammalian cells   
 COS-7 cells were infected with VACV Evans Rev vGAAP-HA or ΔvGAAP at 3-5 
plaque-forming units (p.f.u.) / cell for different periods of time (from 2-24 h). The single 
sucrose cushion purified viruses were stored until use at -80 °C. When needed they 
were thawed, sonicated, vortexed, diluted in 2.5 % FBS MEM or DMEM and added to 4 
ml of 2.5 % FBS MEM per 10 cm petri dish or 500 µl per 12 well plate well. The dishes 
were rocked every 20 min for 2 h, after which the inoculum was aspirated and replaced 
with fresh medium. 
  
2.3 Protein analysis 
2.3.1 Preparation of cell lysates 
 Cell lysates were prepared by washing cells twice on ice with ice-cold PBS 
followed by scraping in an appropriate volume of cell lysis buffer (50 mM Tris-HCl, pH 
7.5, 100 mM NaCl, 2 mM EDTA, 1 % 3-[(3-Cholamidopropyl)dimethylammonio]-1-
 propanesulfonate (CHAPS) (w/v), supplemented with protease inhibitors (Roche), and 
phosphatase inhibitors (Roche) for immunoblotting with phospho-specific antibodies). 
The cells were collected in eppendorf tubes and the cell debris were removed by 
centrifugation at 14,000 g for 15 min, 4 °C. The cleared lysate was retained and 
transferred to a new tube. 
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2.3.2 Protein quantification 
 To quantify the protein content of cell lysates a bicinchoninic acid (BCA) protein 
assay kit (Pierce) was used according to the manufacturer’s protocol. 
 
2.3.3 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
 Proteins were resolved by SDS-PAGE using vertical electrophoresis units from 
BioRad or Invitrogen. The gels consist of a ~1 ml staking gel layer (125 mM Tris-HCL 
pH 6.8, 5 % acrylamide, 0.1 % SDS, 0.1 % ammonium persulphate and 0.1 % TEMED) 
on top of ~4 ml of 10-12 % resolving layer (375 mM Tris pH 8.8 10–12 % acrylamide, 
0.1 % SDS, 0.1 % ammonium persulphate and 0.04 % TEMED). Protein samples were 
mixed with 20 % (v/v) of 5x sample loading buffer (50 mM Tris-HCl pH 6.8, 2 % [w/v] 
SDS, 10 % [v/v] glycerol, 0.1 % [w/v] bromophenol blue, 10 % reducing agent [β-
mercaptoethanol (BME) or Dithiothreitol (DTT])) before being loaded on the gel. 
Samples were electrophoresed at 120 V in running buffer (25 mM Tris, 250 mM 
glycine, 0.1 % SDS) alongside pre-stained molecular weight markers (Bio-Rad). When 
non-reducing conditions were required neither DTT nor BME were added to the protein 
samples prior to electrophoresis. 
 When the resolution of both GAAP and IP3R or talin was required, precast Bis-
Tris 4-12 % polyacrylamide gradient gels (Invitrogen) were used.  
 All protein resolution required during the yeast expression screen and 
purification process was done in 12 % polyacrylamide Tris-glycine precast gels 
(Invitrogen) without heating the samples, because this type of gel allows in-gel green 
fluorescent protein (GFP) fluorescence detection and good resolution of membrane 
proteins.  
 
2.3.4 Imperial and Coomassie staining  
 Imperial staining (Pierce) was used to stain proteins resolved by SDS-PAGE 
according to the manufacturer’s instructions. The gel was washed with distilled water, 
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incubated for 1-2 h with the stain solution and washed with distilled water until a good 
contrast was achieved.  
 Acrylamide gels (or membranes) were stained for 30 min in Coomassie blue 
stain [0.25 % (w/v) Coomassie brilliant blue R-250 [BDH], 10 % (v/v) acetic acid, 45 % 
(v/v) methanol) and de-stained in de-stain buffer (10 % acetic acid (v/v), 20 % methanol 
(v/v)].  
 
2.3.5 Silver staining  
 When low concentrations of protein were present the SilverQuest Silver 
Staining kit (invitrogen) was used, according to the manufacturer’s instructions, to stain 
proteins resolved by SDS-PAGE. 
 
2.3.6 Immunoblot (IB) analysis 
 Proteins resolved by SDS-PAGE were electro-transferred at 20 V for 25 min 
onto a nitrocellulose membrane (Hybond ECL, Amersham) using a Trans Blot Semidry 
cell system (BioRad) in transfer buffer (25 mM Tris, 190 mM glycine, 0.037 % [w/v] 
SDS and 20 % [v/v] methanol). The membrane was then blocked at RT for 1 h in 
blocking buffer (5 % non-fat dried milk or 5 % bovine serum albumin [BSA] and 0.1 % 
[v/v] Tween-20 [Sigma] in PBS). The membrane was immersed in primary Ab diluted in 
blocking buffer to an appropriate concentration (Table 2.9) and gently rocked overnight 
at 4 °C. The membrane was washed with PBS-T (0.1 % (w/v) Tween-20 in PBS), 
incubated for 1 h with the appropriate secondary Ab (Table 2.9) followed by a new 
wash in PBS-T.  
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Table 2.9 - Antibodies used for immunoblot (IB), immunofluorescence (IF) and flow cytometry (FACS). Monoclonal Ab (mAb), 
polyclonal Ab (pAb). 
 
 
Antibody Source/Reference Description Species IB dilution IF dilution FACS dilution
α-HA Sigma mAb Rabbit 1 : 10 000
α-HA Cambridge Bioscience mAb Mouse 1 : 200
α-GFP Abcam pAb Rabbit 1 : 25 000 1 : 3 000
α-V5 AbD Serotec Ltd. mAb Mouse 1:5000
α-VSV-G l1 Doug Lyles conformational mAb Mouse 1 : 5 000
α-Tubulin Millipore mAb Mouse 1 : 10 000
α-GM 130 BD Biosciences mAb Mouse 1 : 300
α-FAK Santa Cruz pAb Rabbit 1 : 500
α-pFAK Y397 Invitrogen mAb Mouse 1: 1000
α-Talin (N) Chemicon International mAb Mouse 1:1000
α-Talin (C) Invitrogen mAb Mouse 1:5000 1:300
α-Vinculin Invitrogen mAb Mouse 1 : 1000
α-GAAP Gubser et al, 2007 pAb serum generated against the N-terminal reagion of hGAAP and vGAAP (peptide: SSIEDDFNYGSSV) Rabbit 1 : 500 1 : 50
α-Rabbit Stratech Scientific HRP conjugated anti-rabbit secondary Goat 1 : 10 000
α-Mouse Stratech Scientific HRP conjugated anti-mouse secondary Goat 1 : 10 000
α-Rabbit 800CW Odissey IRD Dye 800CW fluorophore conjugated Goat 1:15000
α-Mouse 800CW Odissey IRD Dye 800CW fluorophore conjugated Goat 1:15000
α-Rabbit 488 Invitrogen Alexa fluor 488 conjugated Goat 1 : 500
α-Mouse 488 Invitrogen Alexa fluor 488 conjugated Goat 1 : 500
α-Rabbit 456 Invitrogen Alexa fluor 546 conjugated Goat 1 : 500
α-Mouse 456 Invitrogen Alexa fluor 546 conjugated Goat 1 : 500
α-CD20 FITC BD Biosciences FITC conjugated mAb Mouse 1/20
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 Finally the membranes were incubated with horseradish peroxidase (HRP) 
conjugated secondary Abs and were developed by incubating with enhanced 
chemiluminescence (ECL) reagents (Amersham/Pierce) as directed by the 
manufacturers and exposure to film (X-OMAT/LS, Kodak) for 30 s to 1 h. Membranes 
incubated with fluorophore-conjugated secondary Abs (Li Cor) were developed using 
an Odyssey infrared imaging system (Li Cor). This last developing method allows for 
quantitative western blot. 
 
2.3.7 Immunoprecipitation 
 HeLa or COS-7 cells were seeded 24 h prior to transfection so that they would 
be 70-80 % confluent the next day. The cells were transfected with Lipofectamine 2000 
or PEI and/or infected with different strains of VACV. The cells were collected and 
lysed the next day in 1 % CHAPS buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl, 2 mM 
EDTA, 1 % CHAPS w/v, protease inhibitors and phosphatase inhibitors). After 
centrifugation for 15,000 g for 15 min at 4 °C the supernatant was retained and the total 
protein content was determined by a Bradford Assay (BioRad). Some of the 
supernatant was kept for gel analysis. After 2 h incubation with protein G sepharose 
beads (Roche), the Abs were added to the cell lysates and incubated overnight with 
gentle rocking. Protein G sepharose beads (40 µl) was added the next day and left to 
incubate for 2 h. The beads were washed 4 times with 1 % CHAPS buffer, re-
suspended in 20 µl of 5x SDS sample loading buffer heated at 37 °C for 15 min and 
resolved on a SDS-PAGE. 
 
2.3.8 In gel fluorescence  
 The presence of GFP tagged proteins in protein samples resolved on 12 % 
polyacrylamide Tris-glycine precast gels (Invitrogen) was tested by in-gel GFP 
fluorescence. The gel was exposed to a blue light set at 460 nm with a cut-off filter of 
515 nm for 10 s to 1 min and the image captured with a LAS-1000-3000 charge-
coupled device (CCD) imaging system (Fujifilm). 
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2.3.9 Protein N-terminal sequencing 
 Protein run on Tris-glycine gels was transferred to an immobilon P membrane 
(Millipore). The membrane was stained with 0.1 % Coomassie Blue R in 50 % 
methanol for 5 min and de-stained with several changes, 2 to 5 min each, of 50 % 
methanol, 10 % acetic acid.  
 The dried and stained membranes were sent to the Protein Sequence Analysis 
(Edman degradation) service in the University of Cambridge. 
 
2.3.10 Protein cross-linking  
 Cell lysates from HeLa cells that had been transfected with pcDNA3.1 vGAAP-
HA or pcDNA3.1 hGAAP-HA were prepared as described in 2.3.1. To 40 µl of cell 
lysate the lysine-reactive aryl halide 1,5-difluoro-2,4-dinitrobenzene (DFDNB) (water 
insoluble, membrane permeable, spacer arm length 3 angstroms) was added at a 
range of concentrations of 2.5 to 160 nM. The DFDNB was prepared in Dimethyl 
sulfoxide (DMSO) immediately before use. The mix was incubated for 20 min at 37 °C 
and the reaction was stopped by the addition of 20 mM Tris pH 7.5. 
 
2.4 Protein production and purification  
 The method here described was based on the work of Drew et al. (2006), 
published in Nature Methods and was carried out in the Membrane Protein 
Crystallography Group (Imperial College London, South Kensington campus). This 
method takes advantage of a GFP tag placed at the C terminus of the protein of 
interest to follow the recombinant protein expression in yeast, extraction and further 
purification steps.  
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2.4.1 Yeast transformation  
 The pep4 deletion Saccharomyces cerevisiae strain FGY217 (MATa, ura3-52, 
lys2Δ201, pep4Δ) (Kota et al., 2007) was used to obtain a yeast strain expressing a 
target gene fused with GFP-8His. The vGAAP, hGAAP, hGAAP T88I and BI-1 open 
reading frames were amplified by PCR using primers (Table 2.10) that include 5’ 
overhangs of 35 bp complementary to the upstream and downstream sequences of the 
SmaI site in the GFP-8Histidine (His) vector. This 2µ vector based plasmid (p424 
GAL1) (Mumberg et al., 1995) includes the yeast EGFP15 gene (without the start 
methionine) with a 8His tag, a GAL1 promoter, a uracil (URA) selection marker and a 
tobacco etch virus (TEV) protease cleavage site between the target gene and GFP. 
The PCR products were cloned into the GFP fusion vector by homologous 
recombination after transformation of both plasmid and PCR product into the yeast (for 
schematics see Figure 3.1). 
 Using a sterile loop, 5 ml of YPG medium (yeast peptone medium (YP) + 2 % 
glucose) was inoculated with the yeast strain FGY217 and the culture was left to shake 
at 290 rpm overnight at 30 °C. The overnight culture was diluted into 50 ml of YPG to 
an OD600 of 0.1 and was left to grow to an OD600 of 0.5-0.6. To make the cells 
competent they were washed with water and then with 100 mM lithium acetate (LiAc), 
re-suspended in 100 mM LiAc and kept on ice until use. 
 A tube with 50 % (wt/vol) PEG 3350 and competent cells was vortexed for 5 s 
and kept on ice. Another tube with the SmaI-digested vector p424 GAL1 and the PCR 
product was vortexed for 30 s and kept on ice. The content of the first tube was mixed 
with the content of the second tube and salmon sperm DNA was added. The final mix 
was vortexed for 1 min. Cells were incubated at 30 °C for 30 min and transferred to 42 
°C for 25 min. Cells were washed in water, re-suspended in water and spread onto 
URA minus selective plate and incubated for 2-3 days at 30 °C. 
 The yeast strain expressing Arabidopsis thaliana GAAP3 (AtGAAP3)-GFP-8His 
fusion protein, generated by the same method described above, was a kind gift from 
Dr. Bart Feys (Imperial College London). 
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Table 2.10 - Primers used in PCR to amplify the genes of interest to be cloned 
into the p426 GAL1 TEVp GFP-8His yeast expression vector. 
 
 
2.4.2 Large-scale protein production 
 Five or ten litres of URA- medium (1.92 g of yeast synthetic drop out medium 
w/o Uracil and 6.7 g of Dibco yeast nitrogen base w/o amino acids per litter) with 0.1 % 
glucose were inoculated with an overnight culture of the strain of interest at an OD600 of 
0.12. The culture was incubated at 30 °C and induced with 2 % galactose when the 
OD600 reached 0.5-0.6. The culture was incubated for 24 h, the cells were collected by 
centrifugation at 4,000 g for 10 min and re-suspended in 25 ml of cell resuspension 
buffer (CRB) (50 mM Tris-HCL pH 7.6, 1 mM EDTA, 0.6 M sorbitol) per litre of culture. 
A sample of the cell suspension was used to measure the GFP counts on a 
SpectraMax M2e microplate reader (Molecular Devices). The cells were flash frozen in 
liquid nitrogen and kept at -80 °C. 
 
2.4.3 Large-scale membrane extraction 
 Protease inhibitor (PI) (Roche) was added to the cell suspension and the cells 
were broken with four passes through a cell disruptor (Constant Systems TS series cell 
disruptor from Constant Systems) at 25, 30, 32 and 35 kPSI. A sample of cells was 
used to measure the GFP counts. The unbroken cells and debris were removed by 
centrifugation at 10,000 g for 10 min and the supernatant was centrifuged at 150,000 g 
for 1 h to collect the membranes. The pellet was re-suspended in 6 ml of membrane re-
suspension buffer (MRB) (20 mM Tris-HCL pH 7.6, 0.3 M sucrose, 0.1 mM CaCl2) per 
Oligonucleotide Sequence 5'-3' Allele
hGAAP TEV F tcgacggattctagaactagtggatcccccatggctgaccccgacccc
hGAAP TEV R aaattgaccttgaaaatataaattttccccctttttattaactgcttcc
vGAAP CMLV TEV F tcgacggattctagaactagtggatcccccatggccatgccgagcc
vGAAP CMLV TEV R aaattgaccttgaaaatataaattttcccctttcttattagatacttcc
BI-1 TEV F tcgacggattctagaactagtggatcccccatgaacatatttgatcgaaag
BI-1 TEV R aaattgaccttgaaaatataaattttcccctttcttctctttcttcttatcc
hGAAP TEVpGFP-8His 
hGAAPT88I TEVpGFP-8His
vGAAP TEVpGFP-8His
BI-1 TEVpGFP-8His
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litre of culture using a 21-gauge needle. A sample of membrane suspension was used 
to measure the GFP counts. The membranes were flash frozen and kept at -80 °C. 
 
2.4.4 Small-scale protein production 
 Two litres of URA- medium supplemented with 0.1 % glucose was inoculated 
with the appropriate yeast strains and grown to a final OD600 of 0.12, grown at 30 °C 
until an OD600 of 0.6 was reached and induced with 2 % galactose. After 20-24 h 
incubation at 30 °C (25 °C for hGAAP T88I) the cells were collected and re-suspended 
in CRB, flash frozen and kept at -80 °C. 
 
2.4.5 Small scale membrane extraction 
 A tablet of protease inhibitor was added per 2 litres of culture. The cells were 
broken by passing four times at 25, 30, 32 and 35 PSI through a cell disruptor. The cell 
lysate was centrifuged at 15,000 g for 10 min and the membranes were collected by 
centrifuging the supernatant at 150,000 g for 1 h. The membrane pellet was re-
suspended in MRB, flash frozen and kept at -80 °C. 
 
2.4.6 Detergent Screen 
2.4.6.1 Solubility efficiency  
 Membrane extract (250 µl) from small scale cultures were solubilized in the 
presence of 1 % of two different detergents: n-dodecyl-β-D-maltopyranoside (DDMα) 
and N,N-dimethyldodecylamine N-oxide (LDAO) from Anatrace. The tubes were left to 
agitate for 1 h at 4 °C. The final mix was centrifuged at 50,000 g for 1 h at 4 °C to 
exclude unsolubilized material. The GFP counts were measured before and after 
solubilization and the solubilization efficiency determined by the following formula: 
Solubilization Efficiency = (GFP counts after solubilization / GFP counts before 
solubilization) x 100 
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2.4.6.2 Fluorescence size-exclusion chromatography (FSEC)  
 Protein solubilized with DDMα or LDAO (as described in 2.4.6.1) were loaded 
into a Superose 6 10/300 GL Tricorn size exclusion chromatography column (GE 
Healthcare) equilibrated in gel filtration buffer (20 mM Tris-HCL pH 7.5, 150 mM NaCl 
and 3x the critical micelle concentration [CMC] of detergent of choice). Fractions of 200 
µl were collected in a 96-well plate and the GFP counts were measured at 512 nm by 
excitation at 470 nm. The GFP counts were plotted against the fraction number.  
 
2.4.7 Protein purification from yeast membrane extracts 
2.4.7.1 Protein solubilization 
 Protein from membrane samples obtained from large scale cultures were 
solubilized in the presence of 1 % LDAO or DDMα for 2 h with gentle mixing at 4 °C in 
1x PBS, 10 % glycerol, 100 mM NaCl and protease inhibitors. Samples were 
centrifuged for 1 h at 150,000 g to remove unsolubilized material. The supernatant was 
collected and tested for the presence of GFP and the solubilization efficiency 
calculated.  
 
2.4.7.2 GFP-8His tagged proteins purification 
 Imidazole was added to the solubilized protein to a final concentration of 15 
mM. The samples were either loaded on a 5 ml Nickel His-Trap column previously 
equilibrated with 1x PBS, 15 mM imidazole and 3x CMC of the detergent of choice or 
incubated with 20 ml of Ni-NTA resin (slurry) (for schematics see Figure 3.4). The 
slurry was poured into an Econo-Column (BioRad). The flowthrough from the His-Trap 
column and from the slurry was tested for GFP counts and the binding efficiency 
calculated by the following formula: 
Binding Efficiency = 100 - [(GFP counts flowthrough / GFP counts before binding) *100] 
 Both columns were washed with 15 column volumes (CV) of wash buffer 1 (100 
mM NaCl, 1x PBS, 30 mM Imidazole and 3x CMC of detergent of choice) and with 15 
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CV of wash buffer 2 (150 mM NaCl, 20 mM Tris pH 7.5, 30 mM imidazole and 3x CMC 
of detergent of choice). The protein was eluted from the columns with 150 mM NaCl, 
20 mM Tris pH 7.5, 250 mM imidazole and 3x CMC of detergent of choice. The sample 
was diluted in dilution buffer (150 mM NaCl, 20 mM Tris pH 7.5, 0 mM imidazole and 
3x CMC of detergent of choice) to a final imidazole concentration of 30 mM. 
 
2.4.7.3 TEV protease cleavage 
 His-tagged TEV protease (produced in yeast, purified using His-Trap columns 
and kept at -80 °C until used) was added to pure GFP-8His tagged protein sample to a 
molar ratio of 1:1 of GFP and TEV and left to digest overnight at 4 °C.  
 
2.4.7.4 Reverse His-Trap purification 
 The sample was diluted in dilution buffer to a final imidazole concentration of 15 
mM, filtered through a 0.22 µm filter and loaded on a 5 ml His-Trap column equilibrated 
previously with PBS, 15 mM imidazole and 3x CMC of detergent of choice. The 
flowthrough was collected and concentrated with an Amicon 15 with a molecular weight 
cut off (MWCO) of 30 kDa up to 1 ml.  
 
2.4.7.5 Gel filtration 
 The concentrated protein was loaded on a Superdex 200 SEC column 
equilibrated previously with gel filtration buffer (20 mM Tris pH7.5, 150 mM NaCl, 3x 
CMC of detergent of choice). The 1 ml fractions were collected and a small sample of 
those corresponding to the peak was loaded on a 12 % polyacrylamide Tris-glycine gel. 
The gel was analyzed by in gel fluorescence and with Coomassie staining. 
 The fractions containing pure protein were concentrated to 50-250 µl with an 
Amicon 15 centrifugal concentrator with a MWCO of 30 kDa. The final protein 
concentration was determined by the BCA protein assay (Pierce) using a BSA standard 
curve as reference.  
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2.5 Microscopy  
2.5.1 Immunofluorescence 
 Cells were seeded over a sterile glass cover slip. After aspirating the cell 
medium and washing the cells twice with cold PBS, the cells were fixed with cold 4 % 
PFA (4 % paraformaldehyde, 250 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid [HEPES] pH 7.4 in PBS) for 20 min at RT or with -20 °C methanol for 4 min at 4 °C 
and washed again with PBS. Ammonium chloride (50 mM) was added to the fixed cells 
for 5 min to quench free aldehydes, which can auto fluoresce. After being washed with 
PBS, the cells were permeabilized with 0.1 % Triton X-100. Before incubation with the 
primary Ab (Table 2.9) cells were blocked with blocking buffer (10 % FBS in PBS) for 
30 min at RT. The cover slips were then washed in the blocking buffer before 
incubating with the secondary antibody (Table 2.9). After this incubation the cover slips 
were washed with blocking buffer followed by PBS and distilled water. Finally the 
coverslips were mounted in mounting medium (Moviol4-88) containing 4',6-diamidino-
2-phenylindole (DAPI).  
 Cell imaging was done by confocal microscopy using a LSM 5 PASCAL (Zeiss). 
Image acquisition was done using the LSM image browser software (Zeiss). 
 
2.5.2 Focal adhesions turnover (live cell imaging) 
 Focal adhesion turnover measurements were done based on the work of Webb 
et al. (2004). U2OS cells were transfected with 1 µg of GFP-vinculin using Fugene 6. 
Cells were reseeded 24 h later in 35 mm glass bottom culture chambers (MatTek 
Corporation), coated with fibronectin, in 1 % FBS DMEM conditioned medium. Cells 
were kept in a humidified 37 ⁰C incubator with 5 % CO2 for 1 h before carrying out the 
imaging. GFP fluorescence was monitored at the edges of the cell for approximately 2 
h per cell with pictures being taken every 2 min using a LSM 510 META (Zeiss) 
microscope. Image acquisition was done using the LSM image browser software 
(Zeiss).  
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 The duration of adhesions was calculated by determining the amount of time 
elapsed between the first and last frames in which an individual adhesion was 
observed.  
 
2.5.3 Calcium release (Fura-2-AM)  
 This work was undertaken by Dr. David Prole, Department of Pharmacology, 
University of Cambridge. HEK 293T cells were transfected with 5 µg of GAAP plasmids 
along with 1 µg of mCherry-C1 (Clontech) plasmid as a marker for transfected cells. 
Twenty-four h after transfection, cells were loaded with Fura-2-AM (Invitrogen) for 1 h 
and kept in a Ca2+-free solution. Ca2+ release as a response to ionomycin (10 µM) was 
measured in transfected cells i.e. mCherry positive cells. Traces representing the 
average Ca2+ responses of fields of transfected cells to ionomycin were obtained from 
20-50 cells. The values obtained were corrected for background that was measured 
after quenching with Mn2+.  
 
2.5.4 Förster resonance energy transfer (FRET) 
 HeLa cells were seeded on cover slips so that they would be 20 % confluent the 
next day. One day after seeding cells were transfected with a total of 2 µg of different 
sets of plasmids encoding GFP- or tdTomato (Tom)-tagged proteins. A ratio of 3:1 of 
acceptor encoding plasmid (Tom) to donor encoding plasmid (GFP) was used in the 
transfection.  
 Transfected cells on glass-bottomed culture dishes were fixed in 4 % PFA for 
20 min, 16 h after transfection, and placed on the stage of an Olympus IX81 
microscope equipped with 150 x/1.45 NA and 60 x/1.45 NA total internal reflection 
fluorescence (TIRF) objectives. Cells were illuminated with 488 nm or 561 nm diode-
based lasers via appropriate filters and images were acquired with an Andor iXON 897 
camera. Images were processed using Cell^R software (Olympus, Milton Keynes, UK). 
Cells were visualised using TIRFM with a 60 x/ 1.45 NA TIRF or 150 x/1.45 NA TIRF 
objective.  
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 To determine FRET efficiency (as measured by the increase in donor 
fluorescence intensity after acceptor photobleaching) pictures of the same cell were 
taken on the Tom (561 nm) and on the GFP channels (488 nm) before and after Tom 
photobleaching. At least 10 cells were photographed for each condition and for each 
cell a region of interest (ROI) corresponding to the Golgi was selected and the 
fluorescence intensity was determined. Photobleaching of Tom expressing cells was 
achieved by exposure to an un-attenuated 561 nm laser for 60 s. Background 
subtraction and correction for crosstalk were applied and FRET efficiency (E) was 
determined using the following formula: 
 
 
                                           GFPB – (TomB x C x GFPexp) / Tomexp 
FRET efficiency (E) =   1  -      ____________________________________  
                                                           GFPA – (TomA x C x GFPexp) / Tomexp 
 
 
GFPB – GFP fluorescence intensity before photobleaching 
GFPA – GFP fluorescence intensity after photobleaching 
TomB – tdTomato fluorescence intensity before photobleaching 
TomA – tdTomato fluorescence intensity after photobleaching 
GFPexp – GFP units of exposure 
Tomexp – tdTomato units of exposure 
C - Fraction of the tdTomato excitation that the 488 laser gives, relative to the 561 
laser, per unit of exposure. 
Grey value images were obtained by pixel-by-pixel subtraction of GFP pre-bleach 
from GFP post-bleach images using Image J software.  
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2.5.5 Interference reflectance microscopy (IRM) 
 U2OS cells were seeded in fibronectin-coated glass bottom dishes. Cells were 
fixed with 4 % PFA and stained with phalloidin. The dishes were filled with PBS and 
placed on the microscope. Interference refection images were collected using a LSM 
510 META (Zeiss) microscope (Holt et al., 2008). Images treatment and analysis was 
done using Image J using the phalloidin stain to help define the cell area. 
 
2.6 Apoptosis assays 
2.6.1 Transient assay - Sub G1 population  
 Saos-2 cells were seeded the day before on 6 cm dishes to achieve 80 % 
confluency at the time of transfection. Cells were transfected the next day with a 
plasmid expressing CD20 (1.5 µg) and 5 µg of pcDNA3.1, pcDNA3.1 vGAAP or a 
series of mutant pcDNA3.1 vGAAP. 
 Apoptosis was induced using 1.5 µM STS at 18 h post transfection and the cells 
(floating and adherent) were collected 6 h later. Cells were washed in cold PBS and 
stained with FITC-conjugated anti-CD20 antibody (Table 2.9) for 2 h on ice. After this 
step, cells were washed once in PBS and fixed in cold 96 % methanol for 18 h. Cells 
were washed again in PBS and resuspended in propidium iodide (PI) staining solution 
(0.05 mg/ml PI and 0.05 mg/ml RNase A in ml PBS) for 10 min at RT. 
 Flow cytometry was performed using the DAKO Cyan flow cytometer and data 
were analysed using the DAKO summitv4.3 software.    
 
2.7 Cell attachment, spread and migration assays 
2.7.1 Cell attachment assay 
 Non-confluent HeLa or U2OS cells were detached with trypsin and washed 
twice with 1 % FBS medium. The cells were counted and the same number of cells 
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was seeded in 12-well plates in 1 % FBS medium that had been keep at 37 °C with 5 
% CO2. After different time points after seeding, cells were gently washed twice with 
warm PBS and fixed with 4 % formaldehyde (4 % PFA + 250 mM HEPES pH7.4). 
 To quantify the percentage of cells that had already attached to the wells, these 
were stained with 0.1 % crystal violet in 200 mM HEPES for 1 h. The wells were 
washed 3 times with water and the dye was eluted using 10 % acetic acid. Samples 
were transferred to a 96-well plate and absorbance at 560 nm was measured a 
spectrophotometer. The absorbance was plotted against time to compare the rate of 
adhesion between the different cell lines. 
 
2.7.2 EDTA/ethylene glycol tetraacetic acid (EGTA) cell 
detachment assay 
 HeLa or U2OS cells were seeded in 12-well plates so that they were 60 % 
confluent the next day. Cells are washed with 1 ml of warm PBS twice and incubated 
with 1 ml of warm PBS for 15 min. EDTA or EGTA was added to the cells and 20-40 
min after incubation (at 37 °C) with the drug cells were washed gently with PBS to 
remove any non-adherent cells and the remaining adherent cells were fixed using 4 % 
PFA for 20 min. 
 To quantify the percentage of cells remaining attached to the wells after 
treatment, cells were stained with 0.1 % crystal violet in 200 mM HEPES for 1 h. The 
wells were washed 3 times with water and the dye eluted using 10 % acetic acid. 
Samples were transferred to a 96-well plate and the absorbance was read at 560 nm. 
Taking the untreated cells as 100 % adherent, the level of cell detachment was 
calculated for the different conditions. 
 
2.7.3 Wound healing assay (WHA) – migration assay 
 U2OS cells were seeded in 10 % FBS media and cultured to confluence. Cells 
were rinsed twice with PBS and starved overnight in serum free medium. A horizontal 
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line was drawn using a marker on the bottom of the dish to be used as a guide. Using a 
sterile 200 µl pipette tip the cell monolayer was scratched perpendicularly to the line 
drawn in the step above, in three separate places per well, to create three wounds. The 
cells were rinsed and the medium was replaced with fresh FBS free medium or 
medium containing 10 % FBS. Regions above and below the point where horizontal 
line crosses the different wounds were acquired using a CCD camera with a 10x 
objective. Each region was imaged every 15 min for 12 h.  
 Distance between the two sides of the wound over time was measured using 
Image J and plotted against time to calculate cell migration speed. 
 
2.7.4 Cell spread assay 
 U2OS cells were detached and rinsed twice in FBS-free medium. Cells were 
seeded on fibronectin-coated slides and left to attach for different times. Cells were 
then fixed with 4 % PFA at different time points post-seeding. Image acquisition was 
performed using a LSM 510 META (Zeiss) microscope with a 63x objective. The cell 
area was determined using Image J and the mean was plotted against time.  
 
2.8 Electrophysiology  
 All patch clamp lipid bilayer recordings done with GAAP and BI-1 proteins 
purified by me, were performed by Guia Carrara in the laboratory of Prof. Colin Taylor 
at the Department of Pharmacology, University of Cambridge. The approach used was 
based on the work published by Kreir et al. (2008) 
 
2.8.1 Making giant unilaminar vesicles (GUV) 
 The production of GUVs was done using electroformation from a 1,2-
diphytanoyl-sn-glycero-3-phosphocholine (DPhPC) and cholesterol lipid mix. The lipid 
mix used (20 µl of a 1:10 mM cholesterol (Sigma) to DPhPC (Avanti) in chlorophorm) 
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was spread on the conductive side of an indium tin oxide-coated (ITO-coated) slide and 
the solvent left to evaporated. An O-ring was placed around the area of dried lipid film 
and 1 M sorbitol was placed over the lipids. A second ITO-coated slide was placed 
over the lipids, and the cassette was connected to the Vesicle Prep Pro (Nanion). The 
electroformation programme was initiated under the following parameters: a frequency 
of 5 Hz, 3 V voltages peak to peak, for 128 min at RT. GUVs were then re-suspended 
and kept at 4 °C. 
!
2.8.2 Testing GUVs and forming GΩ planar bilayer seals 
 To test GUVs for their ability to form planar lipid bilayers these were tested on a 
Port-a-Patch (Nanion). Patch clamp buffer (140 mM KCl pH 7, 200 nM CaCl2, 10 mM 
HEPES) were deposited on the inner side of a chip with an aperture of approximately 1 
micron in diameter. The chip was mounted onto the Port-a-Patch system, and Patch 
clamp buffer was deposited on the outer side of the chip. A membrane potential of 20 
mV was applied, and following the addition of GUVs in solution, suction was applied. A 
change in seal resistance from an order of magnitude of MΩ to GΩ, proved that GUVs 
have formed a planar bilayer seal over the chip opening.  
!
2.8.3 Reconstituting purified protein into GUVs 
 To introduce purified protein into GUVs, purified protein was added to 50 µl of 
GUVs solution to a final concentration of 2 mg/ml, to which 100 µl of biobeads were 
added, and incubated for 15 min at RT. The beads were then discarded and the protein 
containing GUVs were used to form GΩ planar bilayer seals as described previously.  
 
2.8.4 Single ion channel recordings 
 The PatchMaster software (Nanion) was used in combination with the EPC 10 
Patch clamp amplifier (HEKA) to collect electrophysiological recordings in response to 
varying membrane potentials ranging between -100 mV and 100 mV.  Recordings were 
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made using a standard electrophysiology buffer (140 mM KCl, 20 nM CaCl2, and 10 
mM HEPES, pH 7).  
 
2.9 Protein alignments 
 All amino acid sequence alignments were done using the CLUSTAL W (1.83) 
multiple sequence alignment program. 
 
2.10 Statistical analysis 
 Statistical analysis of data was performed using GraphPad Prism 5 software. 
For FRET, cell detachment, attachment, protein cleavage, focal adhesion duration and 
flow cytometry, the data were analysed using an unpaired Student’s T-test. For number, 
area and size of adhesions and cell size the data were analysed using a Mann-Whitney 
non-parametric test. * P<0.05, ** P<0.01, *** P<0.001 
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 Chapter III 
Purification of TMBIM family proteins 
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 In an attempt to gain a better understanding of the biochemical and structural 
features of GAAP and other TMBIM family proteins a subset of these were expressed 
in yeast and purified. Ideally, purified protein would be used in crystallization trials with 
the objective of solving the protein structure. Because there is still no solved structure 
for any member of the TMBIM family this could provide a structure upon other TMBIM 
members could be modelled, and this could provide some clues about GAAP function. 
Purified protein would also be used for biochemical characterization and for functional 
assays such as testing ion channel activity in planar lipid bilayers. All the work 
described in this chapter was performed in Dr. Bernadette Byrne laboratory at Imperial 
College London. 
 A GFP-8His tag-based method (Drew et al., 2006) was selected for expression 
and purification of the eukaryotic TMBIM membrane proteins in Saccharomyces 
cerevisiae. This method was selected over others for a number of reasons. Firstly, 
yeast has proven to be one of the most successful heterologous overexpression 
systems for the production and purification of eukaryotic membrane proteins 
(Carpenter et al., 2008). Secondly, the use of a C-terminal GFP tag allowed the 
measurement of membrane integrated protein as the C-terminal GFP will only fold and 
fluoresce if the upstream protein folds properly and integrates the membrane. This 
allows an easy and quick detection of protein production in liquid cultures, protein gels 
and detergent solubilized protein. The use of a tobacco etch virus protease (TEVp) 
cleavage site between the protein of interest and the GFP-8His tag allows the removal 
of the GFP-8His tag to obtain native protein. Finally, the GFP-8His based system also 
allows the initial screening of many different proteins, which allowed an initial small 
screen to be made of 5 different TMBIM alleles, to find those that were most stable and 
highly expressed. The proteins selected for the initial screen were Arabidopsis thaliana 
GAAP3, vGAAP from CMLV, hGAAP and BI-1.  
 This method consists on the insertion of the desired PCR fragments, by 
homologous recombination, in to a yeast expression vector under the control of an 
inducible promoter (GAL1) (Figure 3.1). After induction with galactose the cells are 
collected, disrupted and the membrane fraction was extracted by ultracentrifugation. 
Membrane proteins were extracted from the membrane fraction using a detergent and 
then affinity purified using a His-Trap column. The purified protein was digested with 
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TEV protease to release the GFP-8His tag, and subjected to a reverse affinity 
purification, where the protein of interest (untagged) does not bind the column.  
 
3.1 Creation of GAAP and BI-1 yeast expression strains  
 BI-1, vGAAP, hGAAP and hGAAP T88I, which includes a single point mutation 
found in an ovarian cancer cell line (Benjamin Johnson, unpublished data), were 
amplified by PCR with primers that included sequences to allow homologous 
recombination with the p426 GAL1 TEVp GFP-8His plasmid once co-transformed into 
yeast (Figure 3.1). GAAP3 from Arabidopsis thaliana (AtGAAP3) had been cloned by 
our collaborator, Dr. Bart Feys, Imperial College London. The reverse primers used 
also included a TEV protease cleavage site to allow the removal of the GFP-8His tag. 
The plasmid p424 GAL1 TEVp GFP-8His was derived from p426 GAL1 by Drew et al. 
(2006) by cloning a GFP-8His tag and the desired homologous recombination sites. 
Downstream from the homologous recombination site is GFP (codon optimized for 
expression in yeast) to allow easy protein detection and an 8His tag for protein 
purification using nickel. The plasmid obtained after homologous recombination is 
shown in Figure 3.1. The GAL1 promoter allows the controlled induction of protein 
expression by the addition of galactose to the culture medium.  
 Plasmid DNA was extracted from all yeast strains created, expanded in a 
bacterial system and sequenced to confirm the correct cloning and the absence of 
mutations that could have occurred during PCR. Clones where these conditions were 
verified were selected and used in subsequent experiments. 
 
3.2 Protein expression and sub cellular localization in yeast 
 To determine whether the proteins produced had the correct size and hence 
were expressed correctly, a protein Tris-glycine gel was run with membrane extracts 
obtained by ultracentrifugation from cell extracts (as described in 2.4.5) form two 
clones of each transformation after a 24 h induction with galactose (Figure 3.2A). 
AtGAAP3 was also used as a positive control for both protein expression and 
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approximate protein size in SDS-PAGE as previous preliminary results from Dr. Bart 
Feys (unpublished data) showed that this protein could be expressed using this 
system. Using this approach it was clear that all the proteins run at ∼38 kDa (Figure 
3.2A), close to the predicted size of 40 kDa (20 kDa [vGAAP experimental size] + 23 
kDa [approximately the GFP-8His experimental size, see Figure 3.5]). 
 
 
 
 
Figure 3.1 - Strategy used to clone the genes of interest into the p424 GAL1 
vector. The PCR products and the linearized vector (with SmaI) were transformed into 
the parental yeast strain. The gene of interest in the PCR product was cloned into the 
vector by homologous recombination. As shown in the diagram, the final plasmid 
allowed the expression of the gene of interest fused to GFP and to an 8His tag with a 
TEV protease cleavage site just before the GFP to allow the removal of both tags 
during the purification process.  
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TEV cleavage site 
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Figure 3.2 - Protein expression in yeast. Yeast strains engineered to express the 
TMBIM proteins were induced with galactose for 22 h to activate protein expression 
from the GAL1 promoter. Protein expression levels was determined by (A) in gel 
fluorescence of membrane extracts from two yeast clones of each construct resolved 
by SDS-PAGE and (B) relative GFP units (arbitrary units) from total cell cultures. The 
highest expressing clone values are shown for each strain. * Correspond to an 
endogenous fluorescent ‘background’ protein, L - Fluorescent ladder. The position of 
size markers in kDa is shown on the left of the gel. (C) Membrane localization of 
TMBIM family proteins fused to GFP was tested under confocal microscopy. Two 
representative cells for each strain are shown. Phase contrast was used to determine 
the cell outline. Scale bar corresponds to 2 µm 
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 Protein expression levels were determined by measurement of whole cell GFP 
fluorescence emission from liquid cultures (Figure 3.2B). vGAAP and BI-1 had the 
highest expression levels, comparable with AtGAAP3. Both human GAAP alleles 
tested failed to express at high enough levels to proceed with large scale expression 
and purification although their expression could be confirmed with the in gel 
fluorescence and by confocal microscopy. Band intensity detected by in gel 
fluorescence correlated well with the GFP fluorescence emission. 
 Using confocal microscopy on immobilized live yeast cells from different strains, 
which had been induced with galactose for 24 h to induce protein expression it was 
possible to observe a discrete, intracellular and cytoplasmic pattern compatible with a 
cytoplasmic (BI-1), ER (GAAPs and BI-1) or Golgi (GAAPs and BI-1) subcellular 
localization of the fusion proteins tested (Figure 3.2C). The subcellular distribution 
pattern is more consistent with either an ER or Golgi localization (Newstead et al., 
2007) in all cases. Although further experiments using organelle specific markers would 
be required to dissect the specific subcellular localization, this simple and quick 
approach suggests that the proteins are being integrated into the membrane as 
expected. 
 Given that only AtGAAP3, vGAAP and BI-1 expressed at high enough levels to 
enable protein purification, these three alleles were selected for further characterization 
before protein purification was attempted. 
 
3.3 Protein monodispersity and solubility in DDMα and 
LDAO 
 After yeast membrane purification using 1 L cultures (as described in 2.4.5) the 
GFP-fusion proteins were solubilized using different detergents to extract the 
membrane-associated proteins. The solubilisation efficiency for the different proteins in 
different detergents was calculated as described in methods section 2.4.6.1. As a first 
approach the two detergents tested were (DDMα) and (LDAO). 
 Both detergents used were able to solubilize BI-1-GFP and GAAP-GFP fusion 
proteins from yeast membrane extracts with an efficiency of around 70 to 80 % (Figure 
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3.3A). LDAO solubility efficiency appeared to be slightly higher that DDMα for all three 
proteins. 
 
 
 
Figure 3.3 - Detergent screen. (A) Solubilisation efficiency of TMBIM proteins in two 
detergents, DDMα and LDAO. Membrane extracts from yeast cultures 22 h post 
galactose induction were solubilized in either DDMα or LDAO and protein solubilisation 
efficiency was determined (see methods for more details). (B) Fluorescent size 
exclusion chromatography (FSEC) analysis of AtGAAP3, vGAAP and BI-1. Membrane 
extracts from small-scale cultures were solubilized using LDAO or DDMα and analysed 
by size exclusion chromatography (SEC) as described in materials and methods. The 
GFP emission for each fraction was measured and the GFP relative fluorescent units 
(RFU) were plotted against the fraction number. 
  
vG
AA
P%
BI
(1
%
At
GA
AP
3%
A B
0%
1000%
2000%
0% 20% 40% 60% 80% 100%
RF
U
$
Frac(ons$
0%
1000%
2000%
0% 20% 40% 60% 80% 100%
RF
U
$
0%
1000%
2000%
3000%
4000%
0% 20% 40% 60% 80% 100%
RF
U
$
DDMα%
LDAO%
AtG
AA
P3
vG
AA
P
BI
-1
0
20
40
60
80
100
So
lu
bi
lity
 e
ffi
ci
en
cy
 (%
)
DDMα
LDAO
  
             100 
 
 Given that all TMBIM proteins were fused to GFP it was possible to test protein 
monodispersability after detergent solubilisation using fluorescence size exclusion 
chromatography (FSEC). Detergent solubilized proteins that are monodispersed are 
typically stable after purification (Kawate and Gouaux, 2006). LDAO or DDMα 
solubilised protein was loaded onto a SEC column, and 200 µl fractions from the 
column were collected in a 96-well plate and tested for GFP expression by measuring 
total GFP fluorescence (Figure 3.3B). The criterion used to access monodispersity was 
that the fusion protein main peak was symmetric and larger than either the peak 
corresponding to the aggregated protein (small peak on the left hand side of the main 
peak) or free GFP peaks (expected between the main and the aggregate peak). All 
three proteins tested appeared to be monodispersed in both detergents used (Figure 
3.3B) because all curves are symmetrical and no other significantly large peaks are 
detected. Only a small peak corresponding to aggregated protein was detected for 
vGAAP and BI-1. In all cases, the GFP RFU values indicate that there were good 
levels (>1000 RFU) of monodispersed protein. LDAO gave higher and more 
symmetrical peaks when compared to DDMα. Free GFP was not detected in this 
experiment.  
 One of the main purposes of this experiment was to screen for the best 
detergent to be used during large-scale protein purification. Taking all these data into 
consideration it was decided to proceed with the production in a large scale of the three 
proteins using LDAO as the extraction detergent. 
 
3.4 Protein purification strategy 
 To obtain pure protein from large-scale cultures, cells were induced with 
galactose, lysed 24 h later and the membranes were purified. Protein was solubilized 
using LDAO, because this was the detergent that showed the best results both for 
protein solubilisation efficiency and monodispersability. Following this step, the 
preferred method used to purify membrane proteins would be binding the protein to a 
Ni-NTA resin (“slurry”) (Figure 3.4) where proteins are allowed to bind to the nickel 
resin in solution with agitation. This mix is then poured into an empty glass column for 
washing and eluting steps. However, this method gave a very poor binding efficiency 
  
             101 
 
(calculated as the difference in GFP fluorescence between the initial sample and the 
column flow through as described in 2.4.7.2), which was less than 15 % for vGAAP.  
 
 
 
 
Figure 3.4 - Schematic of the purification protocol used to purify AtGAAP3, BI-1 
and vGAAP from yeast membrane extracts. After solubilisation, the membrane 
proteins were either bound to slurry Ni-NTA resin (“slurry”) or to a 5 ml His-Trap 
column, washed and eluted with imidazole. The GFP-fusion proteins were then cleaved 
with TEV protease to remove the GFP-8His tag. TEV protease (that contains an 8His 
tag) and GFP-8His were removed from the mix in a reverse purification step using a 5 
ml His-trap column. The purity and monodispersity of the final cleaved protein was 
assessed by SEC and SDS-PAGE.   
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 An extended overnight incubation with the resin increased the protein binding to 
the resin but only up to ~30 %. Given the poor binding to the “slurry” we decided to try 
a His-Trap column (Figure 3.4) to purify the fusion proteins, although we were aware 
that this approach could increase the protein lipid removal and lead to an increase in 
protein instability.  
 After this step the bound protein was washed and the visible green band, mainly 
corresponding to the GFP fusion protein, was eluted with 250 mM midazole. The 
sample was diluted until the imidazole concentration reached 30 mM, Pure TEV 
protease-8His was added to the sample and incubated for 24 h to allow cleavage of the 
GFP fusion protein. To remove the uncleaved GAAP-GFP-8His, TEVprotease-8His, 
free GFP and other possible contaminants the sample was further diluted and passed 
again through a new His-Trap column in what is called a “reverse purification” (Figure 
3.4). In this case the bound fraction was discarded and the flow through retained. The 
final sample was concentrated and run through a SEC column.  
 
3.5 Camelpox virus vGAAP purification 
 The CMLV vGAAP protein was purified from 5 L cultures using the protocol 
described above in Figure 3.4 with LDAO as solubilizing detergent and using a His-
Trap column to bind the GFP-8His tagged protein. Using this protocol a binding 
efficiency of 60-70 % was consistently obtained for vGAAP. 
 When the final cleaved vGAAP purified sample was analysed by SEC four 
peaks were observed (Figure 3.5A). The first peak (at ∼8 ml of elution volume) 
corresponded to aggregated protein while the other three to different oligomers of 
vGAAP (at 12.5 ml, 13.5 ml and 15.5 ml). Most protein was found to elute in second 
and third peaks (Figure 3.5C) and when the protein from all three peaks was 
concentrated and analysed by non-reducing SDS-PAGE at least four intense bands 
(labelled c, d, e and g) were observed in addition to a band corresponding to free GFP 
(labelled as f) and a band corresponding to uncleaved GAAP-GFP. All four bands that 
might correspond to different vGAAP oligomeric forms were detected by the anti-GAAP 
Ab by immunoblot (Figure 3.5D), as well as two additional bands that were probably 
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monomeric and dimeric uncleaved GAAP-GFP because these are also detected by in-
gel fluorescence (Figure 3.5B).  
 Although there was some clear contamination with both uncleaved GFP fusion 
and with some free GFP (labelled a and b, respectively) (Figure 3.5 B) these seemed 
to represent a small fraction of the total final concentrated protein as showed in the 
Coommassie stain (Figure 3.5C). GFP was used as an additional control for both size 
and GFP fluorescence detection. Some additional bands that do not correspond to 
either putative vGAAP or vGAAP-GFP oligomeric forms can be seen but these 
represent a small fraction of the total protein sample and can possibly correspond to 
some cleaved form of vGAAP (see 3.8 for more details). The final yields obtained were 
usually around 0.35 mg of pure protein per litre of starting yeast culture. This amount 
was enough to allow the setting up of crystallization trials at 10 mg/ml of protein in both 
the MemGoldTM ICL6 and ICL9 conditions (Molecular Dimensions under license from 
Imperial College of Science Technology & Medicine, London, (Newstead et al., 2008)) 
at 4 °C and 20 °C. Unfortunately no crystal formation was observed for over 3 months 
for all conditions tested. 
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Figure 3.5 - vGAAP (CMLV) purification in LDAO. vGAAP was purified from a 5 L yeast culture using LDAO as the extraction detergent 
and using a 5 ml His-Trap strategy to bind the protein to the nickel resin. A filter with a molecular weight cut off (MWCO) of 30 kDa was 
used to concentrate the protein after the reverse purification step. The final protein sample was submitted to gel filtration in a Superdex 
200 column. (A) The fractions obtained corresponding to the UV peaks were analysed by (B) in gel fluorescence and (C) Coomassie 
stain. The final concentrated protein was visualized using Coomassie staining and in parallel an (D) anti-GAAP immunoblot was also 
performed. L - ladder, FL - fluorescent ladder. * Corresponds to the aggregation peak and the arrows with the letters a-g correspond to: a- 
vGAAP-GFP, b- free GFP, c- putative 4x vGAAP, d- putative 3x vGAAP, e- putative 2x vGAAP, f- free GFP and g- 1x vGAAP. The 
position of size markers in kDa is shown on the left of each gel. 
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3.6 Arabidopsis thaliana GAAP3 purification  
 Using a very similar purification protocol as the one used to purify vGAAP it was 
possible to obtain purified AtGAAP3 protein. The His-Trap column allowed a binding 
efficiency of 50-60 %, which although lower than that obtained for vGAAP was still high 
enough to allow a final yield of 0.25 mg of protein per litre of starting yeast culture.  
 The final pure protein obtained after reverse purification was concentrated 
through a 50-kDa molecular weight cut off (MWCO) filter (and here referred as the 50-
kDa sample) and the flow through further concentrated using a 30-kDa MWCO filter 
(and here referred as the 30-kDa sample). Both samples were analysed by SEC 
(Figure 3.6A). For the 30-kDa sample there was no detectable aggregation peak and 
there were only two visible peaks (at 14.5 ml and 15.5 ml) that might correspond to the 
dimeric and monomeric forms of the protein by analogy with the results found for 
vGAAP. In the 50 kDa sample SEC profile there was one visible predominant peak (at 
14.5 ml) that overlapped with the putative dimer peak observed in the 30-kDa sample. 
The Tris-glycine PAGE followed by Coomassie stain analysis of the samples revealed 
that the concentrated 50-kDa sample (that contained all the fractions from 10 to 17.5 
ml) showed a higher number and intensity of higher molecular size bands when 
compared with the 30-kDa concentrated sample (that also contained all the fractions 
from 10 to 17.5 ml) where only one band was clearly visible (Figure 3.6C). A small 
contamination with the AtGAAP3-GFP and free GFP was detectable by in gel 
fluorescence for the 50 kDa concentrated sample (Figure 3.5B) and could also be 
detected by Coomassie stain (Figure 3.5C, bands g and e). Considerably less 
additional bands that could not be explained by either oligomerization of uncleaved 
protein were detected for both the 30-kDa and 50-kDa AtGAAP3 concentrated samples 
when stained with Coomassie (Figure 3.6C) when compared with vGAAP, although the 
final protein concentration showed here was considerably lower (∼1 mg/ml) than 
vGAAP.  
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Figure 3.6 - AtGAAP3 purification in LDAO. AtGAAP3 was purified from a 5 L culture using LDAO as the extraction detergent and using 
a 5 ml His-Trap strategy to affinity purify the protein. After the reverse purification step the protein was concentrated through a 50-kDa 
MWCO filter and the flow through was further concentrated through a 30-kDa MWCO filter. Both samples were run through a Superdex 
200 column and (A) the fractions corresponding to the UV peaks of the 30-kDa MWCO sample and the concentrated 50-kDa sample were 
analysed by (B) in gel fluorescence and (C) Coomassie stain. L - ladder, FL - fluorescent ladder. * Corresponds to the aggregation peak 
and the arrows with the letters a-g correspond to: a- AtGAAP3-GFP, b- free GFP, c- putative 4x AtGAAP3, d- putative 3x AtGAAP3, e- 
AtGAAP3-GFP, f – putative 2x AtGAAP3, g- free GFP and h- 1x AtGAAP3. The position of size markers in kDa is shown on the left of 
each gel. 
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3.7 BI-1 purification in LDAO  
 BI-1 is the most extensively studied member of the TMBIM family and has also 
been showed to modulate Ca2+ (Xu et al., 2008), to have Ca2+/H+ antiporter activity 
when reconstituted in liposomes (Ahn et al., 2010) and a peptide containing its C-
terminal portion was recently showed to be able to form a Ca2+ permeable channel 
pore (Bultynck et al., 2011). Using the same approach described above for vGAAP we 
were able to achieve a final yield of 0.1 mg of BI-1 protein per litre of culture. This 
considerably lower yield was partially due to a lower binding efficiency of the protein to 
the His-Trap column (50-60 %).  
 The final purified BI-1 sample obtained after the reverse purification was 
concentrated using a 50-kDa MWCO filter (here referred as the 50-kDa sample) and 
the flow through was concentrated further using a 30-kDa MWCO filter (here referred 
as the 30-kDa sample). The SEC profile obtained for both samples showed several 
peaks or shoulders that were consistent with BI-1 being an oligomer, as seen for 
GAAPs. Three peaks/shoulders, other than the aggregation peak, were visible at ∼12.5 
ml, 14 ml and 15 ml (Figure 3.7A). The peak corresponding to the lower molecular size 
species (15 ml) and the next peak to the left (14 ml) probably corresponded to a 
monomeric and diametric BI-1, respectively. The shoulder on the 14 ml peak 
corresponded to either aggregating protein or most likely to either a trimeric or 
tetrameric species. The very high aggregation peak and the low yield obtained 
suggested that the protein was highly unstable in the conditions used. 
 Using in-gel fluorescence analysis, only residual BI-1-GFP was detected in the 
final protein sample (Figure 3.7B labelled as band a). Since BI-1 could barely be 
detected with Coomassie stain, silver stain was used instead (Figure 3.7C). The overall 
purity of the final protein sample was very difficult to assess due to the very low yield 
obtained but it was clear that the final sample was far from pure. Most of the protein 
detected by silver stain was found to run at a size that could correspond to a dimeric 
form of the protein, (Figure 3.7B, band labelled as b), while almost no monomeric form 
was observed.  
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Figure 3.7 - BI-1 purification in LDAO. BI-1 was purified from a 5 L yeast culture using LDAO as the extraction detergent and using a 5 
ml His-Trap strategy to bind the protein to the resin. After the reverse purification step the protein was concentrated through a 50 kDa 
MWCO filter and the flow through was concentrated further through a 30-kDa MWCO filter. Both samples were run through a Superdex 
200 column and (A) the fractions corresponding to the UV peaks were analysed by (B) in gel fluorescence and (C) silver stain. L - ladder, 
FL - fluorescent ladder. * Corresponds to the aggregation peak and the arrows with the letters a-f correspond to: a- BI-1-GFP, b- free 
GFP, c- putative 4x BI-1, d- putative 2x BI-1, e- free GFP, f –1x BI-1. The position of size markers in kDa is shown on the left of each gel. 
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3.8 BI-1, vGAAP and AtGAAP3 protein stability 
 Protein stability of the TMBIM proteins purified from yeast was tested at the two 
temperatures most commonly used for protein crystal growth, 4 °C and 20 °C, over a 
period of several days. 
 vGAAP appeared to suffer some form of cleavage or degradation because both 
putative dimer and monomer bands showed a clear reduction in size over time as 
shown by Coomassie stain (Figure 3.8A). This reduction in size happened at a faster 
rate for samples kept at 20 °C compared to 4 °C. When the same samples were 
immunoblotted with an Ab raised against the N-terminal region of vGAAP it became 
apparent that the N-terminal region of the protein was being cleaved because the 
signal obtained with the anti-GAAP Ab was reducing with time (Figure 3.8B), although 
a slightly smaller form of the protein could still be detected with the Coomassie stain. A 
similar cleavage pattern was observed for AtGAAP3, but the degradation observed 
occurred at a much slower rate, only being truly clear after 6 days at 20 °C (Figure 
3.8C). The band corresponding to putative monomeric BI-1 showed no cleavage or 
degradation. However, given the very low amounts of protein the bands could not be 
clearly detected, so it was possible that degradation was still occurring but in these 
conditions it was not visible (Figure 3.8B). 
 Protein N-terminal sequencing was used to confirm the vGAAP protein identity 
and to determine to what degree the protein was being degraded (Figure 3.8C). This 
approach identified the 20-kDa band as vGAAP and also showed the expected N-
terminal protein degradation/cleavage when the sample was kept for 7 days at 20 °C 
prior to N-terminal sequencing. In 66 % of the sequences obtained the first 25 amino 
acids had been removed, some other starting sequences were also found but in lower 
abundance.  
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Figure 3.8 - Temperature stability assay. vGAAP (A and B) BI-1 and AtGAAP3 (C) 
were incubated for several days at 4 °C or 20 °C. After different times of incubation 
samples of each protein were collected and stored at -80 °C. All the samples were run 
in a Tris-glycine gel and this was stained by Coomassie stain (A and C) or (B) 
immunoblotted using a polyclonal Ab raised against a N-terminal peptide of vGAAP. 
(D) N-terminal amino acid sequence of CMLV vGAAP, before and after 7 days 
incubation at 20 °C, obtained from protein N-terminal sequencing. The percentage of 
protein that has each one of the represented amino acids as the first amino acid of the 
peptide chain is shown. The position of size markers in kDa is shown on the left of 
each gel.  
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3.9 Summary 
 The SEC profile of the final concentrated purified vGAAP protein is consistent 
with either the presence of two contaminants, because three peaks other than the 
aggregation peak are observed, or with vGAAP behaving as an oligomer (Figure 3.5A). 
The second option seems to be the more likely because all four bands obtained on a 
Coomassie stained gel of purified protein are reactive with the anti-GAAP Ab (Figure 
3.5D). It seems very unlikely that the residual GFP fusion protein by itself could 
account for any of the SEC peaks, because this was almost undetectable by in gel 
fluorescence (Figure 3.5B) and hardly visible by Coomassie stain (Figure 3.5C). 
Nevertheless this was not formally ruled out by any of the experiments performed. 
Further experiments were done in a mammalian cell expression system with both 
hGAAP and vGAAP to further explore the GAAP oligomerization hypothesis. These 
results are presented in chapter V of this thesis.  
 The yeast-based method chosen to express TMBIM proteins enabled the 
production and purification of three different members of the TMBIM family, vGAAP, 
AtGAAP3 and BI-1. Using this approach and taking into account data shown above for 
each protein purification process, it became clear that AtGAAP3 was the most pure and 
stable of all the three TMBIM proteins tested. 
 The final protein obtained allowed some very elementary biochemical 
characterization as well as lipid bilayer patch clamp experiments (described in chapter 
IV) to be performed. However all crystallization trials attempted did not generate any 
crystals. Further optimizations to improve protein purity, stability and solubility are 
probably needed if the crystallization of any of these proteins is ever to be attempted 
again. 
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 Chapter IV 
 GAAP is an ion channel 
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 Previous work reported that overexpressed hGAAP interacted with endogenous 
IP3R type three (de Mattia et al., 2009). IP3R but not SERCA was able to co-
immunoprecipitate with hGAAP. However, it was not determined if this interaction was 
direct or indirect and one difficulty with this model was that the majority of IP3R is 
located in the ER, whereas GAAP is present in the Golgi. Endogenous hGAAP was not 
used, as there was not then and still there is not a good anti-GAAP Ab that is able to 
immunoprecipitate GAAP. 
 The finding that hGAAP can modulate intracellular stores Ca2+ content led to the 
two alternate hypotheses to explain the effects of GAAP overexpression and knock 
down in Ca2+ homeostasis. The ability of hGAAP to co-immunoprecipitate with IP3R 
combined with the fact that hGAAP can modulate IP3-induced Ca2+ signaling (de Mattia 
et al., 2009) led to the hypothesis that hGAAP could modulate Ca2+ by regulating IP3R 
channel activity, perhaps as part of a larger protein complex. The alternative 
hypothesis was that GAAP could itself function as an ion channel and regulate Ca2+ 
content by allowing the flow of Ca2+ ions (Figure 4.1).  
 
 
 
 
Figure 4.1 – Two possible mechanisms by which GAAP is able to reduce the Ca2+ 
filling state of intracellular stores. GAAP could either exert its effect on the Ca2+ 
filling state of intracellular stores by modulating another Ca2+ channel activity (left) or by 
acting as a Ca2+ channel itself (right).  
 
Golgi&
Ca2+&
Ca2+&
GAAP&
Ca2+&channel&Golgi 
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4.1 Interaction between GAAP and IP3R was observed by co-
immunoprecipitate when both proteins were overexpressed 
 As a first approach to understand GAAP’s anti-apoptotic and Ca2+ modulating 
mechanisms, a further characterization of the nature of the GAAP-IP3R interaction was 
attempted. The existence of a similar interaction between vGAAP and IP3R was also 
tested. 
 To further explore and characterize the interaction of GAAP with the IP3R a 
yellow fluorescent protein (YFP)-tagged IP3R type 1 was used in co-
immunoprecipitation experiments (kindly provided by Prof. Colin Taylor, University of 
Cambridge). This protein has a single residue change in the pore region (VG2550DVLR 
to VGAVLR) (Parker et al., 2004) that inactivates the channel, allowing stable 
overexpression without deleterious effects for the cells. COS-7 cells were transfected 
with a plasmid that encodes YFP-IP3R and 24 h later cells were either infected with a 
recombinant VACV strain Evans lacking vGAAP (ΔvGAAP), or a VACV strain Evans 
with a C-terminally HA-tagged copy of vGAAP (rev-vGAAP-HA), or the cells were 
transfected with an expression plasmid encoding an HA-tagged hGAAP (pcDNA3.1-
hGAAP-HA). The YFP-IP3R was immunoprecipitated using an anti-GFP Ab and to 
determine if vGAAP or hGAAP were co-immunoprecipitated, the immunoprecipitates 
were immunoblotted with an anti-HA Ab. The reciprocal experiment was also 
performed for hGAAP: hGAAP was immunoprecipitated using an anti-HA Ab and the 
co-immunoprecipitation of IP3R was assessed by immunoblotting using an anti-GFP 
Ab. To test for non-specific precipitation of ER or Golgi membrane proteins the 
immunoprecipitates were also tested for the presence of SERCA.  
 Data obtained showed that it was possible to co-immunoprecipitate vGAAP and 
hGAAP using an anti-GFP Ab when co-expressed with YFP-IP3R but not when 
expressed on their own (Figure 4.2A and B lane 1). YFP-IP3R was also found to co-
immunoprecipitate with hGAAP when an anti-HA immunoprecipitation was performed 
(Figure 4.2B lane 1), although the YFP-IP3R band observed was very weak. SERCA 
was not co-immunoprecipitated in any of the samples tested, reducing the possibility of 
the above results being due to an unspecific pull down of Golgi and ER membranes. 
The tubulin immunoblots for the whole cell extracts (WCE) show that the initial total 
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protein content of the samples used in the immunoprecipitations was very similar in all 
the samples. GAAP and YFP-IP3R expression was confirmed by immunoblot of the 
WCE using anti-HA and anti-GFP Abs, respectively.  
 
 
 
 
Figure 4.2 - Overexpressed vGAAP and hGAAP can interact with overexpressed 
IP3R. Co-immunoprecipitation between vGAAP or hGAAP and YFP-tagged type 1 
IP3R. (A) COS-7 cells were transfected with pYFP-IP3R and 24 h later cells were 
infected with either ΔvGAAP or rev vGAAP-HA virus and collected after 16 h. (B) Cells 
were transfected with pYFP-IP3R and 24 h later cells were retransfected with either 
pcDNA3.1 or pcDNA3.1hGAAP-HA and collected after 16 h. (A and B) The cell lysates 
were immunoprecipitated with either an anti-HA Ab or an anti-GFP Ab and the 
immunoprecipitates were analysed by SDS-PAGE and immunoblotted (IB) using anti-
HA, anti-YFP Ab, anti-SERCA and anti-tubulin Abs as indicated. Tubulin was used as 
loading control. The position of size markers in kDa is shown on the left of each gel. 
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4.2 Attempt to map GAAP-IP3R interaction 
 In an attempt to map the IP3R domain involved in the interaction with vGAAP, a 
series of plasmids encoding for different portions of the transmembrane regions of the 
IP3R with an YFP tag were used (Figure 4.3A and B) (Parker et al., 2004). These 
expressed proteins were used in co-immunoprecipitation assays with vGAAP. 
Additional proteins tagged with YFP or GFP that localize to different cellular organelles 
were included as additional controls for non-specific co-immunoprecipitation due to the 
presence of the YFP tag. 
 Full length (fl) and all seven truncated forms of YFP-IP3R were expressed in 
COS-7 cells for 24 h. After this time cells were infected with either a ΔvGAAP or a rev 
vGAAP-HA VACV for 16 h and cell lysates were prepared for immunoprecipitation. All 
YFP-IP3R proteins were expressed but not all at the same levels. In an overexposed 
film it was visible that vGAAP could be co-immunoprecipitated by YFP-IP3R as shown 
before. But vGAAP was also co-immunoprecipitated with all seven truncated YFP-IP3R 
proteins tested. It was noted that even in cases like TMD1-2 and TMD5-6 that do not 
share any overlapping regions, both truncated forms of YFP-IP3R immunoprecipitated 
vGAAP efficiently.  
 The fact that a positive vGAAP co-immunoprecipitation could also be obtained 
with all of the negative control GFP- or YFP-tagged molecules (Figure 4.3C - 
overexposed HA blot) raised the possibility that the co-immunoprecipitation between 
vGAAP and fl YFP-IP3R detected previously was probably non-specific. 
 A similar experiment was conducted in which the cells were infected with VACV 
for just 6 h, in an attempt to reduce the vGAAP expression levels, hoping that this could 
increase the IP specificity (Figure 4.4). This time no vGAAP co-immunoprecipitation 
could  be  detected  with  any  of  the  negative  control  proteins  but  still  a vGAAP co- 
immunoprecipitation could be detected with most of the YFP-IP3R protein fragments 
tested confirming the non-specific nature of the co-immunoprecipitation. 
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Figure 4.3 - vGAAP is co-immunoprecipitated with all of IP3R TMDs. Co-immunoprecipitation (co-IP) between vGAAP and full length 
and truncated versions of YFP-tagged type 1 IP3R (plasmids were kindly provided by Colin Taylor, University of Cambridge). Schematic 
representation of (A) the full length and (B) the truncated forms and YFP-IP3R used to map the interaction. COS-7 cells were transfected 
with the different plasmids encoding all the IP3R-YFP alleles and 18 h later cells were infected with either ΔvGAAP or rev vGAAP-HA 
VACV and collected after 16 h. (C) Following co-IP with the anti-GFP Ab the immunoprecipitates and the whole cell extracts (WCE) were 
resolved by SDS-PAGE and were immunoblotted with anti-YFP, anti-HA, anti-SERCA (used as control for ER and Golgi membrane 
proteins contamination) and anti-tubulin (loading control) Abs. Four additional Clontech vectors that express YFP- or GFP-tagged proteins 
that localize to different cell organelles were used as negative controls: ER-YFP (YFP tagged peptide that localizes to the ER), YFP-
LamB1 (YFP tagged peptide that localizes to the nucleus), GFP-Tub (GFP tagged peptide that localizes to the cytosol) and pEYFP-C1 
(expresses free YFP). The position of size markers in kDa is shown on the left of the gel. 
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Figure 4.4 - vGAAP is co-immunoprecipitated with almost all of IP3R TMDs at 6 h 
post infection. Co-immunoprecipitation (co-IP) between vGAAP and full length and 
truncated versions of YFP-tagged type 1 IP3R. COS-7 cells were transfected with the 
different IP3R-YFP alleles and 18 h later the cells were infected with either ΔvGAAP or 
rev vGAAP-HA virus and cell lysates were prepared after 6 h. Immunoblots were 
performed following co-IP with the anti-GFP Ab and whole cell extracts (WCE). 
Membranes were immunoblotted with anti-GFP, -HA, -tubulin, and –SERCA Abs. ER-
YFP and pEYFP-C1 were used as negative controls. The position of size markers in 
kDa is shown on the left of the gel. 
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4.3 GAAP can allow the passage of ions through a lipid 
bilayer 
 Given the lack of specificity showed for the vGAAP-IP3R interaction it was 
unlikely that GAAP was modulating IP3R and therefore we sought to test the second 
hypothesis for GAAP mediated Ca2+ modulation in which GAAP would act as an ion 
channel itself. This would require vGAAP to have the ability to allow ions to flow 
through the membrane rather that controlling another ion channel such as IP3R.  
 Taking advantage of the purified proteins generated for biochemical and 
structural purposes, it was tested, in collaboration with Prof. Colin Taylor, if CMLV 
vGAAP and AtGAAP3 could allow the passage of ions when loaded into an artificial 
lipid bilayer. CMLV vGAAP was tested instead of VACV Evans vGAAP because the 
latter could not be purified using the same approach as used for CMLV vGAAP, 
AtGAAP3 and BI-1. BI-1 was also tested at the time for completion because it had 
been proposed that BI-1 could itself allow the flow of Ca2+ (Ahn et al., 2009; Bultynck et 
al., 2011). The adenosine A2 receptor that had been purified using the same protocol 
as GAAPs and BI-1 was used here as a negative control because no ion channel 
activity has been described for this protein (Lebon et al., 2011) (kindly provided by 
Bernadette Byrne, Imperial College London). All electrophysiological recording were 
done using the following buffer, 140 mM KCl, 20 nM CaCl in 10 mM HEPES, pH 7. This 
means that the only three ions that can possibly flow through the channels to generate 
a measurable current are K+, Cl- or Ca2+.  
 When reconstituted in planar lipid bilayers both GAAP proteins and BI-1 allowed 
the passage of ions when different artificial membrane potentials were applied (Figure 
4.5). The passage of ions is shown as “openings”, these openings are detected in 
amperage traces containing a baseline (corresponding to the closed channel) and are 
characterized by a sharp shift away from the baseline (channel opening) and back to 
the baseline (channel closing). These form very characteristic “square” openings. 
 Different amplitudes of opening were seen for vGAAP, AtGAAP3 and BI-1 and 
the absence of openings detected with both the detergent only and AA2R control 
suggest that the openings observed for the GAAP and BI-1 proteins are specific and 
are not due to any contaminants that remained during the purification procedure. 
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Figure 4.5 - CMLV vGAAP, AtGAAP3 and BI-1 allow the passage of ions when 
reconstituted into planar lipid bilayers. This experiment was carried out by Guia 
Carrara, Imperial College London, using proteins purified by me and is here 
reproduced with her permission. Artificial lipid bilayers patch clamping of human BI-1, 
AtGAAP3 and vGAAP from CMLV. The different proteins were reconstituted in GUV’s 
and added to a lipid bilayer. The artificial lipid bilayer was subjected to different 
membrane potentials using a single channel patch clamp system. Representative 
traces are shown and represent typical channel openings when the different membrane 
potentials were applied (-30 mV to -100 mM). To establish a base line, recordings were 
made in the absence of any protein (n=35). The dotted line defines the baseline 
amperage recorded in the absence of any protein. Any shifts below this line are 
considered to be due to channel openings, and the returning to the baseline represents 
closure of the channel. Adenosine A2 receptor (AAR) (n=6) and 1% LDAO (n=10) 
(detergent used for protein purification) were used as negative controls. Scale of 
amplitude in picoamperes (pA) over time in milliseconds (ms) is shown in the figure. 
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 This was the first electrophysiological ion channel-like activity data recorded for 
any of these proteins. This includes BI-1 where Ca2+/H+ anti-porter activity had been 
described indirectly through measurements of Ca2+ changes in liposomes where BI-1 
was reconstituted (Ahn et al., 2009) or Ca2+ channel activity using a peptide 
corresponding to its C-terminal domain (Bultynck et al., 2011). These results therefore 
show that CMLV vGAAP and AtGAAP3 are probably ion channels or ion exchangers 
and that this function is conserved within the TMBIM4 subfamily of proteins and in BI-1, 
another TMBIM family member.  
 
4.4 GAAP shown sequence similarity with other ion 
channels and pumps 
 In an attempt to identify key residues or domains in GAAP that could be 
involved in ion selectivity, gating and/or transport across the membrane, the BLAST 
algorithm was applied using individual GAAP TMDs and the full length amino acid 
sequence (Altschul et al., 1990). This approach allowed a further characterization of 
the ion channel. It would also suggest which amino acid residues might be mutated in 
an attempt to ablate or modify GAAP ion channel activity.    
 Most of the alignments obtained using this method were with Na2+/H+ 
exchangers and with several ion channels (Figure 4.6). If GAAPs were Na+/H+ anti-
porters, then E108 of vGAAP would be a good candidate for the putative Na+ binding 
site, as it aligned with the Na+ binding residue of E. coli Na+/H+ antiporter A (NhaA) 
D164 (Padan et al., 2009) (Figure 4.6A).  
 Another hypothesis is that GAAPs were cation channels. If this was the case 
then examination of the GAAP sequence might identify some regions that could 
correspond to the “selectivity filter” region similar to that found in Ca2+ and Na+ 
channels. Between vGAAP TMD4 and 5, TMD5 and 7 and TMD6 and 7 three clusters 
of highly conserved acidic residues were identified, D147FS, ETVE178L, and SPE207E 
respectively. Each one of these three motifs aligned with either the sodium leak 
channel (NALCN) pore region (DFS and ETVEL vGAAP motifs) (Figure 4.6D) (Lu et al., 
2007) or the potassium channel from Streptomyces lividan (KcsA) (SPEE vGAAP 
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motif) (Figure 4.6B) and most of these acidic residues are very well conserved within 
the GAAP family (Figure 4.8).  
 vGAAP acidic residues D196 and D219 align with cation channels and are both 
absolutely conserved among GAAPs. Moreover D219 from vGAAP aligns perfectly with 
BI-1 D213 that has been showed to be essential for its C-terminal domain to form a 
Ca2+ channel (Bultynck et al., 2011) (Figure 4.7). A G153AG155 motif similar to selectivity 
filter of K+ channels (GYG) (Jiang et al., 2002), IP3R and other cation channels was 
found in GAAP’s TMD5 (Figure 4.6C). The first G153 is absolutely conserved amongst 
GAAPs and second G155 is conserved in most GAAPs (Figure 4.8). The four COO- 
groups provided by the highly conserved glutamic acids and aspartic acids (at positions 
196, 207, 208 and 219 of vGAAP) at the N-terminal region of all GAAPs could 
correspond to the typical selectivity filter found in many Ca2+ channels (Kew and 
Davies, 2010). 
 A glycine hinge is often found in the pore-lining TMD segments, and these are 
predicted, by analogy with other ion channels, to be located just after the selectivity 
filter (Magidovich and Yifrach, 2004). Given this and its high degree of conservation 
within the GAAP family, G185 was also considered as a target for mutagenesis (Figure 
4.6 and 4.8). 
 Using the information collected from these alignments eight residues were 
chose to be mutated in vGAAP. Glutamic acid residues were mutated to glutamine, 
aspartic acid to asparagine and glycines were mutated to alanines. This alteration in 
charge would affect ion channel conductivity if the mutated amino acid residue were 
located within the pore region and were involved in gating or ion selectivity. The 
localization of each mutated residue within vGAAP topology can be seen in Figure 4.9. 
In an attempt to narrow down the number of mutants to be purified to ultimately be 
tested for ion channel activity in artificial lipid bilayer experiments the mutant vGAAPs 
were tested for expression, subcellular localization, anti-apoptotic activity and ability to 
modulate Ca2+.  
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B 
C 
D 
A 
Alignment of GAAP with the E. coli Na+/H+ anti-porter NhaA  
 
 
vGAAP_Evans     -------------------------MAMP-SLSACSSIEDDFNYGSSVASASVHIRMAFL 34 
hGAAP           -------------------------MADPDPRYPRSSIEDDFNYGSSVASATVHIRMAFL 35 
NhaA            MKHLHRFFSSDASGGIILIIAAILAMMMANSGATSGWYHDFLETPVQLRVGSLEINKNML 60 
                                         *  . .  . .  .* ::   .:  .::.*.  :* 
 
vGAAP_Evans     RKVYGILCLQFLLTT-------------------------------ATTAVFLYFDCMRT 63 
hGAAP           RKVYSILSLQVLLTT-------------------------------VTSTVFLYFESVRT 64 
NhaA            LWINDALMAVFFLLVGLEVKRELMQGSLASLRQAAFPVIAAIGGMIVPALLYLAFNYADP 120 
                  : . *   .:* .                               ..: ::* *:   . 
 
vGAAP_Evans     FIQGSPVLILASMFGSIGLIFALTLHRHKHPLNLYLLCGFTLSESLTLASVVTFYDVHVV 123 
hGAAP           FVHESPALILLFALGSLGLIFALILNRHKYPLNLYLLFGFTLLEALTVAVVVTFYDVYII 124 
NhaA            ITREGWAIPAATDIAFALGVLTLLGSRVPLALKIFLMALAIIDDLGAIIIIALFYTNDLS 180 
                : : . .:     :.    :::*   *   .*:::*:    : :  ::  :. **   :  
 
vGAAP_Evans     MQAFMLTTAAFLALTTYTLQSKR------------------------------------- 146 
hGAAP           LQAFILTTTVFFGLTVYTLQSKK------------------------------------- 147 
NhaA            MASLGVAAVAIAVLAVLNLCGVRRTGVYILVGVVLWTAVLKSGVHATLAGVIVGFFIPLK 240 
                : :: :::..:  *:. .* . :                                      
 
vGAAP_Evans     ---------------------------DFSKLGA--------GLFAALWILILSGLLG-- 169 
hGAAP           ---------------------------DFSKFGA--------GLFALLWILCLSGFLK-- 170 
NhaA            EKHGRSPAKRLEHVLHPWVAYLILPLFAFANAGVSLQGVTLDGLTSILPLGIIAGLLIGK 300 
                                            *:: *.        ** : * :  ::*:*    
 
vGAAP_Evans     ------IFVQNETVELVLSAFG--------ALVFCGF----IIYDTHSLIHKLSPEEYVL 211 
hGAAP           ------FFFYSEIMELVLAAAG--------ALLFCGF----IIYDTHSLMHKLSPEEYVL 212 
NhaA            PLGISLFCWLALRLKLAHLPEGTTYQQIMAVGILCGIGFTMSIFIASLAFGSVDPELINW 360 
                      :      ::*.  . *        . ::**:     *: :   : .:.**     
 
vGAAP_Evans     ASINLYLDIINLFLHLLQLLEVSNKK-- 237 
hGAAP           AAISLYLDIINLFLHLLRFLEAVNKK-- 238 
NhaA            AKLGILVGSISSAVIGYSWLRVRLRPSV 388 
                * :.: :. *.  :     *..  :    
 
 
Alignment of GAAP with the Streptomyces lividans KcsA K+ channel  
 
hGAAP               MADPDPRYPRSSIEDDFNYGSSVASATVHIRMAFLRKVYSILSLQVLLTTVTSTVFLYFE 60 
vGAAP_Evans         MAMP-SLSACSSIEDDFNYGSSVASASVHIRMAFLRKVYGILCLQFLLTTATTAVFLYFD 59 
KcsA                --MP-----------------PMLSG-------LLARL-----VKLLLGRHGSA--LHWR 27 
                       *                 .: *.       :* ::     ::.**    ::  *::  
 
hGAAP               SVRTFVHESPALILLFALGSLGLIFALILNRHKYPLNLYLLFGFTLLEALTVAVVVTFYD 120 
vGAAP_Evans         CMRTFIQGSPVLILASMFGSIGLIFALTLHRHKHPLNLYLLCGFTLSESLTLASVVTFYD 119 
KcsA                AAG---AATVLLVIVLLAGS----YLAVLAERGAPGAQLITYPRALWWSVETATTVGYGD 80 
                    .       :  *::    **    :   * .:  *    :    :*  ::  * .* : * 
 
hGAAP               VYIILQAFILTTTVFFGLTVYTLQSKKDFSKFGAGLFALLWILCLSGFLKFFFYSEIMEL 180 
vGAAP_Evans         VHVVMQAFMLTTAAFLALTTYTLQSKRDFSKLGAGLFAALWILILSGLLGIFVQNETVEL 179 
KcsA                LYPVT---------LWGRLVAVVVMVAGITSFG---------LVTAALATWFVGREQER- 121 
                    :: :          : .  . .:    .::.:*         *  :.:   *.  *  .  
 
hGAAP               VLAAAGALLFCGFIIYDTHSLMHKLSPEEYVLAAISLYLDIINLFLHLLRFLEAVNKK 238 
vGAAP_Evans         VLSAFGALVFCGFIIYDTHSLIHKLSPEEYVLASINLYLDIINLFLHLLQLLEVSNKK 237 
KcsA                ----------RGHFVR--HS--EKAAEEAYTRTTRALH----ERFDRLERMLDD-NRR 160 
                               *.::   **  .* : * *. ::  *:    : * :* ::*:  *:: 
 
Partial alignment of GAAP TMD5-6 with human IP3R pore region: 
vGAAP_Evans_TMD5-6  DFSKLGAGLFAALWILILSG-LLGIFVQNETVELVLSAFGAL-VFCGFIIYDTHSLIH 202 
hGAAP_TMD5-6        DFSKFGAGLFALLWILCLSG-FLKFFFYSEIMELVLAAAGAL-LFCGFIIYDTHSLMH 503 
IP3R_TMD6           GLRS-GGGVGDVLRKPSKEEPLFAARVIYDLLFFFMVIIIVLNLIFG-VIIDTFADLR 2596 
                    .: . *.*:   *     .  ::   .  : : :.:    .* :: * :* **.: :: 
 
Partial alignment of GAAP TMD5-6 with mouse nonselective cation channel NALCN Domain IV pore region: 
vGAAP_Evans          TL-Q--SKRDFSK-LGAGLFAALWILILSGLLGIFVQNETVELVLSAFGALV-FCGF-II 194 
hGAAP                TL-Q--SKKDFSK-FGAGLFALLWILCLSGFLKFFFYSEIMELVLAAAGALL-FCGF-II 195 
NALCN_Domain_IV      VLFRIVTGEDWNKIMHDCMVQPPF--CTPDEFTYWA-TDCGNY---A-GALMYFCSFYVI 1434 
                     .* :  : .*:.* :   :.   :    .. :  :  .:  :    * ***: **.* :* 
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Figure 4.6 - BLAST searches of full length or individual GAAP TMDs. 
Representative alignments of vGAAP and hGAAP with known ion channels and anti-
porters. (A) Alignment with E. coli Na+/H+ anti-porter NhaA reveals the E108 of hGAAP 
aligns with D164 of NhaA, this residue is part of Na+ binding site in NhaA making this a 
candidate residue for mutation if the GAAPs are Na+/H+ anti-porters. (B and C) GAAP 
TMD5 contains a 153GAG155 motif similar to selectivity filter of K+ channels, IP3Rs, 
HCN channels and others. (D) GAAP D148 aligns with selectivity filters of NALCN and 
AtKCO1. Red labelled amino acid residues represent some of the positions mutated in 
vGAAP Evans whereas the blue residues represent residues previously described as 
having some role to play in ion transport/selectivity.  
 
 
 
 
 
Figure 4.7 - Crustal X alignment of BI-1 and GAAP. Red labeled residues represent 
all the positions mutated in vGAAP Evans, the blue residues represent BI-1 amino acid 
residues involved in Ca2+ transport and the blue line delineates the region that was 
shown by Bultynck et al., (2011) to be sufficient to allow the flow of Ca2+ across the 
membrane.   
 
Human BI-1      MNIFDRK---------INFDALLKFSHITPSTQQHLKKVYASFALCMFVA 41 
hGAAP           MADPDPRYPRSSIEDDFNYGSSVASATV-HIRMAFLRKVYSILSLQVLLT 49 
vGAAP           MAMPSLS-ACSSIEDDFNYGSSVASASV-HIRMAFLRKVYGILCLQFLLT 48 
                *   .           :*:.: :  : :      .*:***. :.* .::: 
 
Human BI-1      AAG----AYVHMVTHFIQAG----LLSALGSLILMIWLMATPHSHETEQK 83 
hGAAP           TVTSTVFLYFESVRTFVHESPALILLFALGSLGLIFALTLNRHKYP---L 96 
vGAAP           TATTAVFLYFDCMRTFIQGSPVLILASMFGSIGLIFALTLHRHKHP---L 95 
                :.      *.. :  *:: .    *   :**: *:: *    *.:      
 
Human BI-1      RLGLLAGFAFLTGVGLGPALEFCIAVNPSILPTAFMGTAMIFTCFTLSAL 133 
hGAAP           NLYLLFGFTLLEALTVAVVVTFY---DVYIILQAFILTTTVFFGLTVYTL 143 
vGAAP           NLYLLCGFTLSESLTLASVVTFY---DVHVVMQAFMLTTAAFLALTTYTL 142 
                .* ** **::  .: :. .: *    :  ::  **: *:  *  :*  :* 
 
Human BI-1      YARRRSYLFLGGILMSALSLLLLSSLGNVFFGSIWLFQANLYVGLVVMCG 183 
hGAAP           QSKK-DFSKFGAGLFALLWILCLSGFLKFFFYSEIMELVLAAAGALLFCG 192 
vGAAP           QSKR-DFSKLGAGLFAALWILILSGLLGIFVQNETVELVLSAFGALVFCG 191 
                 ::: .:  :*. *:: * :* **.:  .*. .  :  .    * :::** 
 
Human BI-1      FVLFDTQLIIEKAEHGDQDYIWHCIDLFLDFITVFRKLMMILAMNEKDKK 233 
hGAAP           FIIYDTHSLMHKLS--PEEYVLAAISLYLDIINLFLHLLRFLEA------ 234 
vGAAP           FIIYDTHSLIHKLS--PEEYVLASINLYLDIINLFLHLLQLLEV------ 233 
                *:::**: ::.* .   ::*:  .*.*:**:*.:* :*: :*         
 
Human BI-1      KEKK 237 
hGAAP           VNKK 238 
vGAAP           SNKK 237 
                 :** 
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Figure 4.8 - Alignment of some of the GAAP family proteins. The alignments show the degree of conservation of the residues chosen 
for mutagenesis. Alignment was performed using the clustal W multiple alignment tool. Green lines define the known TMDs (as shown by 
Guia et al, submitted), residues labeled in red correspond to the point mutations made in vGAAP Evans. 
 
GAAP family protein alignment (“ion channels mutations”)           
Vaccinia_Evans              ------------------------------MAMP-SLSACSSIEDDFNYGSSVASASVH---------IRMAFLRKVYGILCLQFLLTTATTAVFLYFDC 60 
Camelpox                    ------------------------------MAMP-SLYACSSIEDDFNYGSSVASASVH---------IRMAFLRKVYGILCLQFLLTTATTAVFLYFDC 60 
Homo_sapiens                ------------------------------MADPDPRYPRSSIEDDFNYGSSVASATVH---------IRMAFLRKVYSILSLQVLLTTVTSTVFLYFES 61 
Pan_troglodites             ------------------------------MADPDPRYPRSSIEDDFNYGSSVASASVH---------IRMAFLRKVYSILSLQVLLTTVTSTVFLYFES 61 
Canis_lupus                 ------------------------------MADPDPRYPCASIEEDFNYGSCVASASVH---------IRMAFLRKVYSILSLQVLLTSVTASFFLYFES 61 
Bos_taurus                  ------------------------------MADFDPRYPCSSIEDDFNYGSCVASASVH---------IRMAFLRKVYSILSLQVLLTTVTLAFFLYFDS 61 
Rattus_norvegicus           ------------------------------MADTDPRYPRSSIEDDFNYGSCVASASVH---------IRMAFLRKVYSILSLQVLLTTVTSALFLYFET 61 
Gallus_gallus               -------------------------------MAAEQLYPRSSIEDDFNYGSNVASASVH---------IRMAFLRKVYSILSIQVLLTTVTSAIFLYSTG 60 
Danio_rerio                 -----------------------------------------------------------------------------------------------MLCNP 5 
Arabidopsis_thaliana_3      ------------------------MDKPYGYASVSMSGIDRSAGKDIDLEMGVGEATLYPGLSYGENQLRWGFIRKVYGILSAQLLLTTLISAVVVLNPP 76 
Caenorhabditis_elegans      MATINSHLREPERVNLLSDHDDSDDDEVHVKRNPQMWPMSMASSAHAEAGIVDADGILPGCVGKANRMIRIAFLRKVLGIVGFQLLFTIGICAAIYNIPN 100 
 
                                                                               
Vaccinia_Evans              MRTFIQGSPVLILASMFGSIGLIFALTLHRHKHPLNLYLLCGFTLSESLTLASVVTFYDVHVVMQAFMLTTAAFLALTTYTLQSKR---DFSKLGAGLFA 157 
Camelpox                    MRKFIQGSPVLILASMFVSIGLIFALTLHRHKHPLNLYLLCGFTLSESLTLASVVTFYDVHVVMQAFMLTTAVFLALTAYTLQSKR---DFSKLGAGLFV 157 
Homo_sapiens                VRTFVHESPALILLFALGSLGLIFALILNRHKYPLNLYLLFGFTLLEALTVAVVVTFYDVYIILQAFILTTTVFFGLTVYTLQSKK---DFSKFGAGLFA 158 
Pan_troglodites             IRTFVHESPALILLFALGSLGLIFALTLNRHKYPLNLYLLFGFTLLEALTVAVVVTFYDVYIILQAFILTTTVFFGLTVYTLQSKK---DFSKFGAGLFA 158 
Canis_lupus                 VRTFVHESPALILVFALGSLGLIFALTVNRHKHPLNLYLLFGFTLFEALTVAFVVTFYDVYIILQAFILTTAVFLGLTVYTLQSKR---DFSKFGAGLFA 158 
Bos_taurus                  IRTFVHESPALILVLALGSLGLILALTVNRHKHPLNLYLLFGFTLLESLTVAFVVTFYDVYVVLQAFILTCAVFLGLTVYTLQSKR---DFSKFGAGLFA 158 
Rattus_norvegicus           LRTFVHDSPALIVVFALGSLGLIFALTLHRHTHPLNLYLLFAFTLSEALTVATVVTFYDGHLVLHAFILTAAVFLGLTAYTLQSKR---DFSKFGAGLFA 158 
Gallus_gallus               VQAFVHERPALLLISVFGCLAISFALALYRHQHPVNLYLLFGFTLLEAFTVAITVSFYDVSIVLQAFILTTAVFLGLTAYTLQSKR---DFSKFGAGLFA 157 
Danio_rerio                 IKNFVHESPSLVLISAIGSLILLLALAFYRHQHPVNLYLLFGFTLLESLSVATAVSFYEYTIVLQAFVLTSAVFLGLTAYTFQSKR---DFSKLGASLFA 102 
Arabidopsis_thaliana_3      VNDLLTGSPGILLFLCIVPFILIWPLHIYHQKHPVNLILLALFTVSLSFTVGVSCAMTEGRIVLQALILTLSVVGSLTAYTFWAAKKGKDFSFLGPILFT 176 
Caenorhabditis_elegans      SNQLLQKHAWIVFPNLLGSIALIIALHVYAREVPLNYVLLAAFTAVQAVTMGCVVTLFEAKVVLEAAVITGLVVASLFAYTLQNKR---DFSVGYASMGS 197 
                             . ::   . ::.   :  : :  .* .  :  *:*  **  **   :.::.   :: :  :::.* ::*  .. .* .**:   :   ***   . :   
 
Vaccinia_Evans              ALWILILSGLLGIFVQN-ETVELVLSAFGALVFCGFIIYDTHSLIHKLSPEEYVLASINLYLDIINLFLHLLQLLEVSNKK 237 
Camelpox                    TLWILILSGLLRIFVQS-ETVELVLSAFGALVFCGFIIYDTHSLIHKLSPEDYVLASINFYLDIINLFLHLLQLLEVSNKK 237 
Homo_sapiens                LLWILCLSGFLKFFFYS-EIMELVLAAAGALLFCGFIIYDTHSLMHKLSPEEYVLAAISLYLDIINLFLHLLRFLEAVNKK 238 
Pan_troglodites             LLWILCLSGFLKLFFYS-EIMELVLAAAGALLFCGFIIYDTHSLMHKLSPEEYVLAAISLYLDIINLFLHLLRFLEAVNKK 238 
Canis_lupus                 VLWILCLSGILKLFFYS-QTLELVLAAVGALLFCGFIIYDTHSLMHRLSPEEYVLAAISLYLDVINLFLHLLRFLEAVNKK 238 
Bos_taurus                  GLWILCLSGILRLFFYS-ETVELVLAAGGALLFCGFIIYDTHSLMHRLSPEEYVLAAINLYLDIINLFLHLLRVLEAANKK 238 
Rattus_norvegicus           CLWILCLAGFLKVFFYS-QTVELVLASLGALLFCGFIIYDTHSLMHRLSPEEYVLAAISLYLDIINLFLHLLKFLDAVNKK 238 
Gallus_gallus               CLWILIFSCFLMVFFHS-EIMELVFAAAGALLFCGFIIYDTHLLMHKLSPEEYILAAINLYLDIINLFLNLLRLLEAFNKK 237 
Danio_rerio                 GLWILIIASFLRFFFYN-DTMELVFAGAGALLFCGFIIFDTHLLMHKLSPEEHVLASINLYLDIVNLFLYILRILDAMKKH 182 
Arabidopsis_thaliana_3      SLIILVVTSFIQMFFPLGPTSVAVYGGFSALVFCGYIVYDTDNLIKRFTYDEYILASVALYLDILNLFLTILRILRQGDN- 256 
Caenorhabditis_elegans      LLCVLLWAGIFQMFFMS-PAVNFVINVFGAGLFCVLLVIDLDMIMYRFSPEDYICACVSLYMDILNLFIRILQIVAEANK- 276 
                             * :*  : :: .*.        *    .* :**  :: * . :: ::::::: *.: :*:*::***: :*:.:   .:  
 
Green – transmembrane domain prediction 
Red – position mutated in vGAAP Evans 
Grey – candidate selectivity filters  
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Figure 4.9 - Diagram showing the localization of the single “ion channel 
mutations” introduced in vGAAP. Topology shown was defined by Guia Carrara et 
al,  (submitted).  
 
 
4.5 vGAAP “ion channel mutants” characterization – 
expression, dimerization and subcellular localization  
 Each residue identified in 4.4 (here referred to as “ion channel mutations”) was 
individually mutated in pcDNA3.1 vGAAP-HA using site directed mutagenesis PCR. All 
the mutant vGAAP-HA expression plasmids obtained were sequenced to confirm the 
presence of the desired mutation and the absence of additional mutations during the 
PCR. The vGAAP “ion channel mutant” proteins were checked for expression, 
dimerization and subcellular localization. Mutant and wt vGAAPs were expressed 
transiently in Saos-2 cells for 18 h before cell lysates were prepared and analysed by 
immunoblotting or fixed for immunofluorescence. All mutant proteins, apart from E107Q 
that was expressed to a much lower level, showed an expression level similar to wt 
vGAAP (Figure 4.10A). The dimerization ability of the mutant vGAAP alleles was then 
assessed using non-reducing (-DTT) SDS-PAGE analysis (Figure 4.10A). The EE207-
208QQ dimer was more sensitive to DTT as shown by a lower dimer to monomer ratio 
in non-reducing conditions when compared to wt vGAAP. 
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Figure 4.10 - vGAAP mutant proteins subcellular localization and basic 
biochemical characterization. (A) GAAP protein expression levels and dimerization 
ability were determined by immunoblot analysis of cell lysates obtained 18 h after 
transfection of pcDNA3.1 with wt vGAAP or mutant gene into Saos-2 cells. Reducing 
(+DTT) and non-reducing (-DTT) SDS-PAGE were used to resolve the protein lysates. 
The position of size markers in kDa is shown on the left of the gel. (B) Saos-2 cells 
were transfected with vGAAP wt and mutant vGAAP expressing plasmids for 18h and 
subcellular localization was assessed by immunofluorescence stain using GM130 as a 
Golgi marker. The proportion of cells with GAAP in the Golgi, Golgi and ER or ER only 
was assessed by counting over 100 individual transfected cells. Data presented as 
mean percentage of total cells. IF was carried out by Dr. Benjamin Johnson, Imperial 
College London. 
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 When tested for subcellular localization using an anti-GM130 Ab as a Golgi 
marker it was found that vGAAP mutants D147N and EE207-208QQ had an altered 
localization and were now present in the ER (Figure 4.10B). This could point to a 
possible incorrect folding of the proteins, which led them to be retained in the ER, or 
due to an altered Golgi localization signal. In both cases it could alter anti-apoptotic 
function and/or Ca2+ modulation. In an attempt to dissect these possibilities two single 
mutants were created E207Q and E208Q, of which only E207Q localized to the Golgi 
while E208Q had a predominant ER localization. Two other mutants, E107Q and 
E178Q, showed a less drastic altered subcellular localization and these two mutant 
proteins were found in both the Golgi and the ER in ∼50 % of the cells. 
 All these data were taken into account when interpreting the mutant vGAAPs 
Ca2+ modulation and anti-apoptotic functional assays results.   
 
4.6 vGAAP “ion channel mutants” characterization – anti-
apoptotic activity and Ca2+ modulation 
 To test wt and mutant vGAAP anti-apoptotic activity a transient expression 
apoptosis assay with STS as the apoptotic stimulus was used. Wild type or mutant 
vGAAPs expression plasmids were co-transfected with cell surface marker CD20 
expression plasmid in a 5:1 ratio in Saos-2 cells and 18 h post transfection cells were 
subjected to either STS or mock treatment. The use of CD20 allowed for the selection 
of transfected cells using a FITC-conjugated anti-CD20 Ab. After staining the cells with 
propidium iodide (PI), these were subjected to FACS analysis. Using this approach it 
was possible to quantify the sub-G1 proportion of the cell population, indicative of 
apoptotic and dead cells, within the CD20-positive cell population (Figure 4.11A and B). 
 The protection from STS-induced apoptosis obtained with wt vGAAP expression 
in Saos-2 cells was very modest but reproducible and statistically significant (Figure 
4.12). When all vGAAP mutants were tested using this method it was clear that most of 
the mutations had no alteration of anti-apoptotic activity. Only mutations E178Q and 
D219N impaired vGAAP’s anti-apoptotic activity in this assay significantly. Mutant 
EE207-208QQ appeared to have some effect although this wasn’t statistically 
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significant. Mutants G152A and D196N showed a slightly increased protection against 
STS induced apoptosis.  
 
 
 
 
Figure 4.11 - vGAAP transient STS apoptosis assay validation. (A) Saos-2 cells 
were co-transfected overnight with a plasmid expressing CD20 and either a plasmid 
expressing vGAAP-HA or empty vector pcDNA3.1. After treatment with STS or DMSO 
(0 µM STS) for 6 h, both attached and detached cells were collected. These cells were 
stained with a FITC-conjugated anti-CD20 mAb and then fixed and stained with 
propidium iodide (PI) prior to FACS analysis. The total population was gated for the 
CD20-positive cells. The X axis corresponds to the cell number and the Y axis 
corresponds to the PI stain levels. The histograms show the distribution of the PI stain 
intensity in the cell population allowing the identification of the sub-G1 population as 
shown by a vertical bar in each histogram. (B) Quantification of the sub-G1 portion 
from the CD20-gated population.   
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 It has not been shown so far that the GAAP anti-apoptotic function is linked to 
its Ca2+ handling activity. Taking this into consideration Ca2+ release experiments were 
performed (by Dr. David Prole at University of Cambridge) with wt and mutant vGAAPs. 
HEK293T cells transiently expressing the wt or mutant vGAAP were loaded with Fura-
2-AM and kept in a Ca2+ free solution. Ca2+ release as a response to ionomycin (that 
causes emptying of intracellular Ca2+ stores) was measured in cells expressing GAAP. 
The mean peak Ca2+ responses from 3-4 independent fields of cells was calculated. 
vGAAP was able, as was hGAAP (de Mattia et al., 2009), to reduce the amount of Ca2+ 
released in to the cytosol upon stimulation with ionomycin (Figure 4.13). This suggests 
that vGAAP, like hGAAP, can reduce the filling state of Ca2+ stores in the cell. Mutation 
in vGAAP positions 107, 147, 152, 207 and 219 impaired its ability to reduce Ca2+ 
release from intracellular stores upon ionomycin treatment or in other words impaired 
its ability to reduce the Ca2+ content on the intracellular Ca2+ stores. 
 Taking into account the protein expression, subcellular localization, anti-
apoptotic activity and Ca2+ modulation ability of these mutant proteins, mutations 
D219N, D196N and G152A were proposed for further study because all these mutants 
had an expression level and subcellular localization comparable to wt vGAAP, all 
showed impaired Ca2+ modulation, but D219N was no longer anti-apoptotic and D196N 
and G152A showed an increased protection against STS-induced apoptosis. D207N 
was also chosen due to its high conservation within TMBIM4 members, good alignment 
with other ion channels and due to its inability to modulate Ca2+. All data obtained for 
each of the mutant vGAAP proteins are summarized on Table 4.1.  
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Figure 4.12 - vGAAP wt and mutants transient STS apoptosis assay. Saos-2 cells 
were co-transfected overnight with a CD20-expressing plasmid and either a plasmid 
expressing wt or mutant vGAAP-HA or with empty pcDNA3.1. After treatment with STS 
or DMSO (- STS) for 6 h, both attached and detached cells were collected. These cells 
were stained with a FITC-conjugated anti-CD20 mAb and then were fixed and stained 
with PI prior to FACS analysis. Total population was gated on the CD20-positive cells. 
Sub-G1 percentage from the CD20-gated population was determined (n=1 for - STS 
and n=3 for + STS). Data are representative of three experiments and are represented 
as mean ± SEM. Difference between the wt vGAAP was analysed using the unpaired 
Student’s T-test and is represented as * p<0.05.  
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Figure 4.13 - vGAAP reduces stores Ca2+ content and some “ion channel 
mutations” prevent this effect. This experiment was carried out by Dr. David Prole, 
University of Cambridge, using mutant vGAAP plasmids I generated and is here 
reproduced with his permission. HEK293T cells were transfected with pcDNA3.1, wt or 
mutant vGAAP together with mCherry-C1 as a transfection marker. Twenty-four hours 
post transfection, cells were loaded with Fura-2-AM, bathed in Ca2+-free medium, and 
Ca2+ responses to ionomycin (10 µM) were measured in transfected cells. The graph 
shows the mean peak Ca2+ responses from 3-4 independent fields of cells (n=5-48 
cells in each field). Data are represented as mean ± SEM. Differences between the wt 
vGAAP and mutant GAAPs was analysed using the unpaired Student’s T-test and are 
represented as * p<0.05, ** p<0.01, *** p<0.001.  
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Table 4.1 - Summary table of data acquired for the wt and vGAAP “ion channel 
mutant” proteins. Crosses represent a different phenotype from the wt vGAAP, ticks 
represent a similar phenotype while +/- stand for a intermediate phenotype. (-) Was 
used when data was absent.  
 
 
 
 
4.7 Summary 
 After a first attempt to map the interaction of GAAP with the IP3R it was shown 
that this was not a specific interaction. Although it is important to note that the 
experiments presented here were done using IP3R type 1 over-expression but the 
experiments done by de Mattia et al. (2009) were done using IP3R type 3 specific Abs. 
Also it is worth noting that these are all membrane proteins and that the concentration 
of salt (NaCl in this case) of the IP buffer, hence the stringency of the washes, is crucial 
to obtain a specific co-immunoprecipitation and to get rid of false positive pull downs. A 
high NaCl concentration should allow distinction between a specific or a non-specific 
co-immunoprecipitation, and this could have been attempted in the initial optimization 
stages of these co-immunoprecipitations. Later when looking at a GAAP-GAAP 
interaction by co-immunoprecipitation (chapter V) only at a NaCl concentration as high 
as 500 mM in the wash buffer could we detect a specific interaction. Taken together all 
the co-immunoprecipitation data and the limitations of membrane proteins co-
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immunoprecipitations suggest that the previously found vGAAP (Caroline Gubser, 
unpublished) and hGAAP interactions with IP3R could have been due to an artefact of 
the technique and probably are not a real interaction. Given this result a second 
hypothesis to explain GAAP function was considered, namely that GAAP is an ion 
channel that allows the passage of Ca2+ ions. To address this hypothesis, purified 
vGAAP and AtGAAP3 were tested in artificial lipid bilayer experiments and shown to 
allow the passage of Ca2+ ions through the bilayer when different membrane potentials 
were applied.  
 The GAAP amino acid sequence was also shown to align with some previously 
described ion channels and ion exchangers (Figure 4.6 and 4.7). In an attempt to 
formally prove that GAAP was indeed an ion channel and to characterize its pore and 
selectivity filter domains, a set of single point mutants was generated based on 
alignments with other channels and conservation within the TMBIM4 sub-family. These 
mutants were tested for expression, subcellular localization and function. The vGAAP 
mutants G152A, D196N, E207Q and D219N were chosen to be tested in artificial lipid 
bilayer experiments to try and find a mutant with an altered conductivity (Table 4.1). 
Three mutants (D196N, E207Q and D219N) are part of the proposed GAAP putative 
Ca2+ selectivity filter made up of the four amino acid residues (D or E) that could 
provide the four COO- groups usually found in Ca2+ selectivity filters (Sather and 
McCleskey, 2003). 
 All data collected so far point to a possible ion channel conserved function in 
the TMBIM4 family and maybe for the entire TMBIM family, because pure BI-1 also 
showed ion channel activity. However, these data does not rule out that GAAPs might 
be ion exchangers. These can behave as ion channels in lipid bilayers if both its gates 
are left open: in this case the molecule will appear as an ion channel with these 
experimental settings. 
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 Chapter V 
 GAAP is able to form tetramers 
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 vGAAP and AtGAAP3 produced in and purified from yeast showed additional 
bands when analyzed by SDS-PAGE, and these bands were of an appropriate size for 
oligomeric forms of the protein (see chapter III). The fact that BI-1, another member of 
the same protein family, has been shown to oligomerize when overexpressed (Ahn et 
al., 2010; Xu et al., 2008) was also consistent with our findings for GAAPs.  
 Moreover, given our findings on vGAAP ion channel function in vitro (detailed in 
chapter IV) it would be expected, by comparison with most ion channels described so 
far, that GAAP would require some form of oligomerization to achieve a comparable 
number of TMDs and thereby have ion channel activity. 
 Ultimately, structural determination of GAAP is required to understand its 
oligomeric structure, however it was very difficult to obtain sufficient quantities of this 
highly hydrophobic protein and initial attempts to crystallize vGAAP were unsuccessful. 
Therefore several different approaches were taken to confirm if GAAP can indeed form 
oligomers in mammalian cells. 
 
5.1 GAAP-GAAP interaction detected by co-IP 
 The first approach taken was to investigate a possible GAAP-GAAP interaction 
by co-immunoprecipitation (Figure 5.1). A plasmid expressing GAAP-HA was 
transfected into a cell line that had been engineered previously to express GAAP with a 
C-terminal V5 tag (GAAP-V5) (see Table 2.7 for more details). A cell line engineered to 
express A36 (see Table 2.7 for more details), another VACV membrane protein, with a 
V5 C-terminal tag was used as a control for nonspecific pull down of membrane 
proteins during the immunoprecipitation. An immunoprecipitation assay was then 
performed on cleared lysates from these cells using an anti-V5 Ab coupled to protein G 
sepharose beads. The immunoprecipates were immunoblotted with anti-HA and anti-
V5 Abs. The WCE were immunoblotted with an anti-HA Ab to confirm plasmid 
transfection and protein expression from the transfected plasmid.  
 HA-tagged vGAAP expressed from the plasmid was found to co-
immunoprecipitate with V5-tagged vGAAP, expressed from the cell line, but not with 
V5-tagged A36 although this protein was immunoprecipitated to similar levels as 
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vGAAP-V5 (Figure 5.1). HA-tagged hGAAP also co-immunoprecipitated with V5-
tagged hGAAP but not with V5-tagged A36. Whole cell extracts show similar 
expression levels from the plasmids that encode for hGAAP-HA and vGAAP-HA in both 
GAAP-V5 and A36-V5 expressing stable cell lines. This experiment indicates that both 
vGAAP and hGAAP are able to interact with each other, although a co-
immunoprecipitation cannot prove that this interaction is direct.  
 
 
 
 
Figure 5.1 - hGAAP and vGAAP can interact with themselves. HeLa cells stably 
expressing hGAAP-V5 or vGAAP-V5 were transfected with pcDNA3.1 hGAAP-HA or 
vGAAP-HA for 16 h. Cells were collected, lysed and subjected to immunoprecipitation 
(IP) using an anti-V5 Ab. A HeLa cell line expressing A36-V5 (∼37 kDa), a VACV 
membrane protein, was used as a control for non-specific immunoprecipitation of 
membrane proteins. Immunoblots (IB) using anti-HA or anti-V5 Abs were performed to 
detect both HA and V5 tagged-GAAP proteins. Whole cell extract (WCE) was also 
immunoblotted with anti-HA. The position of size markers as kDa is shown on the left of 
the gel.  
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5.2 Crosslinking with DFDNB revealed the presence of a 
GAAP tetramer 
 In an attempt to characterize the stoichiometry of GAAP oligomerization, 
several crosslinking chemicals were tested. The best results came from the use of the 
lysine-reactive aryl halide DFDNB (Figure 5.2A). This water insoluble, membrane 
permeable crosslinker has a very short spacer arm and the nature of this chemical 
allows it to get inside membrane or lipid micelles making the crosslinking process much 
more efficient for membrane proteins (Kornblatt and Lake, 1980). 
 When incubated with DFDNB, both hGAAP and vGAAP showed an increased 
intensity of higher molecular weight bands detected with the anti-HA Ab. Although 
these bands were already visible with DMSO treatment only, or when untreated, they 
became more pronounced with the addition of the crosslinker (Figure 5.2A). With 
higher concentrations of DFDNB the proteins tended to aggregate and get trapped in 
the wells, indicated by an open arrowhead. In the case of hGAAP the two higher 
molecular size bands were very week and were reproducibly found only when hGAAP 
was treated with higher concentrations of DFDNB. 
 Membrane proteins tend to run on SDS-PAGE gels at a size different from that 
predicted from their molecular mass. To confirm if the bands observed with DFDNB 
treatment represent GAAP oligomeric forms, the predicted monomer copy number of 
each band was plotted in a semi-logarithmic scale with its relative gel mobility (Figure 
5.2B). The linear relationship found for both vGAAP and hGAAP indicates that the 
relative mobility of each band corresponds to its assigned subunit stoichiometry. The 
main bands detected were of ∼20-23 kDa, ∼37-45 kDa, ∼60 kDa and ∼80 kDa, and 
these are consistent with monomeric, dimeric, trimeric and tetrameric forms of GAAP. 
 
5.3 GAAP oligomerization in vitro is pH-dependent  
 It was reported previously that BI-1 oligomerization is regulated by pH (Kim et 
al., 2008) and that this could be linked to its function in the ER as a Ca2+ modulator.  
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Figure 5.2 - hGAAP and vGAAP crosslink with DFDNB. HeLa cells were transfected 
with (A) pCDNA3.1-vGAAP-HA or (B) pCDNA3.1-hGAAP-HA. Cell lysates were 
prepared 18 h post transfection and crosslinked with increasing concentrations of 
DFDNB, untreated (lane 1 in each gel) or treated with DMSO only (lane 2 of each gel) 
and subjected to SDS-PAGE under non-reducing conditions prior to immunoblotting 
with an anti-HA Ab (A and B). The position of size markers in kDa is shown on the left 
of each gel. The predicted oligomeric states of GAAP monomer (1x), dimer (2x), trimer 
(3x) and tetramer (4x) are shown by full arrows. (C and D) The relative mobility of the 
different oligomeric forms was determined and plotted against the predicted oligomeric 
state. Data shown comes from three independent experiments and is represented as 
mean ± SEM.  
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 To investigate if GAAP oligomerization was also dependent on pH, hGAAP-HA 
and vGAAP-HA were expressed in mammalian cells, extracted from membranes using 
CHAPS-based buffers with varying pH and analysed by non-reducing SDS-PAGE. It 
was clear that both vGAAP and hGAAP showed best oligomerization levels at pH 7 or 
higher (Figure 5.3). vGAAP oligomerization levels peaked at pH 7 while hGAAP 
oligomerization levels increased until pH 8, the highest pH tested. Bands 
corresponding to the monomer (∼20 kDa) and putative dimer (∼37 kDa), trimer (∼60 
kDa) and tetramer (∼80 kDa) could be identified for both vGAAP and hGAAP although 
in the case of hGAAP a series of other bands were also visible. In these non-reducing 
conditions the vGAAP and hGAAP band that migrates at ∼37 kDa is in fact composed 
of two bands. 
 
5.4 vGAAP, but not hGAAP, dimerization is sensitive to DTT 
 When vGAAP and hGAAP were analysed by non-reducing SDS-PAGE two very 
close and intense bands of ∼37 kDa (putative dimer) were visible, even in the absence 
of any crosslinker (Figure 5.4, untreated lanes). When treated with increasing amounts 
of the reducing agent DTT these bands gradually disappear in the case of vGAAP but 
the hGAAP bands showed no reduction in intensity even when high DTT 
concentrations were used (Figure 5.4). The very weak bands corresponding to the 
higher oligomeric states of vGAAP also mostly disappear after DTT treatment.  
 These observations led us to hypothesise that the dimerization mechanism in 
vGAAP might be dependent on cysteine disulphide bounds, whereas hGAAP 
dimerization might not rely on disulphide bonds. Alternatively, the hGAAP disulphide 
bonds could be inaccessible to DTT.  
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Figure 5.3 - GAAP oligomerization is pH-dependent. Lysates from HeLa cells 
transfected with pCDNA3.1-vGAAP-HA or pCDNA3.1-hGAAP-HA for 18 h were 
incubated at varying pH, prior to SDS-PAGE in non-reducing conditions and the 
membranes immunoblotted with an anti-HA Ab. Arrows show the different 
oligomerization states of GAAP. Monomer (1x), dimer (2x), trimer (3x) and tetramer 
(4x). The position of size markers in kDa is shown on the left of each gel. 
 
 
 
Figure 5.4 - DTT is able to disrupt the vGAAP but not hGAAP dimer. HeLa cells 
were transfected with pCDNA3.1-vGAAP-HA or pCDNA3.1-hGAAP-HA. Cells lysates 
were prepared 18 h post transfection and treated with increasing concentrations of DTT 
prior to immunoblotting. Samples were resolved by SDS-PAGE and immunoblotted 
with an anti-HA Ab. Arrows show the different oligomerization states of GAAP. 
Monomer (1x), dimer (2x), trimer (3x) and tetramer (4x) U, untreated samples. The 
position of size markers in kDa is shown on the left of each gel. 
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5.5 vGAAP TMDs 5-6 and the C terminus are not required for 
oligomerization 
 BI-1 was shown to lose some of its oligomerization ability when the C terminus 
was deleted (Kim et al., 2008). Truncating vGAAP and hGAAP between TMD 4 and 5 
(Figure 5.5A) allowed us to test if any of these truncated forms of GAAP retained the 
ability to oligomerize and hence map the domains required for this process. 
 Truncated vGAAP and hGAAP molecules, illustrated in Figure 5.5A, were 
resolved by reducing and non-reducing SDS-PAGE. Truncated vGAAP containing 
TMDs 1-4 still retains the ability to dimerize because a very intense band that runs at 
∼25-30 kDa, corresponding to a putative dimer of the 12-14 kDa monomeric form of the 
protein, can be detected at non-reducing conditions. These bands are also DTT 
sensitive because they are not detected when reducing SDS-PAGE conditions are 
used. Both hGAAP truncated proteins tested lost the ability to dimerize in both reducing 
and non-reducing conditions, although a faint band corresponding to the hGAAP 
TMD1-4 dimer could still be detected. 
 This result suggests that the region of vGAAP containing TMD1-4, the first 147 
amino acid residues, is sufficient for protein dimerization and that the last two TMDs 
and the C-terminal portion of vGAAP are not required for dimerization.  
 
5.6 vGAAP cysteines 9 and 60 are essential for 
oligomerization – SDS-PAGE analysis 
 In an attempt to map the essential residues involved in vGAAP oligomerization 
and taking in consideration data from Figures 5.4 and 5.5 an amino acid sequence 
alignment with representative members of the GAAP family was undertaken (Figure 
5.6). This allowed analysis of the conservation level of cysteine residues within the 
GAAP family, which could be involved in creating disulphide bounds between GAAP 
molecules leading to dimerization and possibly to oligomerization. 
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Figure 5.5 - vGAAP TMDs 5-6 and the C terminus are not required for GAAP 
dimerization. (A) Schematics of the wild type and truncated forms of vGAAP and 
hGAAP. Transmembrane domains (TM) (B) Lysates from HeLa cells transfected for 18 
h with plasmids that encode wild type or truncated forms of vGAAP-HA and hGAAP-HA 
were subjected to SDS-PAGE under reducing (+DTT) or non-reducing conditions (-
DTT). Membranes were blotted with an anti-HA Ab to detected GAAP. The position of 
size markers in kDa is shown on the left of the gel. 
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Figure 5.6 – Alignment of GAAP family protein amino acid sequences showing the degree of conservation of the cysteine 
residues. The alignment was created using the Clustal W multialignment tool. Cysteine residues are highlighted in red and 
transmembrane regions are defined by green lines. 
                           TMD1  
Vaccinia_Evans              ------------------------------MAMP-SLSACSSIEDDFNYGSSVASASVH---------IRMAFLRKVYGILCLQFLLTTATTAVFLYFDC 60 
Camelpox                    ------------------------------MAMP-SLYACSSIEDDFNYGSSVASASVH---------IRMAFLRKVYGILCLQFLLTTATTAVFLYFDC 60 
Homo_sapiens                ------------------------------MADPDPRYPRSSIEDDFNYGSSVASATVH---------IRMAFLRKVYSILSLQVLLTTVTSTVFLYFES 61 
Pan_troglodites             ------------------------------MADPDPRYPRSSIEDDFNYGSSVASASVH---------IRMAFLRKVYSILSLQVLLTTVTSTVFLYFES 61 
Canis_lupus                 ------------------------------MADPDPRYPCASIEEDFNYGSCVASASVH---------IRMAFLRKVYSILSLQVLLTSVTASFFLYFES 61 
Bos_taurus                  ------------------------------MADFDPRYPCSSIEDDFNYGSCVASASVH---------IRMAFLRKVYSILSLQVLLTTVTLAFFLYFDS 61 
Rattus_norvegicus           ------------------------------MADTDPRYPRSSIEDDFNYGSCVASASVH---------IRMAFLRKVYSILSLQVLLTTVTSALFLYFET 61 
Gallus_gallus               -------------------------------MAAEQLYPRSSIEDDFNYGSNVASASVH---------IRMAFLRKVYSILSIQVLLTTVTSAIFLYSTG 60 
Danio_rerio                 -----------------------------------------------------------------------------------------------MLCNP 5 
Arabidopsis_thaliana_3      ------------------------MDKPYGYASVSMSGIDRSAGKDIDLEMGVGEATLYPGLSYGENQLRWGFIRKVYGILSAQLLLTTLISAVVVLNPP 76 
Caenorhabditis_elegans      MATINSHLREPERVNLLSDHDDSDDDEVHVKRNPQMWPMSMASSAHAEAGIVDADGILPGCVGKANRMIRIAFLRKVLGIVGFQLLFTIGICAAIYNIPN 100 
 
                  TMD2                                           TMD3                                    TMD4                                    TMD5 
                                                                               
Vaccinia_Evans              MRTFIQGSPVLILASMFGSIGLIFALTLHRHKHPLNLYLLCGFTLSESLTLASVVTFYDVHVVMQAFMLTTAAFLALTTYTLQSKR---DFSKLGAGLFA 157 
Camelpox                    MRKFIQGSPVLILASMFVSIGLIFALTLHRHKHPLNLYLLCGFTLSESLTLASVVTFYDVHVVMQAFMLTTAVFLALTAYTLQSKR---DFSKLGAGLFV 157 
Homo_sapiens                VRTFVHESPALILLFALGSLGLIFALILNRHKYPLNLYLLFGFTLLEALTVAVVVTFYDVYIILQAFILTTTVFFGLTVYTLQSKK---DFSKFGAGLFA 158 
Pan_troglodites             IRTFVHESPALILLFALGSLGLIFALTLNRHKYPLNLYLLFGFTLLEALTVAVVVTFYDVYIILQAFILTTTVFFGLTVYTLQSKK---DFSKFGAGLFA 158 
Canis_lupus                 VRTFVHESPALILVFALGSLGLIFALTVNRHKHPLNLYLLFGFTLFEALTVAFVVTFYDVYIILQAFILTTAVFLGLTVYTLQSKR---DFSKFGAGLFA 158 
Bos_taurus                  IRTFVHESPALILVLALGSLGLILALTVNRHKHPLNLYLLFGFTLLESLTVAFVVTFYDVYVVLQAFILTCAVFLGLTVYTLQSKR---DFSKFGAGLFA 158 
Rattus_norvegicus           LRTFVHDSPALIVVFALGSLGLIFALTLHRHTHPLNLYLLFAFTLSEALTVATVVTFYDGHLVLHAFILTAAVFLGLTAYTLQSKR---DFSKFGAGLFA 158 
Gallus_gallus               VQAFVHERPALLLISVFGCLAISFALALYRHQHPVNLYLLFGFTLLEAFTVAITVSFYDVSIVLQAFILTTAVFLGLTAYTLQSKR---DFSKFGAGLFA 157 
Danio_rerio                 IKNFVHESPSLVLISAIGSLILLLALAFYRHQHPVNLYLLFGFTLLESLSVATAVSFYEYTIVLQAFVLTSAVFLGLTAYTFQSKR---DFSKLGASLFA 102 
Arabidopsis_thaliana_3      VNDLLTGSPGILLFLCIVPFILIWPLHIYHQKHPVNLILLALFTVSLSFTVGVSCAMTEGRIVLQALILTLSVVGSLTAYTFWAAKKGKDFSFLGPILFT 176 
Caenorhabditis_elegans      SNQLLQKHAWIVFPNLLGSIALIIALHVYAREVPLNYVLLAAFTAVQAVTMGCVVTLFEAKVVLEAAVITGLVVASLFAYTLQNKR---DFSVGYASMGS 197 
                             . ::   . ::.   :  : :  .* .  :  *:*  **  **   :.::.   :: :  :::.* ::*  .. .* .**:   :   ***   . :   
 
                TMD6 
 
Vaccinia_Evans              ALWILILSGLLGIFVQN-ETVELVLSAFGALVFCGFIIYDTHSLIHKLSPEEYVLASINLYLDIINLFLHLLQLLEVSNKK 237 
Camelpox                    TLWILILSGLLRIFVQS-ETVELVLSAFGALVFCGFIIYDTHSLIHKLSPEDYVLASINFYLDIINLFLHLLQLLEVSNKK 237 
Homo_sapiens                LLWILCLSGFLKFFFYS-EIMELVLAAAGALLFCGFIIYDTHSLMHKLSPEEYVLAAISLYLDIINLFLHLLRFLEAVNKK 238 
Pan_troglodites             LLWILCLSGFLKLFFYS-EIMELVLAAAGALLFCGFIIYDTHSLMHKLSPEEYVLAAISLYLDIINLFLHLLRFLEAVNKK 238 
Canis_lupus                 VLWILCLSGILKLFFYS-QTLELVLAAVGALLFCGFIIYDTHSLMHRLSPEEYVLAAISLYLDVINLFLHLLRFLEAVNKK 238 
Bos_taurus                  GLWILCLSGILRLFFYS-ETVELVLAAGGALLFCGFIIYDTHSLMHRLSPEEYVLAAINLYLDIINLFLHLLRVLEAANKK 238 
Rattus_norvegicus           CLWILCLAGFLKVFFYS-QTVELVLASLGALLFCGFIIYDTHSLMHRLSPEEYVLAAISLYLDIINLFLHLLKFLDAVNKK 238 
Gallus_gallus               CLWILIFSCFLMVFFHS-EIMELVFAAAGALLFCGFIIYDTHLLMHKLSPEEYILAAINLYLDIINLFLNLLRLLEAFNKK 237 
Danio_rerio                 GLWILIIASFLRFFFYN-DTMELVFAGAGALLFCGFIIFDTHLLMHKLSPEEHVLASINLYLDIVNLFLYILRILDAMKKH 182 
Arabidopsis_thaliana_3      SLIILVVTSFIQMFFPLGPTSVAVYGGFSALVFCGYIVYDTDNLIKRFTYDEYILASVALYLDILNLFLTILRILRQGDN- 256 
Caenorhabditis_elegans      LLCVLLWAGIFQMFFMS-PAVNFVINVFGAGLFCVLLVIDLDMIMYRFSPEDYICACVSLYMDILNLFIRILQIVAEANK- 276 
                             * :*  : :: .*.        *    .* :**  :: * . :: ::::::: *.: :*:*::***: :*:.:   .:  
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 The sequence alignments showed that there was only one highly conserved 
cysteine in the GAAP family. Strikingly, it mapped to TMD 6, which was not included in 
the region that was defined as necessary and sufficient for vGAAP oligomerization 
(TMD1-4). Different vGAAPs differ considerably from all other GAAP family members in 
possessing many more cysteines. Close to the end of TMD 5 most GAAPs analysed, 
except vGAAP and AtGAAP3, show some degree of cysteine conservation. 
 Most of vGAAP unique cysteines were located closer to the N terminus of the 
protein. Considering GAAP topology, there are three cysteines located in the inter-
membrane loops, and not located deep inside the TMDs, and these are indicated in 
grey boxes and are present in both viral GAAPs and Danio rerio GAAP (Figure 5.7). 
Notably both cysteine residues in hGAAP are predicted to be deep within TMD5 and 6 
(Figure 5.7). There are only two cysteines in vGAAP that are not embedded in the 
TMDs, cysteines 9 and 60.  
 These data might suggest that although the cysteine present in TMD 6 is 
essential for GAAP function or structure it might not be directly involved in GAAP-
GAAP interaction. 
 To further investigate the importance of disulphide bonds in both vGAAP and 
hGAAP oligomerization all cysteine residues from both proteins were individually 
mutated to serine. A vGAAP and an hGAAP mutant with all cysteines mutated was also 
generated and was called either vGAAP CXS or hGAAP CXS.  
 All mutant proteins were tested for subcellular localization by 
immunofluorescence, as an indicator for correct protein folding (Figure 5.8). When 
compared with the wild type proteins and using an anti-GM130 Ab as a Golgi marker, it 
was clear that all mutant vGAAP and hGAAP proteins still localized to the Golgi 
complex because their localization overlapped well with that of GM130. Even the CXS 
mutant in which all cysteines have been replaced by serines showed a Golgi 
localization that was indistinguishable from wild type.  
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Figure 5.7 - Diagram of cysteine distribution in vGAAP and hGAAP. GAAP 
topology as described by Carrara et al, (submitted) with the localization of the cysteine 
residues that were subjected to site-directed mutagenesis highlighted by yellow 
crosses. Both vGAAP and hGAAP N and C terminus are located at the cytosolic side of 
the Golgi membrane. The portion after TMD6 was described to be either a re-entrant 
loop or to be free in the cytosol.  
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Figure 5.8 – A Golgi localization persists in hGAAP and vGAAP cysteine to 
serine mutants. HeLa cells were transfected with pcDNA3.1 wt or cysteine to serine 
mutant vGAAP-HA or hGAAP-HA and fixed in 4 % PFA after 16 h. An anti-HA Ab was 
used to detect GAAP and an anti-GM130 Ab was used as a Golgi marker. Cells were 
imaged using confocal microscopy. CXS mutants have all their cysteines mutated to 
serines. The right panels represent phase images. Scale bars correspond to 10 µm. 
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 To investigate the contribution of each individual cysteine residue for hGAAP 
and vGAAP dimerization, each mutant was expressed in mammalian cells and 
analysed by both reducing and non-reducing SDS-PAGE (Figure 5.9A and B). None of 
the hGAAP cysteine mutants lost the ability to form dimers, as shown by the presence 
of a ∼37 kDa band for all mutants in both reducing and non-reducing conditions. Even 
the CXS hGAAP mutant, with all the cysteines mutated, showed the presence of a 
band that migrated at a size corresponding to the dimeric form of the protein, in both 
reducing and non-reducing conditions (Figure 5.9A). For the vGAAP mutants, only 
cysteines 9 and 60 showed a reduced dimer to monomer band ratio in non-reducing 
conditions compared to the wild type vGAAP (Figure 5.9B). When these were mutated 
in combination the double mutant (C9+60S) failed to dimerize to the same degree as 
the protein lacking all cysteines (CXS), indicating that these are the only cysteines 
involved in vGAAP dimerization. Mutants C9S, C60S, C9+60S and CXS also showed a 
reduction in the intensity of putative trimer and tetramer bands. Upon addition of DTT, 
all mutant and wt vGAAP proteins were reduced to a monomeric state only, as shown 
by the absence of any higher molecular size bands, showing equal levels of protein 
and ruling out possible experimental artefacts due to differential protein expression. 
 Taken together these data suggested that cysteine residues 9 and 60 are likely 
to be involved in both dimerization and tetramerization of vGAAP.  
 As shown in Figure 5.2, wild type vGAAP can form dimers, trimers, and 
tetramers and the proportion of the high molecular size forms increases with the 
addition of a crosslinker. Using the same approach for vGAAP C9+60S mutant it was 
shown that these mutations abrogate the appearance of high molecular size bands 
when the protein is resolved by non-reducing SDS-PAGE, even when previously 
crosslinked with DFDNB (Figure 5.10). Putative dimer, trimer and tetramer bands are 
clearly seen for wt vGAAP when crosslinked in the same conditions as the mutant. 
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Figure 5.9 - vGAAP oligomerization is dependent on cysteine residues 9 and 60. 
Individual or multiple cysteine to serine mutations were made in (A) hGAAP-HA or (B) 
vGAAP-HA. Lysates from HeLa cells transfected with pcDNA3.1 wt or cysteine to 
serine mutant vGAAP-HA and hGAAP-HA were run on SDS-PAGE in the presence or 
absence of reducing agent (DTT) and immunoblotted (IB) with an anti-HA Ab. (B upper 
panel) The dimer and monomer bands intensity of the vGAAP-HA mutants was 
measured using Li-Cor and plotted as the ratio between dimer and monomer. The 
predicted oligomerization forms of GAAP are shown, by arrows on the side of the gel. 
Monomer (1x), dimer (2x), trimer (3x) and tetramer (4x). CXS mutants have all the 
cysteines mutated to serines. The position of size markers in kDa is shown on the left 
of each gel.  
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Figure 5.10 - vGAAP C9+60S is not able to oligomerize even when crosslinked. 
Lysates from HeLa cells transfected with either pcDNA3.1 wt or C9+60S vGAAP-HA 
were incubated in the presence of increasing concentrations of the crosslinker DFDNB. 
Samples were resolved by non-reducing SDS-PAGE and membranes were 
immunoblotted with an anti-HA Ab. The predicted oligomerization states of vGAAP are 
shown by arrows. Monomer (1x), dimer (2x), trimer (3x) and tetramer (4x). The position 
of size markers in kDa is shown on the left of the gel. 
 
 
5.7 vGAAP cysteine’s 9 and 60 are essential for 
oligomerization –  FRET analysis 
 To corroborate the SDS-PAGE analysis, hGAAP, vGAAP, vGAAP C9S, vGAAP 
C60S and vGAAP C9+60S were C-terminally fused with GFP or with tdTomato (Tom) 
for FRET analysis (Figure 5.11A). The use of FRET to analyse the GAAP-GAAP 
interaction offered two major advantages when compared to the non-reducing SDS-
PAGE approach: it allowed whole cell analysis, this overcomes the possible membrane 
protein aggregation during extraction of membrane proteins using detergents; and, 
because the proteins remain in the Golgi membrane during FRET analysis, these are 
kDa 
 
100 - 
75 - 
 
50 - 
 
37 - 
 
 
 
25 - 
 
20 - 
 
DFDNB 
U
nt
re
at
ed
 
D
M
S
O
 
U
nt
re
at
ed
 
D
M
S
O
 
DFDNB 
 C9 +60S vGAAP          wt vGAAP 
2x 
1x 
4x 
3x 
2.
5 
5 
   
10
 
20
 
nM 2.
5 
5 
   
10
 
20
 
     
 
                  
 
151 
more likely to retain their native conformation. As a control for proper expression and 
folding, the subcellular localization of each fusion protein was assessed by 
immunofluorescence using an anti-GM130 Ab as a Golgi marker (Figure 5.11B). All 
fusion proteins tested showed the expected Golgi localization as indicated by 
overlapping with GM130 localization. Therefore FRET could be used to investigate 
GAAP-GAAP interactions in a cell based assay where the protein would still be 
inserted in the Golgi membrane. 
 Wild type vGAAP fused with GFP (vGAAP-GFP) was co-transfected in 
mammalian cells with tdTomato fused vGAAP (vGAAP-Tom). This combination allowed 
the detection of a FRET signal as an increase in vGAAP-GFP fluorescence after 
vGAAP-Tom photobleach. This could be seen either by an increase in total cell 
vGAAP-GFP fluorescence after vGAAP-Tom photobleach, as showed by grey scale 
images (Figure 5.12A) or by the calculation of FRET efficiency (E) in regions of interest 
where both signals were detected (Figure 5.12A) (see materials and methods for FRET 
efficiency calculation). None of the vGAAP cysteine mutants tested were able to 
produce a FRET signal, giving similar results to the negative controls, GRASP65-GFP 
and free GFP both in combination with vGAAP-Tom. GRAPSP65-GFP was used as a 
negative control because it is known to localize to the Golgi and its GFP tag was 
engineered so it was localized in the cytoplasmic side of the Golgi membrane (Barr et 
al., 1998), as was the case for GAAP. These data confirm the results found using the 
non-reducing SDS-PAGE approach that cysteine 9 in vGAAP is required for vGAAP-
vGAAP interactions. vGAAP cysteine 60 that had a weaker impact on vGAAP 
dimerization disruption when analysed by non-reducing SDS-PAGE, seems to be 
absolutely required when tested by FRET. 
 Using immunofluorescence it was possible to confirm Golgi localization for both 
wt hGAAP-GFP and hGAAP-Tom (Figure 5.11B). The FRET signal obtained with the 
wt hGAAP-GFP and the wt hGAAP-Tom co-transfection was significantly higher than 
the signal obtained with all the controls used (Figure 5.13A and B), indicating a positive 
interaction between the two proteins. Using this same approach, it was also possible to 
confirm the previously observed hGAAP-hGAAP interaction in cell lysates using non-
reducing SDS-PAGE. 
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Figure 5.11 - Subcellular localization of GAAP-GFP and GAAP-Tom fusion 
proteins. (A) Diagram showing the localization of GFP and tdTomato (Tom) tagged-
GAAP. (B) HeLa cells were transfected with plasmids encoding GFP or tdTomato 
tagged vGAAP and hGAAP or with GFP or tdTomato alone. Cells were fixed 16 h post 
transfection and imaged using confocal microscopy. Golgi localization of the GFP and 
the tdTomato fusion GAAP proteins was assessed by comparison with immunostaining 
with an anti-GM130 Ab. Scale bars correspond to 10 µm 
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Figure 5.12 - vGAAP-vGAAP interaction assessed by FRET. FRET was detected by the increase in GFP fluorescence after tdTomato 
(Tom) photobleach in HeLa cells transfected with plasmids that express vGAAP-GFP and vGAAP-Tom or control proteins. Cells were 
fixed 16 h post transfection. GRAP65-GFP and free GFP were used as negative controls. (A) Representative images of GFP fluorescence 
before and after Tom photobleach. Grey values images were obtained by pixel-by-pixel subtraction of the GFP prebleach images from 
postbleach images. Scale bar, 10 µm (B) Regions where GFP and Tom colocalize from > 10 cells for each condition were selected and 
FRET efficiency was calculated (see materials methods for more details). Data are shown as mean ± SEM and were analyzed using an 
unpaired Student’s T-test and is represented as ** p<0.01 for comparison with GRASP65-GFP + vGAAP-Tom. 
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Figure 5.13 - hGAAP-hGAAP interaction assessed by FRET. FRET was detected by the increase in GFP fluorescence after tdTomato 
(Tom) photobleach in HeLa cells transfected with plasmids encoding hGAAP-GFP and hGAAP-Tom. Cells were fixed 16 h post 
transfection. GRAP65-GFP and free GFP were used as negative controls. (A) Representative images of GFP fluorescence before and 
after Tom photobleach. Grey values images were obtained by pixel-by-pixel subtraction of the GFP prebleach images from postbleach 
images. Scale bar, 10 µm (B) Regions where GFP and Tom colocalize from at least 10 cells for each condition were selected and FRET 
efficiency was calculated (see materials methods for more details). Data are shown as mean ± SEM and were analyzed using an unpaired 
Student’s T-test and is represented as *** p<0.001 for comparison with GRASP65-GFP + hGAAP-Tom. 
 
GFP  
prebleach 
GFP  
postbleach 
GFP Postbleach 
Minus  
GFP prebleach 
hGAAP-GFP + 
hGAAP-Tom 
 
 
GRASP65-GFP + 
hGAAP-Tom 
 
 
GFP + 
hGAAP-Tom 
A B 
FRET Efficiency (E)
0.0 0.1 0.2 0.3 0.4
GFP + hGAAP-Tom
GRASP65-GFP + hGAAP-Tom
hGAAP-GFP + hGAAP-Tom ***
     
 
             155 
 
5.8 Summary 
 All GAAP proteins analysed so far by SDS-PAGE exhibit anomalous gel 
mobility, because they tend to show increased gel mobility when analysed by SDS-
PAGE compared to their known molecular masses. For example vGAAP, with a 
predicted size of 26.5 kDa (Gubser and Smith, 2002) runs with the 20-kDa marker on 
the protein ladder in SDS-PAGE. This could be attributed to the protein’s high 
hydrophobicity, to the possibility that lipids and/or detergent molecules could still be 
bound to the protein when running through the gel and to the absence of a strong 
protein denaturing step (95 °C for 10 min) in the cell lysate preparation protocol that will 
reduce protein denaturation. The binding of lipids or detergent to the protein and the 
incomplete denaturation will make the molecular complexes more globular, this will 
increase the protein gel mobility. It was also noted that both hGAAP and vGAAP (from 
both CMLV and VACV) expressed in mammalian cells showed several bands other 
than the predicted 20-kDa form when analysed by gel electrophoresis. One possible 
explanation is that these additional bands could correspond to dimers, trimers and 
tetramers of GAAP.   
 Using DFDNB it was shown that both vGAAP and hGAAP can form dimers, 
trimers and tetramers. Although not resolved in the conditions used, the existence of 
any species with higher molecular weight than the tetramer could not be completely 
ruled out and require further investigation.  
 It was possible to define the N-terminal region of vGAAP as essential and 
sufficient for vGAAP oligomerization. Yet it was not possible to rule out that the 
truncation made in hGAAP impaired the proper folding of the two truncated proteins 
and that this could account for the loss of oligomerization observed for both the hGAAP 
truncations in Figure 5.5. 
 Using both biochemical and cell-based assays, it was shown that both hGAAP 
and vGAAP can form oligomers, these are most likely tetrameric and that these are 
dependent on pH. Oligomerization of hGAAP, but not vGAAP was found to be 
independent of disulphide bounds. Using FRET and non-reducing SDS-PAGE it was 
possible to identify cysteines 9 and 60 in vGAAP as essential for oligomerization. 
Results obtained using the non-reducing SDS-PAGE approach were very clear and 
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identified cysteines 9 and 60 from vGAAP as important for vGAAP dimerization. 
Nevertheless this approach did not address the fact that GAAP oligomerization occurs 
within the Golgi membrane and that the protein had been extracted and solubilized with 
the help of a detergent (CHAPS). This issue was addressed by using FRET to analyse 
the GAAP-GAAP interaction because this technique allows the detection of the GAAP-
GAAP interaction while the proteins were still embedded in the Golgi membrane and in 
their native state. The use of FRET confirmed the vGAAP-vGAAP and hGAAP-hGAAP 
interactions and the importance of vGAAP cysteine 9 for this interaction. vGAAP 
cysteine 60, that showed only a mild effect on dimerization disruption using the non-
reducing SDS-PAGE technique was shown to be required to the vGAAP-vGAAP 
interaction by using FRET. The use of FRET enabled the clarification and confirmation 
of the results obtained with the non-reducing SDS-PAGE approach. FRET offers many 
advantages when analysing membrane protein-protein interactions because it does not 
require the extraction of the proteins from the membranes with detergent that usually 
lead to both unspecific interactions due to the high protein hydrophobicity and to the 
possible loss of interactions that are dependent on the correct protein insertion in the 
cellular lipid bilayers. 
 It is not known how vGAAP dimers assemble to form the higher molecular 
weight oligomer detected by SDS-PAGE. It may be that vGAAP forms a dimer through 
cysteine-based disulphide bonds and that a dimer of dimers is formed through other 
interactions, such as electrostatic forces. 
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 Chapter VI 
 hGAAP increases cell adhesion 
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 So far hGAAP has been described as an anti-apoptotic protein that can 
modulate the amount of Ca2+ kept in intracellular stores. During apoptosis assays using 
ceramide, it was observed that cells often detached prior to apoptosis, with detachment 
and apoptosis being prevented in the cells in which hGAAP was overexpressed 
(Gubser et al., 2007). Given the essential role of Ca2+ in cell adhesion we therefore 
sought to test whether hGAAP expression affected cell adhesion. 
 
6.1 hGAAP overexpression increases cell adhesion and 
reduces cell detachment  
 As a first approach to test a possible involvement of hGAAP in cell adhesion, a 
simple attachment assay was used to test if hGAAP overexpression affected cell 
adhesion. U2OS and HeLa cells either overexpressing hGAAP or control cell lines 
carrying the empty plasmids (U2OS neo or HeLa puro, see table 2.7 in material and 
methods for more details) were seeded in tissue culture plates and washed at different 
time points to remove non-adherent cells. The cells that had attached to the wells were 
stained with crystal violet and the amount of crystal violet taken up was measured by 
spectrophotometry, after this the crystal violet retained in the cells was eluted with 
acetic acid, to determine the number of cells present. The correlation between levels of 
crystal violet dye and cell number is only possible if the volume is similar between cell 
lines. To control for this parameter viable cell diameter after detachment was calculated 
using the Invitrogen automated cell counter and trypan blue as a marker for viable cells 
(U2OS neo: 11.65 ± 0.25 µm2; U2OS hGAAP 11.68 ± 0.33 µm2 and U2OS hGAAP C-
terminal mutant [Ctmut] 11.49 ± 0.29 µm2), no significant differences in cell size were 
found between U2OS cell lines that could account for the differences observed in the 
attachment assay. 
 Using two independently generated hGAAP overexpressing cell lines in two 
different cell types (HeLa and U2OS hGAAP expressing cell lines were previously 
generated in our lab by Ben Johnson and Caroline Gubser, respectively) it was clear 
that hGAAP overexpression increased the speed of attachment to the substrate (Figure 
6.1A and B). In HeLa cells between 60 and 120 min post seeding, there were 
statistically greater numbers of adherent cell
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in U2OS cells there were more adherent hGAAP expressing cells at 45 and 60 min 
post seeding. In U2OS cells, a cell line expressing a mutated version of the hGAAP 
was analysed in parallel. The C-terminal region of the TMBIM family members is 
characteristically charged. A C-terminal mutant of hGAAP where these charged amino 
acids were replaced by alanines, (Figure 6.1C) was used as an additional control 
because it was shown previously to be unable to inhibit apoptosis using a variety of 
apoptotic stimuli (Caroline Gubser, unpublished). This mutant was shown to express to 
similar levels as the wt hGAAP protein (Figure 6.1D). hGAAP-V5 expression in HeLa 
was confirmed by immunoblot with an anti-V5 Ab (Figure 6.1E). Analysis of the 
adherence of cells expressing hGAAP Ctmut showed they were indistinguishable from 
control cells not overexpressing hGAAP, indicating that the C-terminal charged 
residues are important for induction of increased cell adhesion.  
 The adhesion of cells to the plastic matrix was also assessed using a 
detachment assay. Cell detachment was induced by addition of EDTA to the medium 
and cells remaining adhered to the plastic at different times thereafter were measured 
using the same crystal violet staining method used before. U2OS and HeLa cells 
seeded for 24 h were treated with different concentrations of EDTA and the cells 
remaining attached after treatment were quantified by crystal violet stain. In both EDTA 
concentrations used for both cell types hGAAP overexpression was able to reduce cell 
detachment to a considerable degree (Figure 6.2). Both methods used to measure the 
effect of hGAAP effect on cell adhesion let to the same conclusion: namely, that 
hGAAP overexpression increased the cell’s ability to attach to the substratum. 
 The C-terminal mutations in hGAAP rendered the protein unable to modulate 
Ca2+ in a single cell Ca2+ release assay (Figure 6.3). When Ca2+ from intracellular 
stores was released by the action of ionomycin the amount released by the control cell 
line (neo) and the hGAAP Ctmut cell line were not different, while the cell line 
overexpressing hGAAP releases a significant lower amount of Ca2+ as previously 
shown by de Mattia et al. (2009). The observed effects in cell adhesion, anti-apoptotic 
effect and Ca2+ modulation caused by the C-terminal mutations cannot be accounted 
by a reduction in protein expression because both wild type and Ctmut hGAAP were 
expressed to similar levels when tested by immunoblot using anti-HA Ab (Figure 6.1D).  
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Figure 6.1 - hGAAP overexpression increases cell attachment and its charged C 
terminus is essential for this phenotype. (A) U2OS or (B) HeLa cells expressing 
hGAAP-HA, hGAAP Ctmut-HA or just the plasmid resistance gene (neo or puro) were 
detached using trypsin, counted and seeded in a 12-well plate (n=4). Cells were 
washed in PBS at different time points post seeding to remove non-adherent cells. The 
remaining cells were fixed with PFA and stained with crystal violet. The amount of 
crystal violet remaining after washing was determined by eluting with acetic acid and its 
absorbance measured. Data are representative of three individual experiments and are 
represented as mean ± SEM. Data were analyzed using the Student’s T-test and is 
represented as * p<0.05, **p<0.01 for comparison to the neo or puro cells. (C) Diagram 
showing the hGAAP mutated residues in the hGAAP Ctmut protein. (D and E) Cells 
were lysed and immunoblotted using (D) anti-HA or (E) anti-V5 Abs to confirm hGAAP 
expression. The position of size markers in kDa is shown on the right of each gel. 
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Figure 6.2 - hGAAP overexpression reduces cell detachment upon EDTA 
treatment and mutating the charged C terminus abolishes this phenotype. (A) 
U2OS or (B) HeLa cells were seeded in a 12-well plate for 24 h (n=4) and treated with 
different concentrations of EDTA for 20 min. After treatment, the wells were washed to 
remove detached cells and the remaining attached cells were fixed with PFA, stained 
with crystal violet, and the crystal violet eluted with acetic acid and its absorbance 
measured. Data are representative of three individual experiments and are represented 
as mean ± SEM of the percentage of cells still attached after EDTA treatment 
compared to untreated cells. Data were analyzed using an unpaired Student’s T-test 
and are represented as ** p<0.01, *** p<0.001 for comparison to the neo or puro cells. 
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Figure 6.3 - hGAAP reduces the Ca2+ content of intracellular stores and its 
charged C-terminal region is essential for this function. (A) HEK293T cells were 
transfected with plasmids expressing the indicated proteins along with mCherry-C1. 
Twenty-four hours after transfection, cells were loaded with Fura-2-AM and kept in 
Ca2+-free solution. Ca2+ release as a response to ionomycin was measured in 
transfected cells. Traces show representative average Ca2+ responses of fields of 
transfected cells to ionomycin (n=20-52 cells in each case). (B) Graph shows the 
means ± SEM of peak Ca2+ responses from three independent fields of cells (n=18-64 
cells in each field). Data were analyzed using the Student’s T-test: * p<0.05, for 
comparison to pcDNA3.1 transfected cells. Ca2+ release assays were performed by 
David Prole, University of Cambridge. 
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6.2 hGAAP knockdown increases cell detachment  
 The above data indicated that hGAAP overexpression increased cell adherence 
to the substratum. Reduction in hGAAP expression might therefore be expected to do 
the converse. To test this hGAAP knockdown was achieved by transfection of siRNAs 
and the consequences of this on cell adhesion was measured using the EDTA 
detachment assay described above. Cells were transfected for 36 h with well-
characterized hGAAP siRNA 1or 2 (Gubser et al., 2007) or with a control siRNA. These 
cells were then incubated with either Ca2+ containing medium or EDTA containing 
medium. hGAAP knockdown efficiency was assessed by RT-PCR with hGAAP specific 
primers. When siRNA1 and 2 were used a reduction in hGAAP mRNA levels was 
obtained in the two different cell types tested (Figure 6.4A) although siRNA1 was 
reproducibly better at knocking down hGAAP levels that siRNA2. GAPDH mRNA levels 
were determined and used as a loading control. To address if hGAAP mRNA reduction 
caused a reduction in protein levels the levels of hGAAP-HA was measured 36 h post 
siRNA transfection in hGAAP-HA expressing U2OS cells by immunoblotting. This 
approach was selected because of the lack of a good Ab to easily measure the levels 
of endogenous hGAAP. It was possible to detect a reduction in hGAAP-HA protein 
levels in these conditions with both siRNA1 and siRNA2 but not with a control siRNA 
(Figure 6.4B). Given that the levels of hGAAP-HA are higher when compared to 
endogenous protein levels we can assume that both siRNA 1 and 2 are able to 
knockdown endogenous hGAAP in the conditions used.  
 Cells transfected with either hGAAP specific siRNAs showed an increased cell 
detachment compared to control siRNA, with EDTA concentrations of 0.5 mM, and 5 
mM, and these differences were statistically significant (Figure 6.4A). No alterations in 
cell detachment were seen when 1 mM CaCl2 was used instead. 
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Figure 6.4 - hGAAP siRNA knockdown increases cell detachment upon EDTA 
treatment. (A) U2OS and HeLa cells or (B) U2OS expressing hGAAP-HA were 
seeded in a 12-well plate and transfected with the appropriate siRNA for 36 h. (B) 
U2OS and HeLa siRNA transfected cells were tested for downregulation of 
endogenous hGAAP by RT-PCR with hGAAP specific primers. GAPDH was used as a 
loading control and samples with no RT were used to control for DNA contamination. 
(B) U2OS hGAAP-HA cells were also tested for hGAAP-HA downregulation by 
immunoblot using an anti-HA Ab. The position of size markers in kDa or base pairs (bp) 
is shown on the right of each gel. (C) U2OS transfected with siRNA for 36 h were 
treated with different concentrations of EDTA or with Krebs Ringer buffer containing 1 
mM CaCl2 for 20 min. Wells were then washed to remove detached cells and the 
remaining cells were fixed with PFA, stained with crystal violet and the dye remaining 
eluted with acetic acid and absorbance measured. Data are representative of three 
individual experiments and are represented as mean ± SEM. Data were analyzed using 
the Student’s T-test and is represented as * p<0.05, ** p<0.01, for comparison to the 
control siRNA.  
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6.3 hGAAP affects cell spread on fibronectin  
 In an attempt to better understand and characterize the altered adhesion and 
detachment of cells mediated by hGAAP, the speed of cell spread on the ECM protein 
fibronectin was measured. U2OS cells were seeded on fibronectin-coated slides, fixed 
at different time points and stained with phalloidin. The cell area was measured using 
confocal microscopy and was plotted against time, showing how fast the cells could 
settle down and spread out. hGAAP overexpression made cells spread out faster when 
compared to both hGAAP Ctmut and neo cell lines (Figure 6.5A). In contrast, hGAAP 
knockdown using each hGAAP-specific siRNA slowed cell spread when compared to 
the control siRNA (Figure 6.5B).  
 The fact that hGAAP knockdown can impair cell spread and hGAAP 
overexpression can accelerate it suggests a possible involvement of hGAAP in focal 
adhesion dynamics or actin cytoskeleton reorganization. This is because cell spread in 
response to integrin activation, which in these experimental conditions is mainly 
triggered by integrin binding to fibronectin, is highly dependent on these two events. 
 
6.4 hGAAP overexpression reduces cell migration in a 
wound-healing assay (WHA) 
 A WHA was used to test hGAAP influence in uni-directional cell migration in a 
confluent monolayer of cells. Wounds were generated in confluent monolayers of 
hGAAP, hGAAP Ctmut or neo U2OS cells seeded in fibronectin-free dishes, and cell 
migration was stimulated by addition of 10 % FBS. Wound healing caused by cell 
migration into the wound was monitored for 12 h by measuring the size of the wound 
every 15 min and plotted against time to calculate the speed of cell migration (Figure 
6.6A). The speed at which cells overexpressing hGAAP migrate to fill the wound was 
higher than the speed of hGAAP Ctmut or neo cells (Figure 6.6B). The results obtained 
show that hGAAP overexpression decreased the ability of cells to move uni-
directionally in a monolayer in a fibronectin-free condition.  
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Figure 6.5 - hGAAP overexpression increases cell spread speed whereas hGAAP 
knockdown has the reverse effect. (A) hGAAP, hGAAP Ctmut or neo U2OS cells 
were seeded in fibronectin-coated slides and left to adhere and spread for different 
times as shown. Cells were then fixed with PFA and stained with phalloidin for easier 
determination of cell area. (B) U2OS cells were transfected with the panel of siRNA 
showed for 36 h, after this time cells were re-seeded in fibronectin-coated slides and 
fixed at different times post seeding. Over 35 cells were imaged for each cell line and 
time points and their area (µm2) was measured using Image J software. Data are 
shown as mean ± SEM and significant differences were determined using an unpaired 
Student’s T-test and are represented as ** p<0.01, *** p<0.001 for comparison to the 
neo or control siRNA transfected cells. 
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Figure 6.6 - hGAAP overexpression reduces cell migration in a wound-healing 
assay. U2OS cells were seeded in 6-well plates and grown to confluence. After serum 
starving the cells overnight, three lesions were made per well by scratching a pipette tip 
across the cell monolayer and each wound was imaged every 15 min for 12 h. Cell 
migration was stimulated by replacing the FBS-free medium with 10 % FBS medium 
after creating the wounds. Two examples of typical wounds are shown in A. (B) The 
distance between both sides of the wound was measured for each time points and 
plotted against time to determine cell migration speed. Data shown corresponds to six 
individual wounds. Data are representative of three individual experiments and are 
represented as mean ± SEM. Data were analyzed using the Student’s T-test and is 
represented as ** p<0.01, for comparison to the neo cell line. Scale bar corresponds to 
100 µm.  
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6.5 Overexpression or knockdown of hGAAP does not 
abolish protein trafficking to the plasma membrane  
 Given that the subcellular localization of hGAAP is in the Golgi, and the 
importance of this organelle for the correct traffic to the plasma membrane of many 
proteins involved in cell adhesion processes, it was important to test a possible effect 
of hGAAP overexpression or knockdown in these pathways. In an attempt to show that 
hGAAP overexpression or knockdown was not abolishing or significantly impairing the 
secretory pathway a control experiment was performed to complement data obtained 
by Gubser et al. (2007). Cells overexpressing hGAAP or hGAAP Ctmut, or in which 
hGAAP expression was knocked down by siRNA, were transfected with the vesicular 
stomatitis virus (VSV) glycoprotein G (gpG) fused with GFP (VSV-gpG-GFP). VSV-gpG 
is a well characterised type I membrane protein that is expressed on the cell surface 
(Katz et al., 1977). Cells transfected with VSV-gpG-GFP expressing plasmid were 
fixed, but not permeabilised, and then stained with an anti-VSV-G mAb that, in these 
circumstances, only detected plasma membrane VSV-gpG-GFP, and not internal VSV-
gpG-GFP. The levels of VSV-gpG-GFP at the plasma membrane were very similar 
within the three different cell lines and also within all the three siRNA treated cells used 
in this experiment (Figure 6.7). The total expression levels were also not substantially 
affected as seen in the GFP channel that allows the detection of all VSV-gpG-GFP 
protein within the cell (Figure 6.7). Using this approach it was possible to show that 
neither hGAAP nor hGAAP Ctmut overexpression nor hGAAP knockdown drastically 
altered the ability of the secretory pathway to produce or export the VSV-gpG to the 
plasma membrane. Although further quantitative and functional assays would be 
necessary to completely rule out small and less obvious effects of this pathway. 
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Figure 6.7 - hGAAP knockdown or overexpression do not abolish protein 
trafficking to the plasma membrane. U2OS cells overexpressing hGAAP-HA or 
hGAAP Ctmut-HA or hGAAP siRNA- or control siRNA-treated for 18 h were transfected 
with a plasmid expressing VSV-gpG-GFP for 18 h. After this time, cells were fixed, but 
not permeabilized, and immunostained with an anti-VSV-gpG Ab. Cells were imaged 
for both total VSV-gpG (GFP signal) and cell membrane bound VSV-gpG (Ab). Scale 
bars represented are 10 µm. 
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6.6 hGAAP overexpressing cells have more focal adhesions, 
but these are smaller 
 Given that hGAAP can increase both cell adhesion and cell spread on 
fibronectin, and reduce cell migration, we decided to explore a possible effect on focal 
adhesion dynamics. Focal adhesions are essential for cell to extracellular matrix 
adhesion and play an important role in many cellular processes such as migration. By 
determining the size, distribution and number of these structures it was possible to 
define if hGAAP was having an effect on focal adhesion dynamics. 
 As a first approach, the number of focal adhesions was estimated using vinculin 
as a focal adhesion marker because this is one of the best characterized components 
of the focal adhesion complexes. A plasmid expressing vinculin tagged with GFP was 
transfected into cells overexpressing hGAAP, and these were seeded on fibronectin-
coated plates and the number of focal adhesions was measured by confocal 
microscopy. Phalloidin was used as an additional marker for focal adhesions because 
actin stress fibres are also found in such structures. The number of focal adhesions 
found using this approach for hGAAP overexpressing cell lines was slightly higher than 
the numbers found for the control neo and hGAAP Ctmut overexpressing cell lines 
(Figure 6.8). Although this difference was small, it was statistically significant. 
 The use of interference reflectance microscopy (IRM) allowed the quantification 
of the total number of focal adhesions per cell independently of a particular marker, by 
measuring the number of sites of contact between the cell and the substratum. This 
showed that the number of focal adhesions per cell was higher in the hGAAP 
overexpressing cells than the control cell lines (Figure 6.9A) backing up the data found 
using vinculin as a marker for focal adhesions. Additionally, the size of the focal 
adhesions was found to be significantly smaller in cells overexpressing hGAAP when 
compared to the control neo and the Ctmut cell lines (Figure 6.9B). The average 
percentage of cell-substrate contact area was found to be higher in hGAAP 
overexpressing cells (Figure 6.9C). This result, together with the increased cell spread 
speed observed for hGAAP U2OS cells, could explain the increased adhesion 
phenotype observed in Figure 6.1 with hGAAP overexpression, because the overall 
contact area is increased in these cells when compared with the control cell line. 
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Figure 6.8 - hGAAP overexpression increases the number of vinculin positive 
focal adhesion sites. U2OS cells overexpressing hGAAP-HA or hGAAP Ctmut-HA 
were seeded in fibronectin-coated coverslips for 24 h and hGAAP overexpressing cells 
were transfected with GFP-vinculin. Twelve hours later cells were fixed and stained 
with phalloidin. Confocal microscopy images were acquired and the number of focal 
adhesions was calculated for > 20 cells. Data are represented as mean ± SEM. Data 
were analyzed using the Student’s T-test and is represented as * p<0.05 for 
comparison to the neo cells. 
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Figure 6.9 - Analysis of the cell-substrate interface of hGAAP-overexpressing 
cells using interference reflectance microscopy (IRM). U2OS cells were allowed to 
attach for 24 h to glass-bottom dishes pre-coated with fibronectin. Cells were fixed, 
stained with phalloidin and kept in PBS. IRM images were acquired and (A) the number 
of adhesions per cell, (B) the average adhesion size and, (C) the average cell-
substrate contact area values were calculated for > 30 cells. Data are represented as 
mean ± SEM. Data were analyzed using the Student’s T-test and is represented as * 
p<0.05, **p<0.01, ***p<0.001 in comparison to the neo cells. (D) Example of the image 
treatment done to determine focal adhesion number and size. Individual cells are 
imaged for (a) IRM and for phalloidin. IRM images are then put through a (b) band pass 
filter and (c) threshold to obtain the final image that can be used to determine the 
parameters shown in A, B and C. 
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6.7 hGAAP knockdown causes an elongated morphology, 
fewer and bigger focal adhesions 
 It was noticed that after hGAAP knockdown cells showed an elongated 
morphology (Figure 6.7 and 6.10A) and this phenotype was not observed when the 
control siRNA was used. In cells in which hGAAP was knocked down it was evident 
that the actin stress fibres were mostly positioned along the cell length and very few 
were actually facing the inside of the cell (Figure 6.10A). A possible explanation for this 
phenotype could be linked to the inability of the cells to make enough new focal 
adhesions to allow for cell spread and movement, or with the inability to disassemble 
focal adhesions at the cell rear. To test these possibilities the same strategy described 
in Figure 6.5 was used. Vinculin-GFP was used as a focal adhesion marker and the 
number of focal adhesions per cell was counted. An almost three-fold reduction in focal 
adhesion number per cell was observed in hGAAP siRNA (siRNA1 and siRNA2)-
treated cells (Figure 6.10B). To confirm this result, IRM was used, and this technique 
also showed that the number of focal adhesions per cell was highly reduced after 
hGAAP knockdown when compared to cells transfected with the control siRNA (Figure 
6.11A). 
 Interestingly, knockdown of hGAAP increased the size of individual focal 
adhesions (Figure 6.11B). Furthermore, when the levels of FAK phosphorylated at 
tyrosine 397 were measured there was a reduction of FAK phosphorylation upon 
hGAAP knockdown when compared to control siRNA (Figure 6.12A and B). This result 
supported the relevance of the reduction in the number of focal adhesions. (Figure 
6.11A and B). The levels of FAK phosphorylated at tyrosine 397 were measured using 
both IF and immunoblotting (Figure 6.12A and B). Activation of FAK by integrin 
clustering leads to its autophosphorylation at Tyr397, which is a binding site for the Src 
family kinases (Calalb et al., 1995; Schaller et al., 1994) making this a good indicator 
for active focal adhesions. Talin was used in the IF experiment as a control, as it is also 
present in most focal adhesions because this is one of the first components of the focal 
adhesion structures to be recruited even before maturation into focal adhesions occurs 
(Campbell and Ginsberg, 2004).   
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Figure 6.10 - hGAAP knockdown reduces the number of vinculin-positive focal 
adhesions. hGAAP knockdown alters cell morphology. U2OS cells were seeded in 
fibronectin-coated coverslips and transfected with the indicated siRNA for 24 h. After 
this period cells were transfected with GFP-vinculin. Twelve hours later cells were fixed 
and stained with phalloidin. (A) Confocal microscopy images were acquired and (B) the 
number of focal adhesions (FAs) was calculated for > 20 cells. Data are represented as 
mean ± SEM. Data were analyzed using the Student’s T-test and is represented as 
***p<0.001 for comparison to control siRNA transfected cells. Scale bars correspond to 
10 µm.  
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Figure 6.11 - Analysis of the cell-substrate interface of hGAAP knockdown cells 
using interference reflectance microscopy. U2OS cells were transfected with the 
indicated siRNAs for 24 h. After this time the cells were detached and allowed to 
reattach for 12 h to glass-bottom dishes pre-coated with fibronectin. Cells were fixed, 
stained with phalloidin and kept in PBS. IRM images were acquired and (A) the number 
of adhesions per cell and (B) the average adhesion size values were calculated for > 
20 cells for each condition. Data are represented as mean ± SEM. Data were analyzed 
using the Student’s T-test and is represented as * p<0.05 and **p<0.01 compared to 
the control siRNA transfected cells. 
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Figure 6.12 - FAK activation (phosphorylation on Tyr 397) correlates with focal 
adhesion number per cell. U2OS cells in which hGAAP was knocked down by siRNA, 
were seeded on fibronectin-coated coverslips. (A) Cells were immunostained for 
pTyr397 FAK and for talin using specific Abs. Scale bars correspond to 5 µm. (B) Cells 
were also seeded for immunoblotting with anti-pTyr397 FAK Ab and anti-FAK Ab. Actin 
was used here a loading control. * Corresponds to the full length FAK band. The 
position of size markers in kDa is shown on the left of the gel.  
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6.8 hGAAP overexpression increases focal adhesion 
turnover and hGAAP knockdown reduces it 
 All the data obtained up to this stage pointed to a possible altered focal 
adhesion dynamics due to hGAAP overexpression or knockdown. To investigate this 
hypothesis, focal adhesion duration measurements were performed to determine if 
hGAAP was having any effect on focal adhesion turnover rate. To achieve this GFP-
vinculin was used as a marker for focal adhesion in live cell imaging recordings. Cells 
were allowed to spread in fibronectin-coated glass-bottom dishes for 30 min and after 
this time cells were imaged by confocal microscopy for 2 h and the duration of newly 
formed focal adhesions was determined. Focal adhesions in hGAAP overexpressing 
cells had a shorter duration compared to focal adhesions found in neo or hGAAP Ctmut 
cell lines (Figure 6.13A and B). This is a reflection of an increased turnover rate of focal 
adhesions. In cells where hGAAP was knocked down the opposite effect was 
observed, and focal adhesions lasted for longer (Figure 6.14A and B). This means that 
the focal adhesion turnover was decreased in these cells. The differences observed in 
focal adhesion turnover rate could be due to either changes in disassembly or 
assembly rates or both. 
 Levels of endogenous vinculin in all cells used were determined by immunoblot 
to control for possible differences in vinculin levels that could influence the focal 
adhesion dynamics results. No differences in endogenous vinculin protein levels were 
observed for all the cells tested (Figure 6.13C and 6.14C). 
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Figure 6.13 - hGAAP overexpression reduces focal adhesion duration. (A) The 
indicated U2OS cell lines were transfected with GFP-vinculin for 18 h and reseeded in 
fibronectin-coated glass-bottom dishes for 30 min. After this period, an individual cell 
was imaged for 2 h for newly formed focal adhesions. Representative frames from 
time-lapse sequences used to quantify focal adhesion duration are shown. Arrows 
point to representative adhesions for each cell line. Scale bars correspond to 10 µm. 
(B) Data shown represent the mean duration of focal adhesions per cell ± SEM (n=6 
cells, with 4-10 focal adhesion per cell). Data were analyzed using the Student’s T-test 
and is represented as *** p<0.001 for comparison to the neo cells. (C) Immunoblot 
showing endogenous levels of vinculin in the different cell lines used. The position of 
size markers in kDa is shown on the right of the gel. 
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Figure 6.14 - hGAAP knockdown increases focal adhesions duration. U2OS cells 
were transfected with the indicated siRNA for 20 h and with GFP-vinculin for another 
16 h. After being seeded on fibronectin-coated glass-bottom dishes for 30 min an 
individual cell was imaged for 2 h for newly formed focal adhesions. (A) Representative 
frames from time-lapse sequences used to quantify focal adhesion duration are shown. 
Arrows point to representative adhesions for each cell line. Scale bars correspond to 
10 µm (B) Data shown represents the mean duration of focal adhesions per cell ± SEM 
(n=6 cells, with 4-10 focal adhesion per cell). Data were analyzed using the Student’s 
T-test and is represented as ** p<0.01 or *** p<0.001 for comparison to the control 
siRNA transfected cells. (C) Immunoblot showing endogenous levels of vinculin after 
treatment with different siRNAs. The position of size markers in kDa is shown on the 
right of the gel. 
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6.9 Calpain2-dependent talin cleavage following 
overexpression or knockdown of hGAAP 
 One of the key regulators of focal adhesion turnover is calpain2 (Guroff, 1964). 
This Ca2+-activated protease controls focal adhesion disassembly and assembly by 
cleaving components of the focal adhesion such as talin, FAK, or paxillin (Franco et al., 
2004a; Franco et al., 2004b). Calpain2 is highly dependent on Ca2+ for its activation 
and is regulated by intracellular Ca2+ levels among other factors. Given its important 
function in focal adhesion dynamics and its dependence on Ca2+, it seemed to provide 
a possible link between hGAAP and cell adhesion. 
 The variety of sequences and factors affecting calpain2 proteolycic cleavage 
makes the establishment a consensus sequence for calpain2-specific cleavage difficult 
(Tompa et al., 2004). This fact has hampered the development of a reliable and 
specific assay to analyse calpain2 activity in vivo. Due to this fact, calpain2 dependent 
talin cleavage was analysed by immunoblot as an indirect measurement of calpain2 
proteolytic activity in focal adhesions.   
 Using two different antibodies that recognize each of the two cleaved portions of 
talin, the N-terminal / head domain and C-terminal / rod domain (Figure 6.15A), the 
levels of cleaved talin were assessed in hGAAP overexpression or knockdown 
conditions. Cells overexpressing hGAAP, or in which hGAAP was knocked down by 
siRNA, were seeded for either 2 days or 30 min. Control cells were treated with ALLM, 
a specific calpain2 inhibitor (Franco et al., 2004b). Unfortunately, the calpain inhibitor 
ALLM was not very effective at inhibiting cleavage in these cells under the conditions 
used in this assay. However, in cells expressing hGAAP, but not in cells expressing 
hGAAP Ctmut, differences were seen in the levels of cleaved talin. There was a very 
modest increase in the levels of the talin cleaved rod portion 30 min after seeding 
(Figure 6.15B). There was also a more clear increase in the levels of the talin cleaved 
head after 30 min. No differences were seen in any of the 2 days post seeding samples 
as the levels of cleaved talin were very low.  
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Figure 6.15 - hGAAP overexpression has a modest effect on calpain2-dependent 
proteolytic cleavage of talin. (A) Schematic representation of talin and calpain2 
cleavage site between talin amino acid 433 and 434 (Franco et al., 2004b). (B) U2OS 
cells expressing hGAAP or hGAAP Ctmut or (C) transfected for 36 h with hGAAP 
specific siRNAs were seeded in fibronectin-coated wells for 2 days or for 30 min. 
ALLM-treated cells were incubated with the peptide for 1 h at 50 µm, before being 
collected for immunoblot. Cell lysates were prepared and resolved by SDS-PAGE. 
Membranes were immunoblotted using an anti-talin-head (N-terminal) or anti-talin-rod 
domain (C-terminal) specific Abs. An immunoblot for actin was used as a loading 
control. * Indicates cleaved talin (head and rod) specific bands. The top bands in both 
talin immunoblots correspond to full-length talin. The position of size markers in kDa is 
shown on the left of each gel. 
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 A more striking difference was observed when cells were transfected with 
hGAAP siRNA1. In this case the levels of cleaved talin, were clearly reduced when 
compared to the control siRNA (Figure 6.15C). This was observed for both the head 
and the rod portions of the protein. An anti-actin Ab was used as a control for protein 
content of the samples and although a difference could be observed between the post 
30 min and the post 2 days seeding samples, no difference can be detected within the 
post 30 min or within the post 2 days samples. 
 
6.10 Summary 
 hGAAP overexpression led to an increased cell adhesion phenotype in U2OS 
and HeLa cells. This was analysed further in U2OS cells and showed that this was 
accompanied by an increased number of focal adhesion sites. These data were 
supported by the use of an hGAAP mutant in which the charged residues at the C 
terminus were mutated to alanines and which was shown to be unable to modulate the 
Ca2+ content of the intracellular stores or inhibit apoptosis. The focal adhesions from 
hGAAP overexpressing cells were smaller and had a higher turnover rate than the 
ones found in control cells. In contrast, cells in which hGAAP expression was knocked 
down by siRNA showed the opposite effects and in addition these cells showed a very 
elongated morphology. A plausible explanation for some of these observations is that 
calpain2 is less active in cells where hGAAP was knocked down and that this leads to 
reduction in focal adhesion turnover and adhesion. The reduced levels of calpain2-
dependent talin cleavage observed upon hGAAP knockdown supported this 
hypothesis, although this requires further confirmation by testing other targets of 
calpain2 proteolysis and possibly by using one of the calpain2 specific activity assays 
that are currently being developed with some success.  
 These observations allowed us to propose a model whereby hGAAP 
overexpression would decrease the amount of Ca2+ stored in intracellular stores due to 
the release of Ca2+ from the stores and could also stimulate the entry of extracellular 
Ca2+ regulated by store-operate Ca2+ entry mechanisms, these were shown to play an 
important role in adhesion regulation (Varnai et al., 2009; Yang et al., 2009). Increased 
release of Ca2+ could increase the activity of calpain2, which requires Ca2+ for its 
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activity. With more active calpain2, the elements of the focal adhesions that depend on 
calpain2 for disassembly could be more easily cleaved. This would promote focal 
adhesion disassembly, which could account for the increased numbers and turnover 
rate of the focal adhesions found in hGAAP overexpressing cells. In turn hGAAP 
knockdown would result in reduced focal adhesion turnover and therefore resulting in 
reduced cell adhesion and spreading.  
 The cell migration results obtained using the WHA do not necessarily fit the 
increased focal adhesion turnover and the increased calpain2 activity caused by 
hGAAP overexpression. This is because the knockdown of calpain2 by siRNA is known 
to cause cells to lose motility and to increase adhesion. This result could be due to 
several factors such as the absence of fibronectin to drive focal adhesion formation and 
the fact that this assay only allows the measurement of unidirectional, and not 
multidirectional, migration. Further experiments looking at single cell migration in 
fibronectin-coated dishes or chemotaxis driven migration would be valuable and help 
determine if the results found using the WHA are or are not consistent with the 
proposed model. 
 The mechanism by which hGAAP is increasing cell adhesion remains 
incompletely defined and it might be more complex than expected due to Ca2+ central 
and sometimes apparently contradictory roles in many cell adhesion, migration and 
spread processes. Investigating not only the role of calpain2 in this phenotype but also 
exploring the possible effects in the actin cytoskeleton dynamics or the distribution and 
activity of small GTPases could lead to a better understanding of the mechanism 
behind hGAAP effects on cell adhesion and focal adhesion dynamics. 
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 Chapter VII 
 Discussion and future work 
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 The study of virus-host interactions and the mechanisms that the host and virus 
develop to counteract each other’s actions has led to important findings regarding 
cellular processes. Viruses can exploit the cellular machinery to their own purpose and 
at the same time they are forced to counteract the host cell responses. Different 
viruses use different strategies to avoid host defence mechanisms, which ultimately try 
to abort the initial infection, and thus prevent the completion of the virus life cycle and 
the spread of the virus to other cells. 
 The study of poxviruses has uncovered a large array of strategies used by 
these viruses to control the host immune response. This has not only revealed the 
importance of different cellular molecules and pathways in antiviral response 
mechanisms and contributed to the characterization and understanding of those 
pathways, but also allowed the identification and characterization of novel cellular 
proteins and processes. A good example came from the study of the CMLV genome 
that led to the identification of gene 6L (later known as vGAAP), that was also found to 
be present in some VACV strains, and was characterized as a Golgi anti-apoptotic 
protein (Gubser et al., 2007). A gene encoding a very similar protein was also identified 
in almost all eukaryotes analysed so far, including mammals, fish, amphibians, plants 
and yeast, showing that it is highly conserved and therefore likely to have some 
important cellular functions. The human equivalent of the viral GAAP protein called 
human GAAP was also shown to be a Golgi anti-apoptotic protein and to share the 
same broad range anti-apoptotic activity as both VACV strain Evans and CMLV vGAAP 
(Gubser et al., 2007). These proteins were included in the TMBIM protein family due to 
their six transmembrane domains, a charged C terminus and the high amino acid 
similarity with the members of this family, in particular with BI-1, the most studied 
member of the family (Reimers et al., 2008). 
 Cell death is one of the most basic and efficient methods that organisms have 
to control an infection in a multicellular host. This innate immune response leads to 
both containment of the pathogen in the apoptotic cell, by preventing the completion of 
the pathogen life cycle and so stopping the production of infectious pathogens and their 
release, and by generating stress signals on the cell surface that can be recognised by 
the immune system cells that will remove the infected cell. Although the role of vGAAP 
in preventing cell death during poxvirus infection is not formally proven due to the 
presence of several other viral genes involved in preventing apoptosis during poxvirus 
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infection, work is being currently done in our lab to address this question using the 
VACV Copenhagen strain 811 that contains large deletions in its genome resulting in 
loss of the anti-apoptotic activity of the virus (Benjamin Johnson, unpublished data) 
(Perkus et al., 1991). Using this approach it will be possible to test if introduction of 
vGAAP will have an anti-apoptotic effect during infection. 
 The fact that GAAPs are highly hydrophobic membrane Golgi proteins and have 
a broad spectrum of anti-apoptotic activity suggested a possible link with Ca2+ because 
this cellular secondary messenger has been show to play an important role in 
apoptosis. This hypothesis was shown to be correct by overexpression and knockdown 
of hGAAP (de Mattia et al., 2009) and vGAAP overexpression (Figure 4.13). Using this 
approach it was shown that hGAAP overexpression could reduce the Ca2+ content of 
both the Golgi and the ER Ca2+ stores, reducing the amount of Ca2+ released upon an 
apoptotic stimuli. These data suggested that the mechanism behind GAAP anti-
apoptotic activity was related to its ability to modulate Ca2+.  It is important to note that 
this link has not been formally proven and it is possible that these are two independent 
functions of the protein.  
 
7.1 Purification of TMBIM family proteins 
 Some of the challenges associated with membrane protein expression, 
purification and crystallization have been overcome in these last decades. The 
development of new and improved methods for the production and purification of 
recombinant mammalian membrane proteins allowed great progress in the 
determination of membrane protein 3D structures (Carpenter et al., 2008; Wagner et 
al., 2006). In an attempt to understand GAAP function and given that no structure is still 
available for other protein from the TMBIM family that could be used as the base to 
model GAAP structure, we attempted to express and purify GAAP with protein 
crystallization and structure determination as the long-term goal. The production of 
purified protein would also allow biochemical characterization, such as oligomeric state 
determination, and the use of functional in vitro assays to further our knowledge on 
GAAP function. 
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 Using a panel of different TMBIM alleles, AtGAAP3, CMLV vGAAP, hGAAP, 
hGAAP T88I and BI-1, it was possible to produce and purify CMLV vGAAP, AtGAAP3 
and BI-1 using a yeast-based method to produce recombinant proteins with C-terminal 
GFP-8His tags (Drew et al., 2006). After the production, subcellular localization 
(membrane targeting), protein size, detergent solubility and monodispersion after 
detergent solubilisation were assessed it was decided that vGAAP, AtGAAP3 and BI-1 
were good targets to attempt protein purification. The use of GFP fluorescence to 
monitor protein levels, subcellular localization, detergent solubility efficiency, 
monodispersity and binding to nickel resin efficiency allowed the step-by-step 
optimization of the production and purification protocol. These optimizations included 
testing of different additives to the yeast cultures in an attempt to improve protein 
expression, different detergents used for protein solubilisation from membrane extracts, 
and different protein binding to nickel resins methods to improve binding efficiency and 
protein recovery.  
 Using the final optimized protocol it was possible to produce and purify CMLV 
vGAAP using LDAO in sufficient amounts and purity to attempt crystallization trials 
using a protein concentration of 10 mg/ml. However none of the tested MemGoldTM 
ICL6 and ICL9 crystallization buffer conditions (Molecular Dimensions under license 
from Imperial College of Science Technology & Medicine, London, (Newstead et al., 
2008)) at 4 °C or 20 °C allowed the development of any visible protein crystals. 
Although these preliminary results were discouraging, many more conditions could be 
tested to achieve the production of protein crystals, including the testing of different 
protein solubilising detergents to reduce protein aggregation and increase protein 
stability, different protein concentrations, and other crystallization buffer conditions. 
Although our initial favourite target for protein crystallization and 3D structure 
determination was vGAAP, the purification of AtGAAP3 revealed that this protein was 
more stable, as shown by stability assays performed at 4 °C and 20 °C (Figure 3.8), 
and purer when compared with vGAAP, making this a much more attractive target for 
protein crystallization attempts. 
 As stated above, further optimizations on the protein purification protocol and 
the crystallization conditions, including the screening of more detergents and buffer 
conditions, are probably required to obtain higher amounts of more stable, less 
aggregated and more highly purified protein samples. Other approaches to allow 
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protein crystallization of TMBIM members could include the testing of other TMBIM 
alleles including the related yeast protein Ybh3p (Buttner et al., 2011). It was clear from 
our small screen that the only plant GAAP tested, AtGAAP3, was a lot more stable and 
easy to purify when compared to viral or mammalian proteins, suggesting that other 
plant GAAPs could be tested. Given the high degree of conservation of these proteins, 
it is likely that an elementary function (such as ion channels or transporters) and 
structure are conserved within the family (Hu et al., 2009), making this a possible good 
structure upon which vGAAP, hGAAP and other TMBIM members could be modelled. 
 In addition to structural studies the purified proteins proved to be useful 
reagents for biochemical and functional characterization. Size exclusion 
chromatography and non-reducing SDS-PAGE analysis of purified vGAAP and 
AtGAAP3 provided some hints to its oligomeric state. Several protein bands could be 
detected in a SDS-PAGE analysis, that in the case of vGAAP were all positive in an 
immunoblot analysis using an anti-GAAP Ab (Figure 3.5D); and several peaks were 
observed when the purified proteins were subjected to SEC analysis. Based on all the 
in vitro data collected for purified vGAAP and AtGAAP3 it was hypothesised that these 
proteins were oligomers (possibly including tetramers, see bellow). Using transient or 
stable expression of vGAAP and hGAAP in mammalian cells oligomers could also be 
detected (discussed in more detail in 7.3). By immunoblotting, the anti-GAAP Ab 
detected the monomer signal much better than any of the other oligomeric forms, 
although the levels detected with a Coomassie stain were not so strikingly different. 
This may be because the epitope recognised by the Ab (N-terminal region) might be 
less accessible due to oligomerization, given that the oligomerization domain was 
mapped to this region. Further biochemical characterization of GAAPs might arise from 
the use of techniques such as circular dichroism (Kelly et al., 2005) or SEC coupled to 
multi angle light scattering (MALS) that could provide important information regarding 
alpha-helix content or oligomeric state of these proteins, respectively. Both techniques 
were attempted using the purified protein samples, but with inconsistent results. 
Further optimizations of the purification protocol would generate more stable and pure 
protein, which could then be subjected to such tests and provide important biochemical 
information.  
 The most important finding regarding GAAP function was obtained by the use of 
purified vGAAP and AtGAAP3 in artificial lipid bilayer patch-clamp experiments. It was 
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shown that both proteins allowed passage of ions when reconstituted in an artificial 
lipid bilayer. This property was also observed for BI-1 confirming recently published 
data that suggests that BI-1 has ion exchanger (Ahn et al., 2009; Ahn et al., 2010; Yun 
et al., 2011) or ion channel (Bultynck et al., 2011) activity and is further discussed in 
7.2. 
  
7.2 GAAP is an ion channel  
 Previous data from our lab suggested a possible link between the Ca2+ 
modulation function of hGAAP and the IP3R. The hypothesis that hGAAP Ca2+ 
modulation was occurring through IP3R regulation was supported by both co-IP found 
between hGAAP and IP3R and also by the fact that hGAAP could modulate IP3-
dependent Ca2+ release (de Mattia et al., 2009). Studies with other proteins involved in 
apoptosis regulation such as Bcl-2 (Rong et al., 2008) and Cyt c (Boehning et al., 
2003) suggested that IP3R Ca2+ release modulation by apoptosis regulatory proteins 
was indeed a recurrent phenomenon, making it an even more attractive hypothesis.  
 However, a thorough investigation of the IP3R and vGAAP interaction showed 
that this observation was non-specific and therefore most likely due to an artefact of the 
immunoprecipitation technique used. Notably, no specific interaction was detected 
when the region of IP3R involved in binding vGAAP was attempted to be mapped. This 
strengthened the alternative theory that GAAP could allow Ca2+ to flow out of the Golgi 
by functioning itself as an ion channel or as an exchanger. Using purified CMLV 
vGAAP, AtGAAP3 and BI-1 from yeast cultures this second hypothesis was tested and 
data obtained (in collaboration with Prof. Colin Taylor laboratory, University of 
Cambridge) showed that all these proteins, but not a control protein (Adenosine A2 
receptor) purified from yeast by a very similar process, showed ion channel-like activity 
in artificial lipid bilayers when subjected to different voltages that created an artificial 
membrane potential (Figure 4.5). It is important to highlight that although GAAP 
induced openings detected in these experiments that correspond to an ion channel-like 
activity, these observations are also compatible with activity from a constitutively open 
ion exchanger, because this would behave as an ion channel in these conditions. The 
biggest caveat of this experiment is that if GAAPs co-purify with another yeast protein 
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that has ion channel activity we could be detecting that activity and not GAAP specific 
ion channel activity. This was improbable given that Adenosine A2 receptor that was 
expressed in yeast and purified in a very similar manner did not give ion channel 
activity. In addition, preliminary data obtained by Guia Carrara showed that the single 
channel opening amplitudes of CMLV vGAAP, AtGAAP3 and BI-1 at a given 
membrane potential applied to the bilayer are not the same. This suggests that the 
conductivity of the protein responsible for the openings in the three purified proteins 
samples is different, making the presence of a common contaminant that is responsible 
for the openings even less likely.   
 To further support data obtained with the artificial bilayer recordings, site 
directed mutagenesis of amino acid residues found to align with other known ion 
channels or exchangers and to be conserved within the TMBIM4 family was carried out 
so that a mutant with altered conductivity (altered current-voltage regression slope) 
could be found and so the ion channel-like activity could be directly linked to GAAP. So 
far all the mutants have been generated and tested for biochemical and subcellular 
properties. The function of these mutant vGAAPs was tested using the two functional 
assays available for GAAP: Ca2+ storage content release and anti-apoptotic activity. 
This allowed us to narrow down the number of mutants to purify and eventually test for 
ion channel activity in artificial lipid bilayers. Using this approach and taking in 
consideration the protein amino acid alignments with other ion channels and 
exchangers performed, a small number of mutants were selected and are being 
currently purified and tested for ion channel activity by Guia Carrara. This approach 
can also bring important information on both ion gating and ion selectivity because it 
can contribute to the identification of the key residues involved in the pore and filter 
formation.  
 One question still unanswered about GAAP ion channel activity is its gating 
mechanism. It was proposed for BI-1 that it could be a leaky channel and function as a 
“safety valve” for Ca2+ content of the ER, therefore it is possible to speculate that GAAP 
might have the same function in the Golgi. This hypothesis could explain the effects 
observed in intracellular store Ca2+ content upon hGAAP and vGAAP overexpression 
and upon hGAAP knockdown (de Mattia et al., 2009).  
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 Given that vGAAP and hGAAP can modulate Ca2+, the presence of a highly 
conserved charged acidic sequence motif (4x COO-) closer to the C terminus of all 
GAAPs tested (Figure 4.8), that could fulfil the needs of a Ca2+ filter, the presence of 
Ca2+ in the artificial bilayer experiment buffer, and the recent finding that a peptide 
corresponding to the BI-1 C terminus is capable of allowing Ca2+ to flow across a lipid 
bilayer (Bultynck et al., 2011), we can speculate that GAAP might allow the flow of Ca2+ 
from the Golgi. This hypothesis is further supported by the finding that a highly 
conserved amino acid residue present in both BI-1 and GAAP (vGAAP D219) was 
shown to be absolutely essential for BI-1 Ca2+ channel activity (Bultynck et al., 2011). 
The ion channel selectivity could be investigated by different techniques using pure 
protein reconstituted in either lipid bilayers and using different buffers with different ions 
present or by using GUVs loaded with a Ca2+ indicative dye. This would be very 
important to allow a more complete understanding of GAAP function. 
 We can also speculate on the conservation throughout evolution of GAAP and 
BI-1 ion channel activity, because while a plant GAAP did show this same activity, a C-
terminal peptide of a plant BI-1 was not able to do so (Bultynck et al., 2011). Recently 
the TMBIM4 subfamily was proposed as the ancestral gene for some of the TMBIM 
family genes (Hu et al., 2009). It would be very interesting to investigate the level of 
conservation of GAAP ion channel-like activity not only within the TMBIM4 genes but 
also within the whole TMBIM family. 
   
7.3 GAAP is able to form tetramers 
 Most proteins capable of selective ion transport across the membrane (mostly 
ion channels and ion transporters) show either oligomerization or homologous repeat 
domains (Kew and Davies, 2010). In a very crude and simplistic analysis we can say 
that most ion channels tend to form tetrameric structures while ion exchangers can 
assemble into different oligomeric structures that can improve but are not absolutely 
required for function in some cases (Gadsby, 2009; Kew and Davies, 2010). The 
findings that both hGAAP and vGAAP can oligomerize, and possibly form dimeric or 
tetrameric structures are consistent with the findings that GAAP is an ion channel or an 
ion exchanger. The most abundant oligomeric form of GAAP found in SDS-PAGE 
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analysis, even when the protein is crosslinked, is the dimer. Although tetrameric GAAP 
is also found, it represents only a small fraction of the total protein and the 
physiological relevance of each of GAAP’s oligomeric forms is still not fully understood.  
However, this may be a consequence of limitations in the SDS-PAGE technique. 
 The observation that the levels of oligomeric GAAP (dimers, trimers and 
tetramers) increased at higher pH suggest a possible regulation mechanism equivalent 
to that proposed for human BI-1 (Kim et al., 2008) and for other ion exchangers such 
as the Helicobacter pylori HPNhaA (Taglicht et al., 1991), in which an increase in pH 
would allow GAAP to oligomerize and form a functional ion channel or a more efficient 
ion exchanger. So far no other regulation mechanism has been proposed for GAAP. 
Moreover purified vGAAP and AtGAAP3 were shown to be constitutively active when 
an artificial membrane potential was applied in artificial lipid bilayer ion channel activity 
experiments because neither required any agonist to allow the channel to open. The 
measurement of ion channel activity, the Ca2+ content of intracellular stores and anti-
apoptotic activity of monomeric vGAAP (with both cysteine 9 and 60 mutated to 
serines) would show if GAAP dimerization/oligomerization is required for its known 
functions and activities. These two cysteine mutations combined render vGAAP unable 
to form dimers or other higher oligomeric forms in all the techniques used to assess 
dimerization and oligomerization, so if GAAP function is highly dependent on 
oligomerization it should be greatly affected by the loss of oligomerization ability. These 
data could also provide valuable evidence to determine if GAAP is an ion channel or an 
ion exchanger because a monomeric protein is unlikely to be an ion channel while a 
monomeric ion exchanger might be just less efficient in conducting ions across the 
membrane than the natural oligomer.  
 vGAAP, but not hGAAP dimerization was shown to be dependent on disulphide 
bounds which confirmed that the N-terminal region in vGAAP is important for 
oligomerization. We can speculate that the different oligomerization mechanisms found 
in hGAAP and vGAAP could be related to a functional regulation because a more 
stable vGAAP dimer could mean that the protein is more likely to be active, even in the 
context of viral infection when numerous cellular processes are altered.  
 The fact that tetramers are visible when the protein is crosslinked and analysed 
by non-reducing SDS-PAGE suggests that this could be GAAPs physiological 
     
 
             193 
 
oligomeric state, but further evidence is required to confirm this hypothesis because 
this oligomeric form represents only a small fraction of the total protein when analysed 
by non-reducing SDS-PAGE. We are currently using single molecule photobleaching of 
GFP-tagged GAAP to assess the protein stoichiometry more accurately. This technique 
was used successfully to solve the stoichiometry of other channels such as the CRAC 
channel (Penna et al., 2008). 
  The presence of trimers when the protein is crosslinked does not support the 
dimer-of-dimers mechanism for tetramerization that is common in ion channels 
(Demuro et al., 2011; Tichelaar et al., 2004; Tu and Deutsch, 1999). However, the 
presence of putative trimeric GAAP in non-reducing SDS-PAGE analysis could be due 
to an artefact of the technique; further experiments, such as the single molecule 
photobleaching of GFP-tagged GAAP, are required to confirm and explore the 
physiological relevance of this GAAP form.  
 
7.4 hGAAP increases cell adhesion 
 Simple measurements of the ability of cells either overexpressing or knocked 
down for hGAAP to adhere to a solid support, to remain attached during EDTA 
treatment, and to spread showed that hGAAP overexpression led to an increased cell 
ability to adhere to the substrate. Conversely, hGAAP knockdown reduced cell 
adherence. Increased adherence was associated with a reduced size and increased 
number of focal adhesions when hGAAP was overexpressed, and the converse 
following hGAAP knockdown. These observations were further supported and 
explained by the fact that hGAAP overexpression lead to an increase in focal adhesion 
sites turnover rate while hGAAP knockdown reduced turnover rate and decreased the 
levels of FAK activation. Collectively these data suggest a hypothesis in which hGAAP 
overexpression drives focal adhesion disassembly. The observation that hGAAP 
overexpression increased the cell migration rate in a wound healing assay are difficult 
to explain in this model. This result needs further confirmation with other cell migration 
assays where one can analyse single cell random migration velocity because a wound 
healing assay can only measure unidirectional migration of the cells. Random migration 
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assays and chemotaxis assays will be required to determine accurately the ability of 
the cells to migrate and to respond to directional cues, respectively.  
 Considering the role of hGAAP in Ca2+ modulation, and in light of the results 
that suggest that GAAPs are ion channels, two possible consequences for Ca2+ can be 
suggested. Because there is less Ca2+ in the intracellular stores of a cell 
overexpressing GAAP, as shown by de Mattia et al. (2009), it is conceivable that there 
could be less Ca2+ available to be released to activate effectors in the cytoplasm upon a 
stimulus. Alternatively, the reduced levels of Ca2+ in the intracellular stores would lead 
to the activation of store operated Ca2+ entry, that might lead to a localized increase of 
Ca2+ concentration near the plasma membrane from the extracellular medium. 
Interestingly, it was shown that store operated Ca2+ entry plays an important role in 
breast tumour cell migration and metastasis (Yang et al., 2009). 
 Given hGAAP’s role in Ca2+ modulation (de Mattia et al., 2009) and the effects 
observed in focal adhesion turnover upon hGAAP overexpression and knockdown, we 
began to investigate calpain2 as a possible link between Ca2+ modulation and cell 
adhesion. Calpain2 is dependent on Ca2+ for its activation and its proteolytic activity is 
required for focal adhesion disassembly (Franco and Huttenlocher, 2005). To 
investigate if hGAAP was affecting calpain2 activity the levels of cleaved talin following 
hGAAP overexpression and knockdown were measured as a proxy for calpain2 activity 
at the focal adhesion complexes. Talin is the best described and characterized 
calpain2 substrate and the functional consequences of this proteolytic cleavage are 
essential for adhesion site disassembly and the promotion of adhesion site turnover 
(Franco et al., 2004b). Initial attempts to determine the cleavage levels of this protein 
suggest a possible role for hGAAP in activating calpain2 activity because when hGAAP 
was knocked down the levels of cleaved talin were reduced, while when hGAAP was 
overexpressed slightly higher levels of cleaved talin were detected. More proteolytic 
targets of calpain2 need investigation and specific calpain2 activity assays need to be 
explored, but these preliminary results point to a possible link between hGAAP and 
calpain2 activation as shown in Figure 7.1.  
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Figure 7.1 – Factors affecting adhesion assembly and disassembly in a migrating 
cell – hypothetical model for the role of hGAAP in cell adhesion. At the leading 
edge new adhesions are formed and matured, and this is modulated mainly by integrin 
binding to the ECM proteins and secondarily by small Rho GTPases. At the rear of the 
cell the mature adhesions are disassembled to allow the cell to migrate forward. This 
process is regulated by a series of cellular factors including calpain2 cleavage of 
adhesion components such as talin or FAK. We hypothesise that hGAAP might be 
involved in the activation of calpain2 leading to an increase in adhesion turnover by a 
mechanism still unknown. Adapted from Frame et al. (2002). 
 
 
 Although calpain2 seems an attractive link between modulation of Ca2+ and cell 
adhesion by hGAAP, other routes are possible. Many links between adhesion/migration 
and Ca2+ have been established and were introduced in some detail in section 1.6.3 of 
this thesis. To explore the mechanism by which hGAAP regulates cell adhesion 
thoroughly some of these links must be investigated. hGAAP, neo and hGAAP Ctmut 
U2OS cell lines have been engineered to express Lifeact-GFP, a GFP-tagged peptide 
that binds and acts as a marker of F-actin in live cells without affecting its assembly 
and disassembly dynamics (Riedl et al., 2008), to explore GAAPs possible impact on 
actin dynamics. Another group of important molecules that regulate the focal adhesion 
turnover process are the small GTPases and these are also regulated directly and 
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indirectly by Ca2+ (introduced in section 1.6.3.2) and are responsible for establishing a 
link between mechanosensitive ion channels at the plasma membrane, integrin 
activation, ER Ca2+ release, calpain activation and adhesion (McHugh et al., 2010). 
 Given the role of hGAAP on adhesion and previously published data that 
hGAAP mRNA levels are upregulated in some human cancers (van 't Veer et al., 
2002), it is possible that hGAAP might play a role in metastatic cells, which show an 
increased adhesion to the extracellular matrix (Klein, 2008). Moreover another member 
of the TMBIM family, BI-1, can enhance cancer metastasis in a mouse model (Lee et 
al., 2010b) and cell adhesion (Lee et al., 2010a). Cell adhesion control represents a 
very important and attractive target for the development of drugs that aim to control 
cancer spread and metastasis formation (Ko et al., 2010; Li and Feng, 2011). In this 
context, a more detailed knowledge of hGAAP role in cancer and metastasis could 
provide a new putative target for drug development. 
 
7.5 Open questions on GAAP 
 Many aspects of GAAP function and its relevance for both cellular and viral 
processes are still not fully understood. The degree of amino acid sequence 
conservation found in GAAPs from all eukaryotes identified so far points to a possible 
highly conserved and essential function for these proteins. The fact that hGAAP was 
shown to be an essential protein without which cells die (Gubser et al., 2007) further 
supports this theory. Also it was found in our lab that some prokaryotic proteins shared 
some amino acid similarity with hGAAP (Benjamin Johnson, unpublished data) adding 
to the growing body of data showing that GAAPs are indeed very ancient and important 
proteins.  
 There are still many unanswered questions about the role of GAAPs in cellular 
and viral processes but the most important task at this stage is to determine if the ion 
channel activity of GAAP is related to its ability to modulate the Ca2+ content of 
intracellular stores, and if this function is directly linked to cell protection from apoptotic 
stimuli by GAAP. Other secondary questions on virus-induced cell motility or in cancer 
development are still unanswered and will be crucial to fully understand the role of both 
cellular and viral GAAPs. 
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7.6 Summary 
This study has increased knowledge of the GAAPs (TMBIM4) function and 
biochemical characteristics. Using yeast to express and produce several GAAPs 
enough purified protein was produced for basic biochemical characterization and for 
functional assays. The finding that vGAAP and AtGAAP3 can show ion channel-like 
activity in artificial lipid bilayers suggests that this might be a conserved function among 
the GAAP family. Furthermore characterization of the oligomeric state of GAAP 
suggests the formation of tetramers that is consistent with ion channel-like activity for 
GAAP. vGAAP, but not hGAAP, oligomerization is dependent on cysteine residues 
located at the N terminus of the protein. hGAAP was also shown to have a role in cell 
adhesion, although the mechanism by which hGAAP leads to an increased cell 
adhesion and increased adhesion turnover rate is still unclear and requires further 
investigation.  
To understand more fully how both vGAAP and hGAAP function, and their 
relevance for viral and cellular processes, the possible links between anti-apoptotic, 
Ca2+ modulation, ion channel-like activity and cell adhesion, need to be explored to 
understand if these functions are interdependent or not (Figure 7.2). The high degree 
of conservation of this protein family throughout evolution and the various cellular 
processes modulated by hGAAP and vGAAP make these valuable tools to explore new 
possible links between apoptosis, Ca2+ modulation and cell adhesion. 
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